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The immune system utilizes a plethora of antimicrobial effectors to ensure efficient
microbial eradication. This dissertation focuses on two of these effectors: antimicrobial
peptides (AMPs) and copper ions. The work described here examines both fundamental
and translational aspects of AMPs that contain the amino terminal copper and nickel
(ATCUN) binding unit. The first section details our efforts to define the contribution of the
ATCUN motif to the biological activity of peptides that are expressed in nature containing
the metal binding sequence. In chapter 2, we show how the metal is utilized by an
ATCUN-containing AMP to bring about copper-mediated membrane lipid oxidation. This
activity, in turn is utilized by a homologous peptide to achieve synergistic interactions that
involve oxidized lipid targeting. In chapter 3, we show the first example of an AMP that
can oxidatively cleave microbial DNA in a copper-dependent fashion. This nuclease
activity is intimately linked to its expression profile and to that of a homologous, yet
mechanistically distinct peptide. These two AMPs show complementary effects
associated with oxidation of varying targets in bacteria. The oxidative stress generated
by ATCUN-AMPs lead us to speculate that a similar mode of attack can be imparted to
other therapeutically relevant peptides. Therefore, our goal in the second section was to
generate novel ATCUN-based antibiotics. In chapter 4, we appended the ATCUN motif

Mark Daben J. Libardo, University of Connecticut, 2017

to membrane-targeting AMPs and in chapter 5, added it to an oligonucleotide-binding
peptide. We observed that for both instances, a gain-of-function phenotype resulted from
the exogenous addition of the metal-binding sequence, and that microbial killing was
directly related to the oxidative activity of the conjugates. Finally, in chapter 6, we
developed an ATCUN-based peptidomimetic that can target intracellular Mycobacterium
tuberculosis. We reasoned that antibiotics of this nature can exploit the differential
trafficking of transition metals during infection, be activated in situ by copper in the cellular
milieu and target pathogenic bacteria that evolved to evade the metal’s toxic effects.
Overall, this work highlights the biological importance of ATCUN-containing AMPs and
expands the catalog by which these peptides utilize transition metals for their activity.
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Chapter 1

General Introductions
On Antimicrobial Host-Defense Peptides, Transition Metal Ions
and the Innate Immune Response that bring them together

1

Antimicrobial and Host-Defense Peptides
Considered as one of nature’s oldest forms of antibiotics, antimicrobial peptides
(AMPs) play a major role in the innate immune response of virtually all forms of life.1
AMPs are usually short, cationic and amphipathic molecules (enriched with Arg, Lys and
hydrophobic residues) that provide a first line of defense against invading microbes either
via membrane disruption or intracellular targeting.2, 3 To reflect their emerging roles in
regulating the immune response of multicellular organisms, some AMPs have been
characterized as host-defense peptides (HDPs) – a description that highlights the
immunomodulatory, anti-inflammatory, and chemotactic properties observed under
physiological conditions.4, 5 These peptides are classified based on their secondary and
tertiary structural elements forming four major groups (Figure 1.1): a-helical peptides
(constituting the majority of AMPs), b-sheet peptides (stabilized by two or more disulfide
bridges), extended peptides (usually enriched with Gly, Pro, and Trp), and loop peptides
(containing one disulfide bond).6

Figure 1.1 Diversity in Antimicrobial Peptide Structure. Most AMPs are a-helical,
while a small fraction are b-sheets and disordered loops. Helical and sheet AMPs adopt
an amphipathic structure known to be important for membranolytic activity.
2

A significant number of AMPs exhibit a broad-spectrum activity in the low
micromolar to the nanomolar range against bacteria in axenic cultures. While largely not
fully understood, AMPs’ direct cytotoxic ability relies on electrostatic interaction between
cationic

residues

in

its

backbone

with

the

anionic

bacterial

cell

surface

(lipopolysaccharides in Gram-negative bacteria and the wall teichoic acid in Grampositive bacteria).6 It is also believed that this electrostatic complementarity explains the
preference of AMPs to target bacterial over eukaryotic cells, which contain more
zwitterionic components in their membrane.7 After initial attraction to the cell surface,
these peptides relocate to the interfacial region of the bilayer – a process promoted by
their amphipathic nature8 – and disrupt its structural integrity either via transmembrane
pore formation or micellarization of the membrane (Figure 1.2).3 This membranolytic
effect causes leakage of cellular contents (ions, metabolites and even large proteins) and
collapse of transmembrane potential ultimately leading to cell death.

Figure 1.2. Membranolytic Activity of AMPs. Membrane poration occurs via multiple
mechanisms, most notable of which are depicted in this figure. Transmembrane channel,
toroidal pore, or complete micellarization of membranes lead to leakage of cellular
contents to the extracellular environment.

3

An expanding body of evidence show that some peptides are non-membranolytic
and are able to effect intracellular inhibitory mechanisms as the primary mode of bacterial
killing (Figure 1.3).9, 10 These mechanisms include binding to macromolecules like DNA11,
12

and ribosome,13 inhibition of macromolecular synthesis,14, 15 inhibition of enzymatic

activity,16,

17

and perturbation of septum formation.18 These studies challenged the

paradigm that AMPs act solely on the bacterial membrane and highlight the target
promiscuity of this class of antimicrobials. Indeed, it seems like natural selection favored
the evolution of “dirty” antibiotics that target multiple pathways with modest potency rather
than a single high-affinity target for use in the immune response,6, 19 a concept ought to
be adopted by the pharmaceutical industry. Moreover, because AMPs exhibit multiple
levels of inhibition, it requires bacteria to mutate several genes in a concerted fashion
before resistance is acquired. AMPs therefore pose a seemingly logical solution to the
problem of antibiotics being rendered inactive by acquisition of resistance in the field.
Even though resistance is less likely in this class of molecules, reports have shown
bacteria that can tolerate these peptides mostly through expression of non-specific efflux
pumps and/or proteases.20, 21
While largely regarded as antimicrobials that directly kill bacteria, AMP
concentrations in vivo are usually very low (in the ng/mL range) and their cytotoxicity is
usually inhibited by physiological concentrations of salt, and serum components.4 Recent
evidence suggests that the immunomodulatory activity of these peptides might be more
relevant in a physiological setting forging many to use the term HDPs to describe these
peptides (Figure 1.4). HDPs have been shown to (i) modulate the expression of
cytokines,22, 23 (ii) have anti-inflammatory properties by reducing levels of proinflammatory

4

Figure 1.3. Intracellular Targeting of AMPs. Mechanisms not involving membrane
disruption by AMPs are widely studied, the most notable examples are depicted above.
Peptide translocates across the membrane through unknown mechanisms and binds to
targets in the cytoplasm to interfere with key metabolic pathways.

Figure 1.4. Immunomodulatory Activity of Host-Defense Peptides. Some peptides
have other activities besides direct microbial killing. HDPs activate several signaling
pathways in immune cells to modulate the immune response.

5

cytokines,24, 25 (iii) have chemotactic properties and induce immune cell migration,26 and
(iv) promote macrophage and dendritic cell differentiation.27,

28

Furthermore,

dysregulation of HDP expression in certain tissues result in certain pathologies including
autoimmune disease,29 inflammatory bowel disease30 and even cancer.31, 32 Most of these
immunomodulatory properties of HDPs result from interactions with high-affinity and
specific cell receptors which then activate an intracellular signaling cascade.
Even though any given HDP can be polyfunctional, multicellular organisms likely
rely on a plethora of HDPs to mount a quick, effective and amplified immune response –
a paradigm that is becoming more apparent in recent literature. HDPs exhibit synergy
amongst other peptides within their family,33,
endogenous or exogenous antimicrobials.38,

34

39

with other HDPs,35-37 and even with

It seems reasonable to posit that the

success of the immune system against a wide array of microbes arises not only from the
variety of antimicrobial effectors induced during infection, but also the countless possibility
of functional synergy that exist among them.

Transition Metal Ions in the Host-Pathogen Interface
Transition metals are essential micronutrients required for many cellular
processes, but their concentration must be tightly regulated because they are toxic in
excess. To every organism in the biosphere, they represent a double-edged sword –
requiring robust sensing, acquisition and detoxification mechanisms. In biological
systems, the most common transition metals are Fe, Cu, Zn, Ni and Mn. These metals
are frequently found in metalloproteins that function either in redox- and non-redox
catalysis, storage and/or transport, transcriptional regulation, and signal transduction.4042

Because of the essentiality of transition metals, pathogenic microbes have evolved
6

elegant (and sometimes redundant) mechanisms to acquire metals from their host.43, 44
Indeed, this tug-of-war for metals in the host-pathogen interface highlights the host’s effort
to limit microbial growth and the pathogen’s need for survival in a hostile environment.
To prevent infection, the host relies on two major and contrasting strategies
involving distinct groups of metals (Figure 1.5). First, the host limits the availability of iron,
manganese and zinc in regions containing bacteria by expressing high-affinity metalbinding proteins.41,

43, 44

Termed nutritional immunity, this withholding mechanism

effectively starves pathogens of these essential micronutrients.41 In response, bacteria
secrete siderophores – small molecules that bind these metals with high affinity – which
are then subsequently imported and degraded intracellularly to liberate the free metal.45,
46

Second, the host leverages the inherent toxicity of copper and zinc, and deliberately

traffics these metals into sites of infection.47, 48 The sudden increase in concentration of
these toxic metals causes pleiotropic effects (vide infra) that result in microbial killing.47,
49, 50

To counteract this, bacteria express efflux pumps and metal-scavenging proteins to

minimize direct and secondary damage by copper and zinc.47, 51
In

vivo,

bacteria

encounter

physiological

changes

in

transition

metal

concentrations due to the aforementioned host response to infection. Transcriptional
changes in the bacteria showing induction of metal detoxification pathways and
siderophore biosynthesis suggests that perturbation in transition metal trafficking play a
role in microbial death.52 Similarly, bacteria that have defects in iron uptake and copper
detoxification showed decreased host colonization, indicating that these metalresponsive elements are essential to their pathogenicity.53-55
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Figure 1.5. Nutritional Immunity in the Host-Pathogen Interface. Transition metal
concentrations during infections are tightly regulated by the host to starve the invading
microbe of these essential micronutrients. Nutritional immunity involves several hostderived effectors, most notable of which are the S100 proteins which bind to Zn2+, Mn2+
and Fe2+ ions with high affinity.

A Focus on Copper in the Host-Pathogen Interface: Trafficking, Toxicity and
Bacterial Resistance Mechanisms
All organisms require copper for various biological processes but despite its crucial
role, excess copper can become toxic. The antimicrobial effects of copper have been
observed since antiquity, where as early as 2400 B.C., the metal was used to sterilize
water and wounds. In addition, during a cholera outbreak in the early 1800s, workers in
a copper plant in Paris were observed to be less susceptible to the disease.50 Today,
there is a renewed interest in the antimicrobial activity of copper and research into
mechanisms of copper intoxication in biological systems remains a dynamic field. Copper
exists in biological systems either in the Cu+ (reduced) or Cu2+ (oxidized) state. The
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Cu2+/Cu+ couple has a reduction potential of +150 mV which guarantees that the copper
speciation in the cytosol (E0 ~ -220 mV) is tipped towards Cu+.51 While Cu(II) is a
borderline Lewis acid, Cu(I) is a soft acid with a strong preference for thiol-based ligands.
Indeed, the coordination chemistry of copper in biological systems is dominated by
cysteine, methionine, and histidine ligands in the metal’s first coordination sphere.56
Given the anthropologic use of copper as an antibiotic, it’s not surprising that the
immune system utilizes this metal for its bactericidal action as well. Multiple trafficking
mechanisms involving a variety of immune effectors ensure that copper levels in sites of
infection is enriched (Figure 1.6). In phagocytic cells like macrophages, infection triggers
overexpression of copper transporters (Ctr1 and ATP7A) and chaperones (Atox1)
resulting in increased copper uptake.50,

53

ATP7A, a Golgi-resident transporter gets

trafficked into phagosomes and delivers copper into the lumen of bacteria-containing
vesicles. In fact, during Mycobacterium tuberculosis infections, phagosomal copper
concentration was measured to be 25 – 400 µM.57 Extracellular levels of copper increase
during infections as well. Serum copper levels progressively rise during infection,
irrespective of the agent (viral, bacterial, fungal), mainly due to the upregulation of the
cuproprotein ceruloplasmin.58,

59

While the exact reason why this happens is still

unknown, it’s reasonable to assume that ceruloplasmin – which can bind up to six copper
atoms – helps to deliver copper into sites of infection.49 Indeed, granulomas from M.
tuberculosis-infected guinea pigs were found to contain markedly higher copper
concentrations.60 Furthermore, a significant accumulation of copper in the urine of
patients infected with uropathogenic E. coli was also observed.61 Its apparent that
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boosting copper concentration at sites of infections is advantageous due to the metal’s
inherent antimicrobial activity.

Figure 1.6. Copper Trafficking in response to Macrophage Infection. During infection,
macrophages overexpress copper importers (Ctr1 and ATP7A) and chaperones (Atox1)
to increase intraphagosomal copper concentration. The sudden surge of copper ions in
the bacteria cytoplasm elicits multiple toxic effects like inhibition of aerobic respiration and
oxidative DNA damage.

The classical view to the antimicrobial activity of copper is based on its ability to
form deleterious hydroxyl radicals via a Fenton-like mechanism.51 This direct production
of reactive oxygen species (ROS) not only covalently damages multiple biomolecules but
also depletes bacterial antioxidants. Recent evidence show that low molecular weight
thiols (LMWTs) like glutathione (GSH) can bind to and inactivate the cycling of copper
between its +1 and +2 states.62 This makes copper intoxication via direct ROS formation
less likely. Nevertheless, induction of ROS detoxifying genes occurs upon exposure of
bacteria to lethal levels of copper. Recent work shows that bacterial susceptibility to
copper arises from one or any combination of the following mechanisms. First, copper
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can replace cofactors in metalloproteins leading to inactivation of enzymatic activity (for
the case of catalytic metals) or significant structural perturbation (for the case of structural
metals).48 Next, iron-sulfur clusters of metalloproteins collapse following exposure to
copper due to Cu(I) displacement of Fe(II). This liberates free ferrous ions which can then
catalyze the Fenton reaction.63 The first two routes of copper toxicity can largely be
explained by the metal’s position in the Irving-Williams series: Mn(II) < Fe(II) < Co(II) <
Ni(II) < Cu(II) > Zn(II). From a chemical standpoint, donor atoms from proteins
preferentially bind Cu(II) because it yields the highest complex stability.64 Copper can
therefore easily replace less competitive metals in the series. Finally, copper impairs
membrane function by peroxidizing lipids in the bilayer.65, 66

Figure 1.7. Bacterial Evasion Strategies against Copper Intoxication. In response to
the increased copper concentration that the host imposes, bacteria induce multiple
resistance mechanisms. Bacteria express efflux pumps, copper oxidases, and cytosolic
chaperones all acting in concert to detoxify copper.
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Invading bacteria often mount multiple modes of detoxification in response to the
influx of copper ions to sites containing pathogens (Figure 1.7). Copper-responsive
transcription factors in bacteria detect minute changes in cytosolic copper concentration
and activate the expression of genes that function in copper detoxification.67 Membranebound exporters in E. coli, Salmonella, Streptococcus, and M. tuberculosis have been
widely studied (Figure 1.8).51 These efflux pumps utilize energy from ATP hydrolysis or
electrochemical gradients to pump copper from the bacterial cytosol back to the
phagosomal lumen. Bacteria also express protein- or small molecule-based copper
chelators that bind to cytosolic or periplasmic copper.68,

69

In addition, some small

molecules bind to copper and act as enzyme mimics (superoxide dismutase) to minimize
secondary toxic effects of copper.70, 71 Finally, expression of multicopper oxidases that
convert the more toxic Cu(I) to the less toxic Cu(II) act to prevent the Fenton reaction.72,
73

All of these mechanisms work in concert to ensure that concentration of “free” copper

in the cytosol is maintained below picomolar levels.74 While some of these bacterial
defenses are redundant within any single pathogen, some detoxification modes are more
dominant than others. Indeed, bacteria that cannot neutralize the toxicity of copper are
more susceptible to copper-related toxicity of macrophages.53, 60

Antimicrobial and Host-Defense Peptides Utilizing Metal Ions
One way that nutritional immunity is mediated in the host-pathogen interface is
through expression of high-affinity metal chelators by the immune system. Indeed, several
HDPs are known to sequester transition metals, the largest and most characterized of
which are proteins belonging to the S100 family.75 Members of the S100 protein family
(~20 identified and characterized to date) are EF-hand containing, Ca2+-binding
12

Figure 1.8. Copper chaperones in bacteria. Copper is transported into the bacterial
cytosol by uncharacterized importers and are exported by the Cus system. Labile copper
ions exits in the periplasmic space bound to small organic ligands and are converted to
the +2 state by periplasmic oxidases.

polypeptides expressed by higher vertebrates that perform several functions in innate
immunity. Psoriasin (S100A7), expressed by keratinocytes, binds to Zn(II) and is the main
E. coli-killing protein in the skin.76 Calprotectin (S100A8/A9) and Calgranulin (S100A12)
are expressed by neutrophils, monocytes and macrophages; and are secreted in
response to inflammation. Calprotectin binds Zn(II), Mn(II), and Fe(II) while Calgranulin
binds Zn(II) and Cu(II).77-79 In some cases, HDPs bind metal complexes, such is the case
for Lipocalin-2 (Siderocalin). Expressed in neutrophils and macrophages, Lipocalin-2
binds the iron-siderophore complex and interferes with intracellular bacterial iron
13

acquisition.80 Apart from metal withholding, HDPs also utilize transition metals for
structural purposes. Dermcidin, an AMP from human sweat uses Zn2+ to form a trimer of
antiparallel dimers, its active conformation. This hexameric bundle inserts into the
bacterial bilayer and acts as a transmembrane channel dissipating the membrane
potential.81 Furthermore, Zn2+ in the catalytic domain of matrix metalloproteinase 12
(MMP12, macrophage elastase) serves to stabilize the protein tertiary structure. MMP12
binds to bacterial bilayers and causes membrane disruption through its antimicrobial Cterminal domain.82
While largely studied in the context of human infections, transition metal utilization
of HDPs is certainly not unique to vertebrates. For instance, Microplusin from the hard
tick R. microplus was found to sequester Cu2+ likely from terminal oxidases resulting in
inhibition of aerobic respiration.83 Furthermore, Clavanin A from the tunicate Styela clava
was recently shown to use Zn2+ for its antibacterial action, however, the exact mechanism
remains a question.84
Finally, the metal binding sites in the aforementioned HDPs come from residues
belonging to different domains of the polypeptide. There are however, short sequences
that bind to metals directly, and therefore require a shorter primary structure. The Zn2+
binding sequence, His-Glu-X-X-His (HEXXH) is present in histatins – a group of salivary
AMPs known to have fungicidal activities.16, 85 While the exact target and mechanism of
histatins are still subject to debate, its ability to promote mitochondrial dysfunction and
oxidative stress is widely accepted.86
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The Amino Terminal Copper and Nickel (ATCUN) Binding Motif in Peptide and
Proteins
Analogous to the HEXXH sequence in histatins, another short metal binding
sequence is the Amino Terminal Copper and Nickel (ATCUN) binding motif. It consists of
any two amino acids in the first two positions and histidine in the third (i.e. XXH). It binds
to Cu2+ and Ni2+ ions with high affinity through a free amino terminal –NH2 group, two
intervening backbone amide nitrogens (from residue 2 and His3) and the imidazole d-N
from His3 (Figure 1.9).87 The ATCUN motif is found in many copper-binding proteins,
most notable of which are the serum albumins where they are believed to function as
systemic copper shuttles.88 Bound to copper or nickel, the resulting metallopeptide adopts
a distorted square planar geometry optimally poised to bind to the minor groove of DNA.89

Figure 1.9. Schematic Representation of ATCUN-containing AMP. R1, and R2
represent the first and second amino acid residue. Each amino acid is color coded in this
scheme. Cu(II) binds to the N-terminal of ATCUN-containing peptides leaving the Cterminal fragment free.

From a chemical and antimicrobial standpoint, the ATCUN motif is interesting
because it has the ability to form ROS under physiological conditions.90, 91 While most
ligands prevent the redox cycling of metals, the peptidic backbone actually promotes it.
The redox activity involves Cu(II) and Cu(III) species where the trivalent state is stabilized
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by the strong Lewis basicity of the peptide amide nitrogens.91 The reduction potential of
the Cu(III)-ATCUN/Cu(II)-ATCUN couple is >900 mV (vs NHE) making the redox cycling
accessible to biological reductants.91 Indeed, redox cycling of the ATCUN complexes
have been demonstrated using ascorbic acid and NADH.90 While electrochemical
methods have established the oxidation states pertinent to the redox cycling, the nature
and identity of the ROS formed however, is still a topic of debate. The most accepted
form of the ROS is a metal-bound hydroxo group,90 which is chemically distinct from the
canonical hydroxyl radical, •OH. Because this hydroxo species is bound to a heavy
element, it is far less diffusible than •OH; but because it is bound to a more electropositive
atom, it is far more oxidizing. Indeed Cu-ATCUN and Ni-ATCUN complexes have been
demonstrated to effectively oxidize small organic fluorophores, phospholipids and
oxidatively cleave DNA.66, 91, 92
Of direct relevance to this dissertation is the fact that a number of naturallyoccurring AMPs and HDPs contain an ATCUN motif. Notable examples of which are
members of the histatin family. In addition to containing a Zn2+-binding sequence,
histatins 3 and 5 also contain an ATCUN motif.16 Taking into consideration the relative
abundance of copper in the saliva and the ability of the Cu-ATCUN complex to form ROS,
it’s easy to assume that histatins can cause oxidative stress in the oral fungal flora.
However, contrasting reports have shown that this is not the case. While some believe
that histatins’ ROS formation is the major fungicidal mechanism, recent reports have
shown that histatins can also inhibit enzymatic activity, act as ionophores to disrupt ionic
balance, and activate signaling cascades that lead to apoptosis.85 While multiple modes
of inhibition are expected from AMPs, its tempting to hypothesize a single major driving
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force for fungal death following exposure to histatins. Clearly, more elaborative work is
needed to build a complete picture of cell death, and find harmony in a sea of contrasting
mechanisms.
Apart from their role in histatins, the ATCUN motif have been implicated in the
activity of other naturally occurring AMPs as well. For instance, the activity of myxinidin
(GIHDILKYGKPS) – an AMP from the epidermal mucous of hagfish – against E. coli, K.
pneumoniae, and S. aureus is attenuated when the histidine residue is replaced by
alanine.93, 94 In the clavanin AMP family, peptides isolated from the hemocytes of the
tunicate Styela clava, the ATCUN-containing clavanin C is three times more active than
clavanins A and B.95 Peptides that do not have antimicrobial properties but nevertheless
have biological activity also seem to utilize the ATCUN motif. For instance, human
protamine 2 (HP2), a protein that perform key functions in spermatogenesis and which
contains the sequence Arg-Thr-His (RTH) in its N-terminal, was shown to generate ROS
after binding to copper. Studies in model peptides show that the DNA damaging
properties of HP2 is due in part to the presence of the ATCUN motif.96 Finally, Cu2+
binding in the neuropeptide neuromedin C, containing the ATCUN motif Gly-Asn-His, is
believed to inhibit neurotransmission or the growth factor effects of the peptide.97
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Overview of the Dissertation – What we did, why we did it, and what we learned
As previously mentioned, a number of naturally occurring AMPs and HDPs contain
an ATCUN motif (Figure 1.10). A simple AMP database search yields >50 ribosomally
synthesized, mature peptides containing an XXH sequence in its N-terminal (hereon
referred to as ATCUN-AMPs). These ATCUN-AMPs were isolated from all domains of life
(including bacteria), and exhibit diversity in length, sequence, cellular and tissue
distribution, and biological activity. Although currently unexplored, there is great potential
for ATCUN-AMPs to utilize copper for their antimicrobial mechanism. This hypothesis is
predicated on the fact that copper is upregulated in sites of infection and that the resulting
Cu-ATCUN complex have redox cycling potential under physiological conditions.
Furthermore, because these ATCUN-AMPs were isolated from various organisms, they
may represent a generalized defensive strategy by unrelated groups of organisms.
While reallocating the inherently antimicrobial copper ion into sites of infection
poses certain physiological advantages, a simplistic view of the bactericidal response by
the immune system – one that is based on toxicity of a single element – is certainly
unrealistic. Indeed, in the context of an infection, multiple antimicrobial effectors likely
synergize with each other to eradicate the invading microbe. We therefore propose in this
study that copper redistribution during infection serves two purposes; to generate a pool
of inherently toxic copper (a function that is known and well appreciated) and to provide
a metallic co-factor to other host-derived antimicrobial effectors such as AMPs.
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Figure 1.10. Diversity of ATCUN Motifs found in nature. This schematic shows the
phylum of the organisms from which an ATCUN-AMP have been isolated and the
sequences of the metal-binding motif. Numbers in the parenthesis represent the number
of peptides characterized to date belonging to the family.

This dissertation showcases both fundamental and translational aspects of the
ATCUN motif in the context of AMPs. First, the role that the ATCUN motif plays in the
activity of naturally occurring ATCUN-AMPs is investigated. Chapter 2 describes coppermediated membrane lipid oxidation by the ATCUN-AMP Ixosin as a requirement for
synergy with another AMP, Ixosin B. Chapter 3 details the copper-mediated oxidative
cleavage of DNA by two homologous ATCUN-AMPs, Piscidins 1 and 3. We uncover how
copper-related bioactivities can vary significantly among bacteria in different lifestyles.
Second, the ATCUN motif is used to modify other AMPs to develop more potent
antimicrobials. Chapters 4 and 5 focus on our efforts to develop dual-acting peptides to
target a wide-spectrum of bacteria, while chapter 6 shows the development of an ATCUNbased antimicrobial designed to target intracellular M. tuberculosis.
19

Throughout this dissertation, a central theme will become apparent, one that will
expand the catalog of mechanisms by which AMPs and HDPs utilize metal ions for their
activity. That is, in addition to metal sequestration and using transition metals for structural
purposes, we propose that HDPs and AMPs use transition metals as direct chemical cofactors as well. Here, we put forth the idea that ATCUN-containing peptides leverages the
chemical properties of the resulting copper complex to cause oxidative stress and elicit
synergy with other antimicrobial effectors.
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Introduction
Ticks are the most important arthropod vectors of human diseases, highlighting
their ability to control infections when challenged with various pathogens.98 Unlike
vertebrates, ticks lack an adaptive immune system, which indicates that the mechanisms
by which microbial loads are maintained at a tolerable level solely depend on phagocytic
cells and their humoral response including AMPs.98-100 Most of what is known about tick
immune response comes from experiments oh phagocytes found in their hemocoel.
Fortunately, tick AMPs gained attention and many peptides with novel functions have
been isolated from various species. Microplusin, a 10 kDa polypeptide expressed in
hemocytes of the cattle tick Rhipicephalus (Boophilus) microplus was found to sequester
Cu(II) from terminal oxidases to short circuit aerobic respiration.83 In addition, hemoglobin
fragments produced by various proteases in the tick midgut have been implicated in ROS
production, which may help control bacterial levels.101, 102
Although its importance is mostly overlooked, tick saliva contains multiple bioactive
molecules that participate in immune modulation and inflammatory responses in the hostvector interface.103 In fact, during tick feeding – opportunity when bacteria can be
transferred between reservoirs – bacteria encounter the tick saliva first following collection
and last prior to transmission. A survey of genetic data revealed that of the 14 AMPs
expressed by various tick species belonging to the genus Ixodes, seven are found in the
salivary glands.100 This information seems to support the hypothesis that the tick saliva
plays a major role in sterilizing materials ingested during feeding, preventing infections in
the tick body. One can also theorize that ticks strategically express a variety of AMPs in
the saliva that can act synergistically to mount an effective immune response.
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Ixosin is a 23-amino acid AMP isolated from the salivary glands of the hard tick
Ixodes

sinensis

with

the

following

amino

acid

sequence:

GLHKVMREVLGYERNSYKKFFLR.104 Interestingly, unlike other AMPs isolated from
ticks, ixosin does not have a cysteine residue in its primary structure. Moreover, ixosin
contains basic and acidic residues in the i- and i+1 positions analogous to a-defensins
expressed by higher vertebrates.105 Ixosin activity was proven against E. coli, S. aureus,
and C. albicans with minimum inhibitory concentrations (MICs) in the low micromolar
range.104 We became interested in ixosin because of the presence of the ATCUN motif in
its primary structure.
In this chapter, we probe several molecular determinants of ixosin bioactivity
(including hydrophobicity and cationic character) with a strong emphasis on the role of
the ATCUN motif. Systematic residue substitutions and deletions at the copper binding
site and key positions throughout the peptide were done to piece out individual
contributions of the aforementioned structural properties. Our results reveal that whereas
the ATCUN motif is not essential in the potency of ixosin, it is found to be necessary for
its oxidative mechanism of action. This oxidative damage was found to be exploited by
another tick salivary gland AMP, Ixosin B,106 resulting in a synergistic interaction between
the two peptides.

Results
Sequence, antimicrobial activity and cytotoxicity of designed peptides
We sought to determine the contribution of the copper-binding sequence in ixosin
to the peptide’s bioactivity. We systematically varied the sequence by substitutions and
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deletions of residues at and around the ATCUN motif and then measured their respective
MICs against a panel of microbes. First, we synthesized the wild type (WT) ixosin and its
H3A mutant (to abolish copper binding) and found that they had equal potencies (from
the geometric mean of MICs, Table 1 and 2). When the ATCUN motif was completely
deleted (ixosin4-23), the potency decreased two-fold. The minimum (H3A substitution)
versus maximum (ATCUN deletion leading to loss of both a positively charged and
hydrophobic residue) perturbations in ixosin’s primary sequence indicate that the ATCUN
motif is not essential to the peptide’s potency.
Our studies on truncated ixosin derivatives showed that the C-terminal region
(KFFLR) is necessary for its activity (Appendices, Table S2.2) as its deletion (ixosin1-18)
completely abrogated activity. We then asked whether increasing the hydrophobicity and
cationic character of ixosin1-18 would restore its activity, therefore we introduced three
point mutations (E8K, E13L, and S16V) to generate ixosin-pch (pch for plus cationic &
hydrophobic, Table 1 and 2), a derivative that is an order of magnitude more potent than
the WT. This result is consistent with known facts that positive charge and hydrophobicity
are important factors in antimicrobial activity.2, 107 To study the contribution of the ATCUN
motif to this highly hydrophobic derivative, we synthesized ixosin-pch derivatives
harboring ATCUN mutations. We found that ixosin-pch-H3A was two-fold less potent
while deletion of the ATCUN motif (ixosin-pch4-18) decreased the potency 5-fold. This
suggests that the ATCUN motif is essential for the activity of a highly positively charged
and hydrophobic ixosin derivative.
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Table 2.1. Sequence and Calculated Helicity of the Designed Peptides.
% conformation in TFE
Peptide name

a

Sequence

% conformation in 3:1
POPE:DOPG LUVs

a-helix

b-sheet

a-helix

b-sheet

ixosin (Cu-Ixosin)

GLHKVMREVLGYERNSYKKFFLR

50 (50)

11 (10)

14 (13)

34 (33)

ixosin H3A

GLAKVMREVLGYERNSYKKFFLR

50

10

16

31

ixosin4-23

GLHKVMREVLGYERNSYKKFFLR

32

18

11

40

Ixosin1-18 E8K, E13L, S16V /
ixosin-pch

GLHKVMRKVLGYLRNVYKKFFLR

62

8

9

44

Ixosin1-18 H3A, E8K, E13L,
S16V / ixosin-pch-H3A

GLAKVMRKVLGYLRNVYKKFFLR

63

7

14

45

Ixosin4-18 E8K, E13L, S16V /
ixosin-pch4-18

GLHKVMRKVLGYLRNVYKKFFLR

50

11

10

42

CD spectra were deconvoluted and percent helix was calculated using the software CDNN. b Large unilamellar vesicles

were composed of 3:1 mol ratio of POPE:DOPG suspended in 20 mM MOPS buffer, pH 7.4. c Percent helix in TFE was
obtaines at 50% (v/v) 50 mM sodium phosphate buffer, pH 7.4, and 50% trifluoroethanol.
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Table 2.2. Antimicrobial and Cytotoxic Activity of the Peptides under Study.
% cell viability (@
MIC vs E. coli)

Minimum Inhibitory Concentration, µM
Peptide name
S. aureus

E. coli
(MG1655)

P.
aeruginosa

C.
albicans

Geometric
Meana

HeLa

HEK293

Ixosin WT

64

16 – 32

128

16 – 32

53.8

91 ± 14

107 ± 6

ixosin H3A

64

16

128

64 *

53.8

92 ± 13

101 ± 8

ixosin4-23

>128 *

128 *

>128

128 *

128

81 ± 2

100 ± 14

ixosin-pch

8*

1*

8*

8*

4.7

76 ± 8

86 ± 17

ixosin-pch-H3A

4–8

2–4#

8

16 – 32 #

9.5

72 ± 27

77 ± 15

ixosin-pch4-18

128 #

2

32

32

22.6

81 ± 8

85 ± 3

*, P < 0.05 when compared to ixosin; #, P < 0.05 when compared to ixosin-pch. MICs presented here are the range of MICs
obtained from three independent trials. a When MIC > 128 µM, the value 128 was used to calculate the geometric mean.
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Spectroscopic characterization of conformation and Cu2+-binding site in ixosin
The activity of AMPs is not only dependent on its primary structure but is also
tightly linked to its three-dimensional shape.107 To eliminate the possible conformational
effects in the activity of ixosin and its derivatives, we determined their respective
secondary structure using Circular Dichroism (CD) Spectroscopy in two different media.
First, in the presence of Large Unilamellar Vesicles (LUVs) composed of a 3:1 mole ratio
of

1-Palmitoyl-2-oleoyl-phosphatidylethanolamine

(POPE)

to

dioleoylphosphatidylglycerol (DOPG), we observed CD traces resembling a hybrid
between helical and β-sheet structures (Figure 2.1A). We used a neural network artificial
intelligence program called CDNN108 to deconvolute and calculate the contributions
between different conformations and found that in the presence of a membrane
environment, ixosin and its derivatives predominantly adopt either a β-sheet structure or
is in an unordered state. On the other hand, in the presence of the membrane mimicking
solvent, trifluoroethanol (TFE), all peptides adopt a predominant α-helical structure
(Appendices, Figure S2.2). This flexibility in conformations demonstrates the ability of
ixosin to respond to changes in its environment possibly encouraging different
interactions. Regardless of the environment, we observed minute differences in
conformations between the GLH- and GLA-containing peptides (Table 1, 1-3% for ixosin
WT vs ixosin H3A and 1-5% for ixosin-pch vs ixosin-pch-H3A). This suggests that the
differences in their potency are likely not a result of the extent to which they adopt their
secondary structures. In the contrary, ixosin-pch was found to have more ordered
structures compared to ixosin WT (Table 1, 5-9%), which could have contributed to their
large difference in potencies. Finally, we note that metalation of ixosin WT showed a
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negligible change in % conformation relative to free ixosin, suggesting that copper-binding
neither promotes nor inhibits secondary structure formation.
When a Cu2+ (or Ni2+) ion binds to the ixosin ATCUN motif, the backbone amide
nitrogens of Leu-2 and His-3 get deprotonated to accommodate the metal in a distorted
square planar geometry,109 generating a Cu-ixosin complex having a molecular mass of
2931.96 Da. We mixed 1 eq of ixosin WT with 0.8 eq of Cu2+ and injected the mixture to
an ESI-MS. We observed multiply charged species bearing m/z values consistent with a
1:1 Cu:ixosin stoichiometry (Figure 2.1B). The peaks attributed to [Cu-Ix+3H]3+ and [CuIx+4H]4+ showed large similarities to the simulated isotopic distribution pattern
(Appendices, Figure S2.3), suggesting that these peaks are not an artifact from the
analysis. Furthermore, ixosin H3A did not seem to bind Cu2+ based on our MS analysis
(Appendices, Figure S2.4), indicating that His-3 is required for metal binding.

Figure 2.1. Spectroscopic Characterization of Conformation and Copper-binding.
(A) Circular dichroism (CD) spectra obtained in the presence of 3:1 POPE:DOPG LUVs
at a peptide:lipid ratio of 1:30. (B) ESI-MS spectra of Cu-ixosin WT complex showing 1:1
stoichiometry of binding.
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We then mapped the actual copper-binding site via Heteronuclear Single Quantum
Correlation (HSQC) approach. Upon gradual addition of Cu2+, we observed signal
intensity degradation for a set of protons, while the rest of the HSQC spectra remained
unperturbed. This indicates that, except for the metal coordination site, there are no
conformational changes in the peptide backbone upon Cu2+ complexation. We observed
the loss of 1H-15N correlation starting at ratio Cu:ixosin WT of 1:5 for Leu-2 and at 1:2 for
His-3 amide protons (Figure 2.2A). This is consistent with the deprotonation of these
backbone amides upon copper binding. In addition, we monitored the 1H-13C correlations
and found that at the lowest studied metal concentration (1:5 Cu:ixosin), the HSQC
signals of the imidazole protons ε1-H (~8.55 ppm) and δ2-H (~7.25 ppm) of His-3 become
undetectable while signals from other aromatic residues are unchanged (Figure 2.2B).
Furthermore, the 1H-13C correlations of the α-H of Gly-1 also disappear starting at a 1:2
ratio (inset in Figure 2.2B). Due to the paramagnetic nature of Cu2+, any proton in its
vicinity will experience a shortened transverse relaxation time leading to a significant
broadening of its NMR signal.110 While deprotonation of imidazole residue of His-3 and
α-CH2 of Gly-1 is not expected upon copper complexation, we believe that the bound
Cu2+ broadened the HSQC resonances of these protons beyond recognition. At higher
metal concentrations (up to 1:1 ratio), the α-H of Gly-1 and amide proton of Lys-4
broadens beyond detection as well. Taken together with our MS data, we definitively show
that ixosin WT indeed binds to Cu2+ through its ATCUN motif, and that any other potential
ligands within the peptide chain do not have a high-enough affinity to compete with the
N-terminal sequence. Since the motif is conserved between ixosin WT and ixosin-pch,
we expect the two peptides to have similar Cu2+-binding behavior.
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Figure 2.2. Mapping the Cu2+-binding site in Ixosin. (A) 1H-15N HSQC and (B) 1H-13C
HSQC spectra of free ixosin WT (blue), 1:5 ratio of Cu2+:ixosin WT (red), and 1:2
Cu2+:ixosin WT ratio (green) recorded in 93% 20 mM acetate buffer pH 4.4, and 7% D2O.
NMR spectra indicate that ixosin WT binds to Cu2+ via its ATCUN motif.

37

Ixosin is a bactericidal peptide localizing in the membrane
The initial interaction between AMPs and bacteria occur in the membrane.111 While
some AMPs have been found to cross the membrane and perturb various intracellular
processes,3, 112 most AMPs are membrane active.6 To determine the bacterial localization
of ixosin and its derivatives, we employed laser confocal microscopy. The 5(6)carboxyfluorescein-labeled peptides were synthesized on-resin by coupling the dye to the
ε-amino group of Lys-18, this was done to preserve copper binding (whenever possible)
in the N-terminal as a free –NH2 group is required.109 Thirty minutes post-exposure to the
peptides at their MIC, we observed fluorescent hollow ellipsoids indicative of membrane
localization for ixosin WT, ixosin-pch and their respective H3A derivatives (Figure 2.3).
Furthermore, green fluorescence was not found to co-localize with blue fluorescence from
Hoescht 33342, a DNA tracer (Appendices, Figure S2.5). A closer examination of the
ixosin H3A panel shows some cells stained homogenously while others appear as hollow
ellipsoids (indicated by the white arrow). This observation is consistent with the model of
self-induced peptide uptake where AMPs (and other cell-penetrating peptides) generate
transient pores which they use to cross the membrane and equilibrate its
concentration.111, 113 We also observed this for ixosin WT when incubated for 1 hr as a
more intracellular staining was observed (inset in Figure 2.3). Our microscopy studies
revealed that the structural changes we applied to ixosin did not significantly alter its
localization during the time scale of our experiments.
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Figure 2.3. Cellular Localization of Ixosin. Bacterial localization of ixosin WT (inset:
ixosin WT for 1 h), ixosin H3A, and ixosin-pch (inset: ixosin-pch-H3A) revealed via laser
confocal microscopy. Fluorescence micrographs show extensive membrane staining by
all ixosin derivatives during a 30 min incbubation period.

An increasing number of evidence suggests that initial membrane binding and
destabilization of AMPs at their MICs is not the determining factor for cell death.114-116 To
investigate this, we looked at the killing kinetics of ixosin and its derivatives (Figure 2.4).
We found that at the MIC, ixosin WT is bactericidal (decreasing bacterial content by two
orders of magnitude at the first 4 hrs) with cell death commencing 1 hr post-exposure. On
the other hand, ixosin H3A exhibited a weak bacteriostatic effect at its MIC. Taken
together with our microscopy results, we believe that initial membrane localization
(observed at 30 mins) contributes negligibly to cell death as bacterial population was
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relatively constant for the first hour of incubation. In the case of ixosin-pch, we observed
a decrease in viable bacteria followed by a steady growth beginning at 2 hrs. This trend
was a lot less pronounced for ixosin-pch-H3A where there were little fluctuations in
viability over 8 hrs. Derivatives of ixosin WT and ixosin-pch containing D-amino acids
were also found to be bactericidal (Appendices, Figure S2.6). Our time-kill kinetics results
suggest that the ATCUN-containing peptides are bactericidal at their MIC while their
corresponding H3A mutants are bacteriostatic. This dramatic change in mechanism
arising from a single amino acid substitution suggests the possibility that ATCUNcontaining ixosin derivatives, apart from membrane binding and destabilization, may
utilize an independent pathway which may be more destructive to the cell.

Figure 2.4. Time-Kill Curves of Ixosin-treated E. coli. Killing kinetics of ixosin and its
derivatives showing that ATCUN-containing peptides are bactericidal, whereas the
corresponding H3A mutants are bacteriostatic.

Activity of ATCUN-containing derivatives are dependent on Cu2+ and O2 levels
Our time-kill kinetics studies suggested the involvement of the ATCUN motif in the
bactericidal action of ixosin. The Cu-ATCUN complex has repeatedly been shown to form
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reactive oxygen species in combination with biologically relevant reducing agents.90, 91,
117

Given that the ROS production by the ATCUN motif requires the presence of both Cu2+

and O2 (Equations 1-3, L = ATCUN),90 we next asked whether their concentration affects
the activity of ixosin and its derivatives.
2L-CuII

+

O2

L-CuII-O-O-CuII-L

+

2e- →
→

2L-CuII + HO2- + H+ + e- →

L-CuII-O-O-CuII-L

(1)

2L-CuII + HO2-

(2)

2L-CuII-OH + OH-

(3)

We studied the activity of ixosin and its derivatives with and without copper
chelators (Figure 2.5A), and under normal- and low-oxygen levels (Figure 2.5B). We
resuspended E. coli in a medium that maintains the viability of cells while inhibiting their
growth (HEPES minimal medium),118 this allowed us to have a baseline bacterial count
per trial. After which, we exposed the cells to peptides at their MIC, incubated for two
hours and then plated in LB agar for colony enumeration. We reasoned that a decrease
in copper or oxygen levels will lead to fewer ROS formed and hence will result in lower
potency. We observed a marked increase in the number of colonies when the copper
chelators triethylenetetramine (TETA) or penicillamine (PenNH2) was added and when
oxygen was depleted (Appendices, Figure S2.7). This indicates that individual depletion
of copper or oxygen rescued the growth of bacteria when exposed to ATCUN-containing
peptides, that is, the ATCUN-containing peptides were more active in the presence of
copper and oxygen (Figure 2.5). This however was not the case for the H3A mutants and
the derivatives lacking the ATCUN motif completely. For those peptides, no statistically
significant difference was observed upon Cu2+ or O2 depletion. This data showed that
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there is indeed an involvement of ROS in the activity of the ATCUN-containing ixosin
derivatives, and that ROS formation may even be critical to its bactericidal property.

Figure 2.5. Oxidative Activity of Ixosin is due to the Presence of the ATCUN Motif.
(A) Bacterial survival was determined in the presence of copper chelators,
triethylenetetramine (TETA) and penicillamine (PenNH2). Data highlight the importance
of Cu2+ to the activity of ixosin WT. *, P<0.05. (B) Activity of ixosin and derivatives under
normoxic (+O2) and hypoxic (-O2) conditions shows that O2 plays a role in the activity of
ATCUN-containing peptides suggesting a possible involvement of ROS. *, P<0.01.
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A closer examination of Figure 2.5A shows that copper chelation with 200 µM
TETA did not restore ~100% bacterial survival. While this may be a function of competition
for copper between ixosin and the copper chelator, the added TETA was in a large excess
relative to the copper content of the medium (previously measured as 5 ppm, ~78 µM)119
and to the concentration of ixosin WT (32 µM). It can therefore be assumed that, at these
conditions, most (if not all) Ixosin exists in the non-metallated form. The fact that free
ixosin WT was still able to kill ~25% of the cells (Figure 2.5A) suggests a pathway leading
to cell death that does not involve Cu2+ binding. Our MIC results coupled with our
mutational analysis showed relevance of hydrophobicity and cationic charge to the activity
of ixosin (Table 2). Incidentally, these physico-chemical properties also dictate the extent
of membrane activity. Hence, as one would expect from any prototypical AMP, ixosin may
also possess membrane disruption capability – a copper-independent mechanism –
which may lead to cell death.

ATCUN-containing ixosin derivatives peroxidize lipids in E. coli
Since ixosin is found to localize at the membrane and that ROS is implicated in its
activity, we investigated whether ixosin can oxidize the lipids in the membrane of E. coli.
We hypothesized that the ROS formed is localized in the membrane environment and
hence will target unsaturations found in the bilayer. We employed a standard assay to
measure the extent of lipid peroxidation brought about by our peptides at three different
time points. The peroxidation products (thiobarbituric acid reactive substances, TBARS)
were then quantified using analytical HPLC (Appendices, Figure S2.8). Our data show
that there is an immediate increase in peroxidized lipid following exposure to ixosin WT.
This peroxidation increased sharply through the first hour of incubation. On the other
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hand, a lag phase was observed for ixosin H3A and ixosin4-23 which then modestly
increased after 30 mins. After 60 mins, lipid peroxidation by ixosin WT was three-fold
greater (P<0.001) than its ATCUN-free derivatives. This coincides with the onset of
bacterial killing we observed from our time-kill kinetics studies (Figure 2.6). Taken
together, our results suggest that oxidatively damaging the membrane may be a
significant step in the bactericidal activity of ixosin. Moreover, addition of the copper
chelator, TETA, lead to ~35% reduction in lipid peroxidation (at 60 mins post-exposure),
suggesting that peroxidation is indeed Cu2+-dependent.

Figure 2.6. Lipid Peroxidation Activity of Ixosin. The extent of lipid peroxidation
promoted by ixosin measured over the first hour of incubation and calculated as
micromoles of thiobarbituric acid reactive substances (TBARS). A significant increase in
peroxidized lipids by ixosin WT was observed, indicating a major role in its activity. * and
#, P<0.005; **, P<0.001.

The MIC of the ATCUN-containing peptides were measured after pre-incubation
with Cu2+ and found to be similar to those of the naïve peptide. Furthermore, an attempt
to boost bacterial copper content was made by growing E. coli in media containing 50 µM
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Cu2+ (a concentration far below its MIC which was determined to be 1 mM). The MIC
against the “copper-loaded” bacteria was also unchanged. In contrast, the tick AMP,
microplusin, was rendered inactive by exogenous Cu2+ in the media.83 Silva, et. al.
hypothesized based on their O2 consumption experiments in the presence of cyanide and
the energy uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP), that
microplusin might be sequestering Cu2+ from one or more of the heme-copper terminal
oxidases (member of the electron transport chain which act to reduce O2 to H2O).83 We
hypothesize a distinct mechanism of action for ixosin – one that does not involve
sequestration of essential copper for the following reasons: (1) there exists a pool of labile
copper ions in E. coli (and other bacteria), most of which are found in the periplasm bound
to methionine, cysteine, or glutathione.62, 120, 121 This labile pool of copper ions is most
likely in the +2 state (preferentially bound by the ATCUN motif) due to the presence of
multicopper copper oxidases which act to detoxify Cu(I) by oxidizing it to Cu(II).51
Therefore, pre-loading ixosin with Cu2+ contributes negligibly since there is plenty of labile
copper that ixosin can theoretically scavenge. (2) Our normoxic and hypoxic experiment
(Figure 2.5B) showed increased survival of ixosin-treated cells when O2 was depleted. If
ixosin bound copper belonging to a respiratory metalloprotein (or any copper-binding
protein), a decrease in oxygen is expected to force the ixosin-treated cells into a
metabolically impaired state (untreated cells would be in a metabolically dormant state),
perhaps even pushing the cells to extreme starvation which should lead to cell death.
Hence, it is clear that even though microplusin and ixosin both seem to utilize Cu2+ in their
activity, the manner at which they do so is very different. Finally, we found that ixosin
generated high levels of peroxidized lipids (Figure 2.6), a phenotype expected only if the
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peptide is metallated. In theory, if ixosin WT did not bind copper, the amount of TBARS
between ixosin WT and ixosin H3A would have been comparable. Overall, our results
thus far indicate the likely possibility that ixosin is metallated in cella and that this
metalation is causing peroxidation of lipids in the membrane.

The ATCUN motif in ixosin promotes synergy with ixosin B
Multiple secreted salivary gland peptide orthologs have been identified in hard
ticks.100 Because of the crucial role played by tick saliva in modulating the immune
response at the host-tick interface, expression of an arsenal of salivary gland AMPs
suggests possible synergistic interactions between these molecules.5, 122 Like ixosin,
ixosin B (QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY) is an AMP isolated from the
salivary glands of Ixodes sinensis.106 We examined possible synergy between ixosin and
ixosin B through the context of lipid oxidation. Using a 1:1 mixture of ixosin and ixosin B,
we measured the fractional inhibitory concentration (FIC) index, which is assessed as:
FIC = [AMP1]/MICAMP1 + [AMP2]/MICAMP2, where MICAMP1 and MICAMP2 are the MICs of
AMPs 1 and 2 alone and [AMP1] and [AMP2] are the MICs of the AMPs in combination.
An FIC index < 0.5 indicates good synergy (representing a ≥ 4-fold increase in activity),
whereas an FIC index of 0.5 to 1.0 represents additive activity. When tested against E.
coli PDJ1, a parental strain, we found that all 1:1 peptide mixtures used exhibited additive
activity (Table 3). To confirm importance of lipid oxidation in the synergistic effect, we
measured FIC indices in E. coli MWF1 (an isogenic mutant derived from PDJ1), a strain
containing elevated levels of unsaturated fatty acids in its membrane.65 Not surprisingly,
we observed a synergistic interaction between ixosin and ixosin B while the additive
activity of ixosin H3A and ixosin B was preserved. Furthermore, when ixosin and ixosin
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H3A was mixed, a synergistic interaction was also observed albeit to a lesser extent.
These results indicate that the ATCUN motif is imperative in eliciting a synergistic
interaction between ixosin and ixosin B. Moreover, the differences observed from the two
E. coli strains indicate that membrane lipid unsaturations – a substrate for peroxidation –
is a requirement for synergy.

Table 2.3. Interactions between Ixosin Derivatives and Ixosin B Expressed as the
FICa.
FIC Index (effect)
Peptide Combination

a

E. coli PDJ1

E. coli MWF1

ixosin WT + ixosin B

0.562 (Additive)

0.281 (Synergistic)

ixosin H3A + ixosin B

0.625 (Additive)

0.625 (Additive)

ixosin4-23 + ixosin B

1.000 (Additive)

1.000 (Additive)

ixosin WT + ixosin H3A

0.750 (Additive)

0.375 (Synergistic)

Fractional Inhibitory Concentration (FIC). Because regulation and relative expression of

ixosin and ixosin B are currently unknown, we measured FIC indices using a 1:1 mixture
of both peptides.

Ixosin B interacts differently with membranes containing oxidized phospholipids
It has been previously suggested that oxidized phospholipids in the lipid bilayer
can be a potential target of AMPs.123, 124 The amine groups from the AMP may act as
nucleophiles toward the electrophilic carbonyl groups in oxidized lipids to generate Schiff
bases.125 To test whether this is a potential avenue of synergy between ixosin and ixosin
B, we studied the interaction of ixosin B with model membranes by following quenching
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of tryptophan fluorescence as a consequence of acrylamide titration. We used 3:1
POPE:DOPG LUVs and pre-oxidized them using the copper complex of ixosin for 36 hrs.
Since we were working with a purified system, we added ascorbic acid to promote ROS
formation.91 We confirmed that our oxidation did not alter the diameter and size
distribution of the LUVs by dynamic light scattering (Appendices, Figure S2.9). To
determine the membrane interaction of ixosin B, we generated a Stern-Volmer plot from
which we calculated KSV (Stern-Volmer quenching constant), a direct measure of Trp
accessibility from the aqueous environment.123 Compared to free ixosin B, our data
showed a decrease in quenching constant when native LUVs are added, furthermore, a
statistically significant decrease was observed when oxidized LUVs are used. There is
therefore a greater membrane interaction by ixosin B when the lipids in the membrane
are oxidized. These results are consistent with the results obtained by Matilla et. al.
utilizing oxidized phospholipids to generate LUVs instead of oxidizing the LUVs. We note,
however, that while Matilla et. al. observed ~90% decrease in KSV, we only saw a ~30%
difference in our experiments.123 This can be attributed to several factors, including LUV
composition, amount of oxidized lipids in LUVs, and more likely, the fact that ixosin B has
two Trp residues close to both the N- (W7) and C-terminal (W28). While the relative
orientation and affinity of ixosin B within the membrane is unknown, there is a slim
probability that both tryptophans are projected away from the aqueous phase. This leads
us to speculate on a conformation where only one is protected from acrylamide while the
other is kept accessible. However, we can say with certainty that ixosin B has a stronger
membrane interaction in the presence of oxidized phospholipids.
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Figure 2.7. Measurement of Ixosin B Affinity Toward Oxidized Membranes. The
decrease in tryptophan fluorescence resulting from titration of the water-soluble collisional
quencher, acrylamide is a direct readout of the degree of accessibility of Trp residues in
the peptide. F and F0 are fluorescence intensity with and without quencher. KSV is a direct
measure of solvent accessibility of Trp residue and a reporter of membrane interaction.
*, P<0.01 compared to free ixosin B; **, P<0.01 compared to ixosin B + LUV.

The ATCUN motif in ixosin causes ixosin B to delocalize into the bacterial membrane
To identify a cellular basis of the synergy between ixosin and ixosin B, we looked
at

their

interaction

in

live

E.

coli.

We

labeled

ixosin

B

with

5(6)-

carboxytetramethylrhodamine at its N-terminal and observed its co-localization with ixosin
WT and ixosin H3A. We found that ixosin B alone stains the cells homogenously indicative
of diffusion throughout the entire cell (Figure 2.8A). From the plot of fluorescence
intensities (Figure 2.8B), one can see a clear co-localization of ixosin B with DNA stained
by Hoescht 33342. When E. coli was co-treated with ixosin and ixosin B (at their FIC for
30 mins), a strong co-localization between the green and red fluorescence is observed
which manifested as yellow hollow ellipsoids (Figure 2.8C). Furthermore, intracellular
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staining by ixosin B seems to have decreased, as did its co-localization with DNA. This
shows that in the presence of ixosin, the affinity of ixosin B to the bacterial membrane is
increased. On the other hand, the intracellular localization of ixosin B was not affected by
co-treatment with ixosin H3A because ixosin B again co-localized with DNA (Figure 2.8E).
Taken together, our results demonstrate that the presence of the ATCUN motif in ixosin
causes ixosin B to delocalize to the bacterial membrane, a phenomenon that (to the best
of our knowledge) has not been reported to date.

Figure 2.8. Cellular evidence for Ixosin and Ixosin B Synergy. (A) Localization of
TAMRA-ixosin B and (B) fluorescence intensity curves showing ixosin B co-localizing with
bacterial nucleoid. (C) Co-localization studies of E. coli MWF1 cotreated with ixosin (WT
and H3A) and ixosin B; (D) Increased localization of ixosin B to the bacterial periphery as
a result of co-treatment with ixosin WT. (E) Restoration of native ixosin B localization via
co-treatment with ixosin H3A.
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The proposed mechanism of action of ixosin highlights the central role of the ATCUN
motif
Pooling our data together, we propose a plausible mechanism of action of ixosin,
the details of which are illustrated in Figure 2.9. Ixosin expression is induced when the
tick is challenged with bacteria. Ixosin then binds copper either endogenously located in
the target bacteria or from the host. Human serum albumin (also containing an ATCUN
motif, Asp-Ala-His) has been proposed to function as a copper transporter with a
picomolar affinity.126 Since isolated ATCUN motifs and shorter peptides containing this
sequence have been reported to bind copper with affinities in the same range (or even
higher), ixosin can also compete and sequester Cu2+ from albumins. Once bound to
copper, the complex resides in the bacterial membrane. Non-metalated ixosin residing in
the membrane can sequester labile copper from the bacteria itself. Once bound to the
membrane, ixosin may induce local perturbations leading to membrane disruption. With
the aid of dioxygen, Cu-ixosin forms ROS, which then diffuse to and react with nearby
unsaturations in the bilayer causing lipid (per)oxidation. The (per)oxidized lipids then
become a target to other AMPs (including ixosin B) leading to a synergistic effect. Work
is currently being done to elucidate the exact molecular details of the oxidized lipid
targeting by ixosin B. We hypothesize however that if Schiff bases are indeed formed,123
this leads to ixosin B being covalently anchored to the membrane as opposed to binding
via dispersion and ionic forces. What this implies is that ixosin B (and other AMPs) has
the potential to generate “non-transient” pores due to their increased residence time in
the membrane. While this may not lead to cell death directly, it gives other antimicrobial
effectors a continued access to the bacteria, a scenario where bacterial recovery is
virtually impossible. It should also be noted that the ROS formation by Cu-ATCUN
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complexes are highly catalytic.117 This means that even a small amount of copper-bound
ixosin has the potential to elicit the same biological effect.

Figure 2.9. Proposed Mechanism of Action of Ixosin and its Synergy with Ixosin B.
Both peptides are depicted as helical, and ixosin is shown to form toroidal pores in the
membrane are for illustration purposes only. Oxidized phospholipid targeting would not
be possible without copper-mediated lipid oxidation.
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Discussion
AMPs represent a large class of molecules that multicellular organisms use for
defense against pathogens. Considered as one of nature’s oldest antibiotics, AMPs rely
on their overall positive charge, and conformational plasticity to recognize multiple targets
and have broad-spectrum activities. Many modes of action have been proposed and
proven for a lot of AMPs, most of which converge on the idea that AMPs bind
electrostatically to the anionic bacterial membrane, induce local perturbations and
generate pores. In addition, AMPs have been found to translocate across the membrane
and inhibit intracellular processes including protein, and DNA synthesis. This seemingly
diverse mechanism of action can be intuitively attributed to the AMP’s inherent flexibility
allowing it to recognize a wide variety of targets. Regardless of the mechanism, three
distinct physical properties seem to dictate a peptide’s biological activity; amphipathicity,
hydrophobicity, and cationic charge. Herein, we study the molecular determinants to
ixosin’s bioactivity and find that it is indeed, in part dictated by its hydrophobicity and
positive charge. Although largely unexplored in this study, ixosin, much like any canonical
AMP (due to its membrane affinity) may also generate membrane pores. We focused on
the contribution of the copper-binding motif (Gly1-Leu2-His3) to the biological activity of
ixosin. Our findings reveal that the ATCUN motif GLH, confers bactericidal properties to
ixosin at its MIC. The affinity of ixosin for the bacterial membrane allows the ATCUN motif
in ixosin to produce oxidative damage to the membrane lipid unsaturation in a copperand oxygen-dependent manner. Once the lipids are peroxidized, it paves the way for
other AMPs to act synergistically via an unknown mechanism. Taken altogether, our
results indicate that there are at least two modes of action by ixosin – membrane
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binding/disruption (from the hydrophobic and positively charged portion) and membrane
oxidation (from the ATCUN domain). We believe the two domains likely act in a
cooperative fashion (as highlighted by the synergy between ixosin WT and ixosin H3A)
and that the ATCUN motif requires the rest of the peptide to generate its full oxidative
effect. From a molecular standpoint, this may represent economic efficiency and an
evolutionary advantage because the tick expressing ixosin gets multiple modes of action
from one single molecule allowing it to combat a deluge of microorganisms. We present
an undocumented case of an AMP acting in concert with Cu2+ to generate oxidative
effects as part of its mechanism of action and as a key element for its synergy with ixosin
B – another AMP expressed in the same tick gland. Surely AMPs and other antimicrobial
effectors – no matter how seemingly unrelated they are – exhibit a dynamic interplay to
generate a quick, amplified, and effective immune response. This paradigm is becoming
more apparent in recent literature.
The fact that ATCUN-containing AMPs have been isolated from very diverse forms
of life, may represent a generalized defense mechanism from unrelated organisms. Of
special relevance to this is that metchnikowin, an ATCUN-containing AMP from
Drosophila has been shown to be induced constitutively in response to any microbial
challenge (Gram +/- and Fungi), while other AMPs (e.g. Diptericin, Cecropin A, and
Drosocin) have been induced only selectively.127 It is tantalizing to assume that the
ATCUN-containing AMPs may be a point of convergence for most AMPs since their
capability to form ROS may sensitize microbes to attack by other AMPs. In particular,
Borrelia burgdorferi, the causative agent of Lyme disease transmitted by ticks, possess
membranes enriched with polyunsaturated fatty acids that are particularly sensitive to
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attack by ROS.128 Our study also reveals another avenue to which tick AMPs utilize
copper in their activity (much like microplusin) at the same time, unifying it with ROS
production (like hemoglobin fragments).
While we are unsure of the molecular details of their synergy, our results may have
important ramifications in the understanding of the tick innate immune response, more
specifically a possible reason for its vector competence. Indeed, a comparison of three
tick species based on their expression of ixosin and their relative ability to transmit B.
burgdorferi, an inverse relationship seems to arise. That is, ticks that express ixosin do
not act as vectors for the spirochete but species that lack ixosin in their saliva are able to
transmit the bacteria. Furthermore, evidence for a borreliacidal activity of A. americanum
and non-borreliacidal activity of I. ricinus have been reported.129 We therefore posit that
expression of ixosin in the tick salivary glands causes membrane lipid peroxidation in B.
burgdorferi, attenuating the spirochete prior to assimilation or transmission – perhaps to
levels that would cause bacterial death. Work is underway to test this hypothesis.

Methodology
Peptide Synthesis, Purification, and Quantification. Peptides in their C-terminal
amidated forms were synthesized manually on a Rink Amide resin (ChemPep Inc,
Wellington, FL) using standard Fmoc-protected L-amino acids (Matrix Innovation,
Quebec, Canada). Coupling reactions were done with 4 eq of amino acids and 4 eq of
HBTU, deprotection using 20% piperidine in DMF and cleavage using 95:2.5:2.5
TFA/H2O/TIS. Free peptides were purified via RP-HPLC (Schimadzu LC-20AD) on a C18
semi-prep 250x10mm column (Grace Davison, Deerfield, IL) using 0.1% TFA in H2O
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(Buffer A) and 0.1% TFA in ACN (Buffer B). Peptides were purified (up to >95% purity as
confirmed by analytical RP-HPLC) using a linear gradient of 30-60% Buffer B over 30
mins. 5(6)-Carboxyfluorescein (Sigma Aldrich) labeled peptides were synthesized onresin by attaching the fluorophore to the peptide N-terminal. Pure fractions were collected
and the identities confirmed by ESI-MS ran on a positive ionization mode. All peptides
were quantified using a method suggested by Gruppen. Briefly, lyophilized pure peptides
were dissolved in nanopure water and a small aliquot was diluted in 80:20:0.1
H2O/ACN/Formic Acid and absorbance of this solution was read using a Varian Cary
50Scan UV-Vis Spectrometer at 214 nm. Molar extinction coefficient of each peptide was
calculated on a sequence-specific manner based on the reported values for each amino
acid and the peptide bond.
Antimicrobial Assay. Antimicrobial susceptibility testing were done using the broth
microdilution method as suggested by Hancock.130 Gram positive Staphylococcus aureus
(ATCC 25923); Gram negatives Escherichia coli (DL7), and Pseudomonas aeruginosa
(PAO1) were grown in Mueller-Hinton Broth (MHB, Difco) until mid-log phase for 3-5 hrs.
The fungus Candida albicans were grown in Yeast Mold Broth. Peptide stock solutions
were diluted in PBS (Gibco) pH 7.40, 50 μL two-fold serial dilutions (starting from 32 μM)
were placed on a sterile 96-well poplypropylene plate (Greiner). To each well, 50 μL of a
bacterial suspension was added resulting to a final inoculum of 5x105 CFU/mL per well.
Ampicillin (Sigma Aldrich) was used as positive control and PBS as negative control.
Plates were incubated at 37°C for 18-20 hrs. Minimum Inhibitory Concentration (MIC) was
defined as the concentration that prevented visual growth of bacteria. MICs reported here
are the mode of three independent trials. To test synergy between ixosin and ixosin B, a
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1:1 molar ratio of peptides were mixed and added to a culture of E. coli PDJ1 and E. coli
MWF1. FIC Index was calculated using the formula: FIC Index = ([A]mix / MIC A) + ([B]mix
/ MIC B). A FIC Index of <0.5 indicated good synergy (a four-fold increase in MIC in
combination) and a FIC Index = 1.0 indicates additive effects.
Cytotoxicity Studies. The cytotoxicity of ixosin and its derivatives were assessed
using a standard MTT (3-(4,5-dimethylthizol-2-yl)-2,5-diphenyltetrazolium bromide)
Assay on the Cervical Carcinoma (HeLa) cell line, and the Human Embryonic Kidney
(HEK293) cell line. HeLa and HEK293 cells were grown in Dubelco’s Modified Eagle
Medium (DMEM, Gibco) supplemented with 10% Fetal Bovine Serum and incubated at
37°C in a 5% CO2 incubator. 5000 cells were seeded per well and incubated overnight
prior to exposure to a two-fold serial dilution of the peptides for 24 hours. After which, the
media was aspirated out and replaced with complete growth medium containing 5 mg/mL
of MTT and the cells were returned to the incubator for another 4 hours. Then, the media
was removed and 200 μL of DMSO was used to extract insoluble formazan product. The
absorbance at 570 nm was read and used against a negative control (treatment with
buffer) to estimate % viability. The values reported here are the Mean ± SD obtained from
three independent experiments performed in duplicates.
Circular Dichroism Spectroscopy. Spectra were recorded on a Jasco J-710
Spectropolarimeter. 50 μM of peptide solutions in 50% (v/v) TFE in 50 mM sodium
phosphate buffer, pH 7.40 in a 1 mM cuvette. For spectra recorded with LUVs, 30 μM of
peptide was added to 900 μM of LUV (P:L ratio of 1:30) both in 20 mM MOPS buffer at
pH 7.4. Spectra were collected as the average of 15 scans and the two trials were found
to be <2% different from each other.
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Time-Kill Kinetics. The number of viable cells was determined after 1, 2, 4, and 8
hours of exposure to the peptide. A 350 μL aliquot of peptide at concentration 2X the MIC
was mixed with 350 μL of 106 CFU/mL of (E. coli MG1655) bacterial suspension in MHB,
to yield a final inoculum containing 5x105 CFU/mL and peptide at MIC. At each specified
time-point, 10 μL of the mixture was withdrawn and was diluted 1000-fold and spread on
LB agar plates and allowed to grow for an additional 16 hrs. The number of single colonies
were counted and plotted against time to generate curves representative of three
independent trials.
Nuclear Magnetic Resonance Studies. NMR data were collected at 25°C on an
Agilent (Varian) INOVA 600 MHz NMR spectrometer equipped with a cold probe. The
standard BioPack pulse sequences were used. The NMR sample of 2.3 mM of unlabeled
ixosin in 20mM acetate buffer at pH 4.4, 7% D2O was used to obtain the sequence specific
chemical shift assignment of the NMR resonances. For this, a set of spectra was collected
and analyzed: 2D 1H-15N HSQC, 1H-13C HSQC, 1H-1H TOCSY (mixing time 0.07 s) and
NOESY (mixing time 0.15 s), and 3D 15N-edited TOCSY (mixing time 0.07 s) and NOESY
(mixing time 0.3 s). The spectra were processed with NMRPipe131 and analyzed with
CCPNMR132 Analysis. The binding of Cu2+ to Ixosin was studied by HSQC titration
approach. The NMR signals from nuclei participating in coordination with a metal will
disappear from the HSQC spectrum due to deprotonation. In addition, since Cu2+ exhibits
paramagnetic properties, the NMR signals of peptide nuclei adjacent to the metal
coordination site will experience broadening and decrease of their intensities compared
to the free peptide spectra. Thus, to identify the metal binding site, the NMR sample of
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unlabeled Ixosin was titrated with CuCl2 and 1H-15N and 1H-13C HSQC spectra were
collected at stoichiometric ratios 5:1, 2:1, 1:1, 1:2 and 1:5.
Confocal Fluorescence Microscopy Imaging. Images were acquired on a Nikon
A1R spectral confocal microscope using a 100X oil immersion objective at a pixel
resolution of 1024 × 1024. E. coli MG1655 were labeled by incubating them with 5(6)carboxyfluorescein labeled peptides at their MIC for 30 mins. The cells were then pelleted
and resuspended in PBS prior to imaging. For co-localization studies, the same treatment
was done except that E. coli MWF1 strain was used. Fluorescence intensity was obtained
from micrograph analysis using ImageJ.
Activity of Ixosin in O2- and Cu2+- starved Conditions. 50 μL of 106 CFU/mL
bacterial (E. coli MG1655) suspension (in 5 mM HEPES, 100 mM KCl, 5 mM glucose, pH
7.30) was mixed with 50 μL of peptide at 2X its MIC. The resulting mixture was split into
two 50 μL aliquots, one of which was incubated in a 37°C incubator, while the other is
placed in a gas tight anaerobic chamber at the same temperature. After two hours, 10fold dilutions were plated onto LB agar plates and allowed to grow overnight. For the
copper-chelation experiments, the same manipulations were done except that the cells
were co-treated with 200 μM triethylenetetramine or 50 μM penicillamine. Colonies were
counted manually and the bars represent the Mean ± SEM from three independent trials.
Lipid Peroxidation Assay.133 E. coli strain MWF1, fabR::kan recD::Tn10 (containing
a higher level of unsaturated fatty acid in its membrane) were grown, washed and
resuspended in 20 mM HEPES, 100 mM NaCl pH 7.40 and was incubated with peptides
at their MIC without addition of exogenous Cu2+ for 2 hours. After which the suspension
was subjected to a standard thiobarbituric acid (TBA) assay to determine amount of
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peroxidation product. Briefly, 50 μL of treated bacteria was added to 150 μL of HClO4 and
150 μL of 40 mM TBA. The mixture was heated in a dry block for 60 mins at 97ºC followed
by a 20 min cool-down at -20ºC. Then 300 μL of methanol and 100 μL of 20%
trichloroacetic acid was added. A 100 μL aliquot was injected in a C18 analytical column
and eluted at 1 mL/min (for 15 mins) using 72:17:11 50 mM KH2PO4 pH 7:MeOH:ACN. A
97% tetramethoxypropane (Sigma) at different concentrations were used as external
standard to quantify μmoles of TBARS. Bars represent Mean ± SEM obtained from three
independent trials.
Tryptophan Fluorescence Quenching. LUVs composed of 3:1 POPE:DOPG was
prepared and a sample was pre-oxidized with 100 μM Cu-ixosin WT and 1 mM ascorbate
for 36 hrs. Ixosin B was added to native or oxidized LUVs to a final concentration of 20
μM (with LUV at 200 μM). Initial fluorescence was recorded using a Varian Cary50
Spectrofluorometer with excitation set at 295 nm, emission at 310-390 nm and PMT
voltage at 650. Then a small aliquot of acrylamide was titrated into the mixture with
subsequent recording of fluorescence quenching. Points represent Mean ± SEM from
three independent experiments obtained from different LUV preps.
Statistical Analysis. Data were analyzed for statistical differences using Graph-Pad
Prism® v6.0 software. One-Way or Two-Way ANOVA was used to determine statistical
significance and was set at P < 0.05.
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Chapter 3

The ATCUN Motif in Microbial DNA Oxidation
Copper-mediated Nuclease Activity of Piscidin 1 and 3 Coupled with their Contrasting
Expression Profiles Reveal Novel Insights into Vertebrate Immune Response
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Introduction
Two of the first Antimicrobial Peptides (AMPs) discovered in the mast cells of
vertebrates were piscidin 1 (p1, FFHHIFRGIVHVGKTIHRLVTG-NH2) and piscidin 3 (p3,
FIHHIFRGIVHAGRSIGRFLTG-NH2), members of the Class I piscidins that exhibit
activities against a wide panel of bacteria.134, 135 While piscidins were initially isolated from
the hybrid striped seabass, there is now significant evidence of piscidins being expressed
by several fish species belonging to a range of taxonomic families.136-138 Moreover,
piscidins were found to be omnipresent in several cell types including phagocytic immune
cells, hematopoietic cells, epithelial cells, chondrocytes and cells of the mucosal
tissues.139, 140 The ubiquity of piscidins in both the organism and ecological levels, coupled
with their potency against various pathogens, is reflective of their important role in the fish
innate immune response.139
The piscidins p1 and p3, much like other AMPs, are multifunctional molecules.
Aside from direct microbial killing, p1 and p3 exhibit immunomodulatory properties,141
have wound-healing effects142 and anesthetic143 activities. The ability to bind to and act
on different molecular targets highlight the conformational plasticity that p1 and p3
possess due to their inherently disordered nature. From the antimicrobial standpoint, p1
and p3 represent good archetypes of AMPs that have membrane disruptive abilities
because they are cationic, amphipathic and α-helical when bound to model
membranes.144,

145

However, no studies thus far have definitively linked p1 and p3’s

membrane activity to their bactericidal action. Numerous evidence in literature have
shown that some AMPs translocate across the bacterial membrane and bind to internal
targets leading to perturbation of essential processes.10 Indeed, p1 and p3 were shown
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to localize intracellularly at sub-inhibitory concentrations and bind to DNA in vitro,146
however, there exists no evidence of a direct association between DNA binding and cell
death. Clearly, other factors are involved and need to be uncovered before a
comprehensive narrative of piscidin-induced bacterial death can be made. At present, it
is clear that p1 and p3 have complementary effects on phosphate-containing targets, that
is, p1 seems to be more membrane disruptive while p3 is more DNA condensing.146
Initial examination of p1 and p3’s primary structure reveals that both isoforms
contain an Amino Terminal Copper and Nickel (ATCUN) binding motif, FFH- for p1 and
FIH- for p3. Chapter 1 of this dissertation showed that the ATCUN motif in the tick AMP,
Ixosin, was necessary for its lipid oxidation mechanism leading to synergistic interactions
with another AMP (Ixosin B) via oxidized phospholipid targeting.147 While it is very likely
that the ATCUN motif in p1 and p3 can afford these peptides a similar oxidative mode of
attack, the demonstration that both piscidins traverse the bacterial membrane at subinhibitory concentrations lead us to test the possibility that they could oxidatively damage
not only phospholipids but also DNA. The ROS formed by the copper-ATCUN complex
retains the oxidizing power of classical ROS, and have been shown to effectively damage
DNA within minutes.117 Taken together with the fact that both peptides bind to DNA in
vitro, we speculated that copper-bound p1 and p3 have nuclease activity that might be
involved in its bactericidal action.
In this chapter, we demonstrate that p1 and p3 have nuclease activity and show
how it relates to the antimicrobial activity of the peptides against planktonic cells,
persisters, and biofilms. We use structural, electrochemical, computational, and kinetic
information obtained from in vitro studies to rationalize the observed trends in the
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biological activity of the peptides. We found that whereas Cu-p1 is a stronger oxidizing
agent, Cu-p3 has a faster rate of oxidative DNA cleavage likely due to its stronger DNA
interaction. Treatment of log phase E. coli with both peptides resulted in a dose- and
copper-dependent DNA damage, with p3 being more effective. P. aeruginosa biofilms
and persister cells were found to be more susceptible to Cu-p3 than to Cu-p1. We found
that this trend in susceptibility is correlated with the nuclease activity of the peptides as
Cu-p3 was more efficient in degrading extracellular DNA in biofilms and elicited a stronger
SOS response (DNA repair) in persister cells relative to Cu-p1. Finally, we couple our
results to the genomic and localization studies performed by others to unveil a
sophisticated defensive strategy employed by fish against invading microbes.

Results
Both p1 and p3 bind to Cu2+ in vitro
To confirm and determine stoichiometry of Cu2+ binding by p1 and p3, we
incubated equimolar solutions of peptide and Cu2+, and subjected it to ESI-MS analysis.
We observed m/z values of 878.9, 659.3, and 527.8 for Cu-p1, and m/z 852.8, 639.7, and
512.2 for Cu-p3. These values are consistent with the [M+3H]3+, [M+4H]4+, and [M+5H]5+
multiply charged species of a 1:1 complex of both isoforms (Figure 3.1A). We then
employed two-dimensional solution NMR to confirm that Cu2+ binds to the ATCUN motif.
Because Cu2+ is paramagnetic, any proton in its vicinity will exhibit a significant
broadening of its NMR signal. To circumvent this problem, we used Ni2+ as a
spectroscopic probe (both Cu2+ and Ni2+ bind to the ATCUN motif in a similar fashion and
with comparable dissociation constants).109 Upon titration of Ni2+ to either p1 or p3, we
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observed an upfield shift of the aromatic proton signals in His-3 (Figure 3.1B), consistent
with a previous report,148 indicating metal binding to the ATCUN motif of the peptides.
Our results suggest that p1 and p3 bind to Cu2+ in vitro in a 1:1 fashion via their ATCUN
motif, and that no other potential ligands in the peptide backbone can compete for the
Cu2+ ions.

Figure 3.1. Spectroscopic Characterization of Piscidin Copper-binding. (A) ESI-MS
spectra of a 1:1 mixture of piscidin and Cu2+. m/z values show p1 and p3 bind to copper
with a 1:1 stoichiometry. (B) One dimensional slices from solution NMR heteronuclear
quantum correlation (HMQC) spectra of

15

N-H3-labeled p1 and p3 titrated with Ni2+

indicating perturbation of chemical shifts of d-proton (7.0 ppm) and e-proton (7.7 ppm of
His3. Experiment in (B) was performed by Prof. Myriam L. Cotton (W&M) and Dr. Riquiang
Fu (NHMFL).
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p3 binds DNA more strongly than p1
Having proven copper binding, we set out to determine whether both peptides bind
to DNA in vitro. To this end, we utilized the electrophoretic mobility shift assay (EMSA) to
determine relative strengths of DNA binding between p1 and p3 (Figure 3.2). Using a
constant amount of linearized pNEB206A plasmid and increasing amounts of each
peptide, we observed a progressive decrease in the fraction of migrating DNA. This
suggests that in vitro, both p1 and p3 are able to bind DNA, perhaps causing charge
neutralization and/or aggregation resulting in a markedly lower electrophoretic mobility.
When the data were fitted to a simple one-site binding model, the peptide weight that
caused 90% inhibition of migration was found to be 730 ng and 650 ng for p1 and p3,
respectively. These IC90 values suggests that p3 has a stronger interaction with DNA.

Figure 3.2. in vitro DNA binding of Piscidins 1 and 3. (A) Electrophoretic mobility shift
assay was used to assess the degree of DNA binding by p1 and p3. (B). Curve fits for the
gel images shown in (A). Curves show that p3 bind to DNA cooperatively.
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We set out to provide molecular-level insight of the DNA-p1/3 interactions using
MD

simulations.

The

DNA

duplex

structure

formed

by

the

sequence

AAATACACTTTTGGT and its complement was used for molecular simulations focusing
on the binding of monomeric (non-aggregated) piscidin to DNA, that is, without
considering the subsequent aggregation step. Under these conditions, the most stable
conformation of DNA-p3 was found to have a binding energy to DNA that was favorable
(-1.4 ± 10.1 kcal/mol) while its p1 equivalent was unfavorable (81.4 ± 14.1 kcal/mol). The
Arg7 in p3 engages in five H-bonds with DNA while Arg7 in p1 only has two (Figure 3.3A
and 3.3B). Moreover, the Arg14 residue in p3 is engaged in a stronger interaction with
DNA than the Lys14 in p1 (Appendices, Figure S3.1). Neither p3 nor p1 formed stable
soluble binary complexes with DNA (binding energies > 0 for both p1 and p3 ensembles),
reflecting that DNA-peptide complexes form polymeric aggregated states in solution.
Indeed, the most stable DNA-p3 complex shows exposure of p3’s hydrophobic surface
(black arrows in Figure 3.3C). We then calculated the binding energy when the
monomeric complex was allowed to form dimers. We observed more favorable binding
energies for both piscidin isoforms, -189.3 ± 18.7 kcal/mol for (p3-DNA)2 and -69.6 ± 27.6
kcal/mol for (p1-DNA)2, confirming that higher order oligomerization promote binding
between peptide and DNA. Not surprisingly, the most stable conformation of the dimers
(Figure 3.4) show the hydrophobic residues interacting in a manner analogous to leucine
zippers. Overall, our simulations support our multiple observation of p3 binding to DNA
more tightly.
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Figure 3.3. Molecular Dynamics Simulation of Monomeric Piscidin-DNA Complex.
Hydrogen-bonding network between Arg7 of p1 (A) and p3 (B) shows more interactions
in p3, confirming its tighter DNA binding. (C) When p1 or p3 form a binary complex with
DNA, a surface of hydrophobic residues (indicated by black arrows) is exposed to the
solvent. Structures were calculated by Dr. Buyong Ma, Dr. Jun Zhao, and Dr. Ruth
Nussinov (NCI, NIH).
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Figure 3.4. Molecular Dynamics Simulation of Aggregated Piscidin-DNA Complex.
The solvent-exposed hydrophobic residues in the monomeric complex promotes
dimerization of piscidin-DNA complexes as shown here for p1 (A) and p3 (B). Structures
were calculated by Dr. Buyong Ma, Dr. Jun Zhao, and Dr. Ruth Nussinov (NCI, NIH).

The N-terminal of piscidins adopts a structure optimized for metal coordination when
bound to DNA
We next wanted to determine whether metal binding leads to structural changes
at the N-end of piscidin when bound to DNA. Because DNA is aggregated in the presence
of piscidin, we also employed rotational-echo double-resonance (REDOR) solid state
NMR on a

13

C-carbonyl and

15

N-amide labeled p1 and p3 for distance measurement at
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the N-terminal. The isotopic labels were placed in i and i + 4 positions to span the length
of hydrogen-bonding partners in a canonical α-helix (~4.2 Å). Notably, we found that Nip1 exhibited a

13

C-F2 –

15

N-F6 distance of 3.55 ± 0.29 Å (Figure 3.5), comparable to the

distance (3.46 ± 0.51 Å) in the non-metallated p1. The same was true for p3, where
metalation did not significantly change the 13C-I2 – 15N-F6 distance. These distances are
shorter than the expected distance in an α-helical pitch indicating twisted configuration of
the peptides when bound to DNA, in contrast to the fraying observed when bound to lipid
bilayers.144 These results also indicate that the ATCUN motif is poised for metal
coordination when p1 or p3 is bound to DNA. When a similar technique was done to
measure the distance between residue 8 and 12 of both p1 and p3 bound to DNA, we
also observed distances within the α-helical range suggesting the possibility of a fully
helical peptide fold when p1 and p3 are bound to DNA, experimentally validating the
structures calculated in Figure 3.3.

Figure 3.5. Distance Measurements in Piscidin N-terminal. Solid state NMR was used
to measure distance between H-bonding pairs in p1 (A) and p3 (B) with and without Ni2+.
Curves suggest that structures at the ATCUN motif of p1 and p3 are unchanged upon
metalation. Experiments performed by Dr. Myriam Cotten and Dr. Riquiang Fu.
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Cu-p3 cleaves DNA more efficiently that Cu-p1 in vitro
The Cu-ATCUN complex has been shown to have DNA cleavage activity, effecting
DNA damage within minutes in the presence of pro-oxidants.117 To confirm a similar in
vitro nuclease activity of the peptides, we monitored the time-dependent cleavage of the
plasmid pUC19 when incubated with Cu-p1/p3 in the presence of H2O2 and ascorbic acid.
We observed a progressive loss of the supercoiled (S) form with a concomitant increase
in the nicked (N) and linearized (L) forms of the plasmid (Figure 3.6A and Appendices
Figure S3.2). When the data was fitted into a pseudo-first order rate equation (d[DNA]/dt
= -kcleavaget, Figure 3.6B), Cu-p3 was found to have approximately three-fold greater DNA
cleavage rate constant than Cu-p1 (Table 3.1). This is counterintuitive to what we
observed from our voltammetric studies which indicates that Cu-p1 is a stronger oxidizing
agent (E° in Table 3.1). To justify the observed trend in DNA cleavage, we applied the
Freifelder-Trumbo (F-T) statistical analysis. F-T analysis suggests that when single strand
breaks occur at sites that are close to each other (as a result of localized ROS formation),
the forces that tend to stabilize the doible helix is overcome resulting in linearization of
plasmid DNA. The F-T relationship suggests that if the cleavage occurs via random
mechanisms, 100 single strand breaks (at interspersed regions of the DNA) is required
for linearization,149 that is n1/n2 ≥ 100 (where n1 = number of single strand breaks and n2
= number of double strand breaks). We calculated n1 and n2 values from the fraction of
supercoiled and linearized plasmids remaining after each time point and reasoned that
since p3 has a stronger DNA binding ability, it should have a lower n1/n2 ratio. Indeed, we
found a lower ratio for Cu-p3 relative to Cu-p1 (Table 3.1), suggesting a more concerted
mechanism of DNA cleavage by Cu-p3 likely resulting from the longer lifetime of the Cu-
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p3:DNA complex. Altogether, our data indicate that Cu-p3 has a better nuclease activity
than Cu-p1, despite the latter being a stronger oxidant.

Figure 3.6. in vitro DNA Cleavage of Cu-piscidin Complexes. (A) Electrophoretic
monitoring of piscidin-induced cleavage of pUC19 showing loss of supercoiled (S)
plasmid with corresponding increase in the nicked (N) and linearized (L) form. (B)
Pseudo-first order intergrated rate law plots of in vitro DNA cleavage promoted by
piscidins. Blank runs represent experiments with H2O2 and ascorbic acid but without any
metallopeptide.

Table 3.1. Summary of values obtained from electrochemical, kinetic and statistical
analysis of metallopeptides.
Parameter

Cu-p1

Cu-p3

Cu2+

E° vs NHE (V)

0.990

0.972

n.d.

kclevagae (min-1)

6.3 ± 0.5

18.2 ± 0.7

22.1 ± 0.6

n1/n2

34

27

27

n.d. = not determined
75

p1 and p3 both use copper in their bactericidal activity against planktonic bacteria
Having confirmed in vitro redox activity of the corresponding copper complexes,
we set out to determine their respective antimicrobial activity against planktonic bacteria.
We measured the Minimum Inhibitory Concentration (MIC) of p1 and p3 with or without
pre-incubation with an equimolar amount of Cu2+. Consistent with previous studies,150 we
found that for all Gram-negative bacteria tested, p1 was more active than p3, and that
against the Gram-positive S. aureus, both peptides exhibited similar MICs (Table 3.2).
Interestingly, no change in MIC was observed upon pre-incubation of the peptides with
Cu2+. Since the Mueller-Hinton Broth contains ~78 µM of copper,119 a concentration in
excess of the highest peptide concentration tested (16 µM), it is likely that both p1 and p3
are copper-saturated in the growth medium. Moreover, the pool of labile copper ions in
bacteria (bound to methionine, cysteine or glutathione)120, 121 may act as a copper source
for p1 and p3, since the peptides have a considerably higher affinity towards the metal.
These two possibilities reasonably explain the similar MICs obtained with and without preloading of copper. When tested against the isogenic mutant strain E. coli TD172 (a strain
harboring a deletion in the recA gene, essential for DNA damage repair), a four-fold
increase in p3 activity was observed (relative to WT E. coli) whereas p1 activity was
unchanged. This result implicates DNA damage in the mechanism of action of p3, at par
with the strong DNA binding and cleavage observed in vitro.
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Table 3.2. Antimicrobial Activity of Piscidin Isoforms.
Minimum Inhibitory Concentration (MIC), µM
Bacteria
p1

Cu-p1

p3

Cu-p3

E. coli WT

4

4

8

8

E. coli (DrecA)

4

4

2

2

S. aureus

2

2

2

2

P. aeruginosa

16

16

32

32

Figure 3.7. Bactericidal Property of Piscidins. Time-kill curves of piscidin-treated E.
coli in the presence and absence of 100 µM of the copper-chelator, tetrathiomolybdate
(TTM). *, P<0.01 compared to corresponding runs without TTM.

To test the copper-dependence of the activity of p1 and p3, we monitored the killing
kinetics of the peptides at their MIC in the presence and absence of 100 µM
tetrathiomolybdate (TTM), a copper-selective, cell-permeable chelator.151 We reasoned
that if p1 and p3 uses Cu2+ for its activity, copper depletion should result in a lower
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bactericidal activity. We observed rapid sterilization of the culture – decreasing viable
count by 4 orders of magnitude – by p1 with and without TTM within the first hour of
exposure (Figure 3.7). However, p1 + TTM exhibited a resumption of growth two hours
post-exposure, likely arising from a slower rate of inhibition relative to the rate of bacterial
growth. On the other hand, p3 showed a slow and steady decline in bacterial viability
(~1.5 log) which slowed down further when TTM was added. Our results indicate that
copper depletion affects the activity of p1 and p3 negatively, and suggests that both
isoforms use Cu2+ for their bactericidal action.
Piscidins, like most AMPs, have membrane binding and disruptive properties on
model membranes and live cells;146 furthermore, ATCUN-containing AMPs are known to
oxidatively damage lipid bilayers (Chapter 2).147 For this reason, we tested whether lipid
peroxidation is an important step in the mechanism of p1 and p3. Using a standard
thiobarbituric acid assay, we found a three-fold increase in peroxidized lipids in E. coli
treated with p1 or p3 at their MIC (Figure 3.8A). However, no statistical difference between
p1- and p3-treated cells were observed, indicating that the differences in MICs between
the two isoforms is likely not a result of oxidative attack on the lipid bilayer. Piscidin 1 has
been reported to be highly membranolytic, able to effect cell lysis in the span of
minutes.146, 150 Despite the lack of a significant difference between p1 and p3 in terms of
lipid peroxidation, we proceeded to characterize the affinity of p1 to oxidized membranes.
We performed titrations of lipid vesicles into a solution of p1 and monitored membrane
partitioning of the peptide via CD spectroscopy. We utilized large unilamellar vesicles
(LUVs) composed of either 70:30 POPE:POPG of 65:25:10 POPE:POPG:AldoPC (1palmitoyl-2-(9’-oxo-nonanoyl)-sn-glycero-3-phosphocholine, a phospholipid containing
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an aldehyde functionality). We find that p1 adopts significantly more pronounced helical
conformations in the presence of vesicles containing oxidized phospholipids (Figure
3.8B). When partition coefficient and free energy of binding was calculated based on
published procedures,152,

153

we found that p1 has a significantly greater partition

coefficient in oxidized LUVs (6.1X103) compared to normal LUVs (1.8X103). This result
indicates that p1 indeed has a higher affinity toward oxidized membranes. Ixosin B
exhibits a similar behavior, as shown in Chapter 2.

Figure 3.8. Membrane Oxidizing and Affinity of Piscidins. (A) E. coli cells were treated
with p1 or p3 at the indicated concentrations and subsequently harvested for peroxidized
lipid quantification using a standard thiobarbituric acid assay. TBARS = thiobarbituric
reactive substances. *, P<0.05; **, P<0.01; ***, P<0.005 compared to the PBS control. ns
= not significant. (B) Relative affinity of p1 toward bilayers containing normal
phospholipids (top) and oxidized phospholipids (bottom) measured using CD
spectroscopy. Wimley-white paramters are shown within the CD spectra and indicates
that p1 has greater affinity towards oxidized membranes.
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To definitively piece out whether p1 and p3 can competitively sequester copper
and to determine whether the copper is coming from extracellular (in the media) or
intracellular (inside the bacteria) sources, we tested their activities in different growth
media. We first grew the bacteria in either copper-containing complex media (MHB) or in
copper-deprived minimal media (M9 + glucose). Then we washed the bacteria and
resuspended them in the either MHB or M9 prior to treatments. This set-up gave us three
conditions: (i) A, bacteria both grown and tested in MHB will have both extracellular and
intracellular copper, (i) B, bacteria grown in MHB but tested in M9 will only have
intracellular copper, and (iii) C, bacteria both grown and tested in M9 will have neither
extracellular nor intracellular copper. We determined relative activity by plating dilutions
of cultures following exposure to apopeptides or their corresponding metallated forms. In
agreement with our MIC data, we found that pre-loading the peptides with copper (Cu-p1
and Cu-p3) does not yield an increased potency only in MHB. However, conditions lacking
extracellular copper exhibited a markedly higher potency upon pre-incubation with copper
(Figure 3.9). This indicates the clear synergy between p1 or p3 with copper ions.
Comparing bacterial survival in condition A with that in B shows that both p1 and p3 utilize
extracellular copper. However, removal of intracellular copper only seemed to positively
affect p1 (Figure 3.9). Taken together, these results suggest that p1 has the ability to
(sequester and) utilize both extracellular and intracellular copper while p3 synergizes only
with extracellular copper.
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Figure 3.9. Synergy between Cu2+ and Piscidins Against Planktonic Bacteria. To
determine piscidin’s copper source and synergy with copper, bacteria were grown and
tested at different conditions. MHB is a complex medium containing copper, able to suppy
both extracellular and intracellular copper. M9 is a minimal medium that has trace
amounts of copper and cannot supply copper. #, P<0.05 compared to condition A; *,
P<0.05 compared to non-metallated piscidin, ns = not significant. Dotted line represents
the limit of detection of the assay.

Only p3 has the ability to damage DNA in live E. coli in a Cu2+-dependent manner
Since p1 and p3 have been shown to cross bacterial membranes even at sublethal concentration, and their corresponding complexes was found to cleave isolated
DNA, we tested whether this nuclease activity is preserved in cella. We utilized the
Terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) assay to assess
intracellular DNA damage in wild type E. coli. Since pre-incubating the peptides did not
alter the MICs, we mixed the naïve peptides with bacteria in the presence or absence of
100 µM TTM. Our results show that there is indeed DNA damage in piscidin-treated cells
(Figure 3.10A). When p1 was used at 2X MIC, a two-fold increase in DNA nicked ends
was observed which was unchanged upon co-treatment with TTM (Figure 3.10B).
Meanwhile, p3 at its MIC afforded a statistically significant 1.5-fold increase in TUNEL
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fluorescence which decreased slightly in the presence of TTM (P<0.05). Furthermore,
when used at 2x MIC, p3 affords a four-fold greater DNA damage which decreased
considerably upon addition of TTM. Our data demonstrates that only p3 has a significant
copper-dependent nuclease activity in live bacteria. It should be noted that TTM treatment
alone did not alter the TUNEL fluorescence of the control cells (Appendices, Figure S3.3),
suggesting that the observed decrease in fluorescence is a consequence of decreased
copper availability. While several reports have shown that treatment of bacteria with
bactericidal antibiotics result in buildup of ROS (which could lead to DNA damage),154, 155
the fact that we observed a copper-dependence in TUNEL response suggests that the
DNA damage is likely a direct result of the oxidative capacity of p3. Furthermore, the p3induced DNA damage was observed at 2 hours post-exposure, a time at which cell killing
have already commenced (Figure 3.7), suggesting that oxidative DNA cleavage may be
a major contributor to p3’s bactericidal action.
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Figure 3.10. DNA Cleavage in Live Bacteria by Piscidins. (A) Representative
histograms obtained from flow cytometric analysis of piscidin-treated E. coli. The
fluorescence intensity is directly proportional to the amount of DNA strand breaks. (B)
The geometric mean fluorescence intensity was normalized against that of the untreated
cells (assigned a value of 1) to compare relative nuclease efficiency of p1 and p3 in live
bacteria. *, P<0.05; **, P<0.01; and #, P<0.05 compared to untreated control.

Synergy between p1 and p3 is possible only in the absence of a robust DNA repair
mechanisms
Having seen effective cidal activities of both p1 and p3 against planktonic cells, we
next wanted to determine whether the two peptides interact synergistically and effect a
stronger sterilizing effect in combination. In a physiological setting, both p1 and p3 are
expressed simultaneously (albeit to varying levels), hence we postulated on a dynamic
interplay between the two homologous peptides. We performed the checkerboard assay
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to determine fractional inhibitory concentration (FIC) indices of p1 and p3 in combination.
When tested against WT E. coli, we observed, at best additive interactions between the
two peptides as evidence by FIC indices >0.50 (Figure 3.11A). Because we have been
observing a strong implication of DNA damage to the activity of these peptides, we
repeated the checkerboard assay using E. coli TD172 – a strain harboring a deletion in
the DNA repair enzyme RecA. Not surprisingly, in the mutant strain we observed actual
synergistic interactions between p1 and p3, with and FIC index of 0.38. Moreover, a
combination of both peptides, clearly and visually prevent growth of the mutant E. coli in
culture (Figure 3.11B).

Figure 3.11. Synergy Between p1 and p3. (A) The checkerboard assay was used to
assess synergy between p1 and p3 following overnight incubation with varying ratios of
both peptides to either WT E. coli (left) or recA deletion mutant (right). Numbers at the
boundary of the zone of inhibition and zone of growth represent FIC indices calculated

84

from the corresponding well at which they appear. (B) Sub-inhibitory concentrations of p1
and p3 either alone or in combination was used to treat E. coli. Growth was inhibited only
when the recA mutant was treated with both peptides.

p1 and p3 act synergistically with Cu2+ to disperse preformed biofilms
Since p1 and p3 exhibit potency against planktonic cells, we sought to determine
if they can inhibit P. aeruginosa PA01 growth in the context of biofilms. To determine the
importance of copper-binding to this activity, we treated pre-formed biofilms (grown in rich
medium) with peptides and their corresponding copper complexes in copper-free MOPS
buffer (all subsequent assays hereon after were performed in MOPS buffer pH 7.40). We
reasoned that by using a medium with defined components, the only source of copper for
the peptides is the exogenously added Cu2+ or the bacterial bioavailable pool. We
observed a modest inhibitory activity for both non-metallated pisicidin isoforms, effecting
only an order of magnitude decrease in viable bacteria at 16 µM (Figure 3.12). When the
peptides were pre-incubated with Cu2+, a stronger biofilm clearance effect was observed
which was more pronounced at higher concentrations. It is important to note that while P.
aeruginosa biofilms are susceptible to the toxic effects of free Cu2+ (it was previously
shown that PA01 biofilms are sensitive to 1 mM Cu2+),156 we observed a statistically
significant (P<0.01) difference in the inhibitory activities of the metallated piscidins and
Cu2+. This indicates that piscidin and Cu2+ act synergistically and suggests that the toxicity
of Cu-p1 and Cu-p3 is not a result of the biofilm’s sensitivity to oxidative effects by Cu2+.
We further note that from 2 through 8 µM, Cu-p3 was more active than Cu-p1, mirroring
the trends we observed in the in vitro (Figure 3.6) and in cella (Figure 3.10) DNA cleavage
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experiments. This lead us to speculate an involvement of oxidative DNA damage to the
anti-biofilm mechanism of copper-bound piscidins.

Figure 3.12. Synergy between Piscidin and Copper against Biofilms. 24-hour old P.
aeruginosa PA01 biofilms were treated with piscidins at the indicated concentrations for
3 hours followed by CFU enumeration. *, P<0.05 compared to the corresponding nonmetallated peptide; #, P<0.01. Experiment performed by Dr. Ali Adem Bahar and Dr.
Dacheng Ren (Syracuse).

Cleavage of biofilm extracellular matrix occurs during piscidin treatment
The biofilm extracellular matrix is composed of a multitude of secreted
biomolecules that mostly serve structural and signaling functions.157 Studies show that
extracellular DNA (eDNA) in biofilms function in strengthening the matrix and as such are
necessary for biofilm formation.158 Therefore, eDNA represents an important point of
attack for anti-biofilm agents, especially the ones that have nuclease activity. We treated
24-hour old P. aeruginosa PA01 biofilms with p1 and p3 with and without pre-incubation
with Cu2+, extracted the biofilm eDNA, and characterized it using electrophoresis.
Untreated biofilms contained eDNA of ~11 kbp in length (Figure 3.13), far from the size
of the PA01 genomic DNA (6.3 Mbp)159 confirming no intracellular DNA contamination in
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the assay. Piscidin treatment of the biofilms resulted in eDNA cleavage as evidenced by
the smearing pattern in the treated lanes. Our results show that naïve p1 and p3 cleave
eDNA to similar extents in a dose-dependent manner. Because nuclease activity is a
phenotype expected only if the peptides are metallated, our results also suggest that p1
and p3 were able to sequester copper from the biofilm’s bioavailable pool. Indeed, the
exopolysaccharide (EPS) matrix of P. aeruginosa biofilms was shown to retain Cu2+ and
that a similar metal-sequestration phenotype protected Erwinia amylovora biofilms from
copper stress.160, 161 In this context, the EPS may very well be the copper source for p1
and p3. When Cu2+ is added, it is apparent that Cu-p3 cleaved eDNA more efficiently than
Cu-p1. Because the trends we observed for the eDNA cleavage parallel the potency
trends in our biofilm inhibition assay (Figure 3.12), we believe that eDNA cleavage plays
a major role in the action of p1 and p3 against biofilms – a hypothesis supported by the
demonstration that DNAse I effectively dispersed 60-hour old PA01 biofilms.158 Since
other biomolecules in the biofilm extracellular matrix are potentially susceptible to
oxidative attack, we cannot discount other pathways leading to biofilm growth inhibition
without exhaustive investigation.

Figure 3.13. Biofilm eDNA Cleavage by Piscidins. Electrophoretic characterization of
cleavage of biofilm extracellular DNA (eDNA) following exposure to peptides at the
indicates concentrations. MW of eDNA isolated ~11 kDa.
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Only the copper complex of p3 is bactericidal against P. aeruginosa persisters
Persisters are a subpopulation of transiently antibiotic-tolerant bacteria that are
often the cause of recurring infections. Although target recognition is not abolished, a lack
of downstream effects due to the metabolic idleness of persister cells renders current
antibiotics less effective.162 Recent studies showed efficient persister cell eradication via
ROS production by conventional anti-TB drugs.163 It has also been suggested that multihit agents that can damage DNA can be potentially cytotoxic to persisters.162 For this
reason, we tested the activity of p1, p3, and their corresponding copper complexes
against P. aeruginosa PA01 persisters. We found that naïve p1 and p3 have moderate
bactericidal activity against persisters, reaching a maximum of 1 log of reduction in
viability at 16 µM (Figure 3.14). While several studies have reported different Cu2+ MIC
values against P. aeruginosa persisters ranging from low micromolar164 to millimolar160
values, in our hands, they succumbed to ≥4 µM of the metal. Across all concentrations,
we observed a similar activity between free Cu2+ and Cu-p1, suggesting that Cu-p1
toxicity has very likely, the same oxidative effect on PA01 as cupric ion. On the contrary,
Cu-p3 exhibited a stronger bactericidal effect than Cu2+ alone, indicating that p3 is
synergistic with the metal in eradicating persisters. Once again, it was evident that Cu-p3
was more active than Cu-p1 across all concentrations, echoing the trends we have been
observing thus far, leading us to wonder whether DNA damage has a role in piscidininduced persister cell death.
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Figure 3.14. Synergy between Piscidin and Copper against Persister Cells. P.
aeruginosa PA01 persisters were treated with the indicated concentrations of peptides
for 3 hours prior to CFU enumeration. *, P<0.01 compared to corresponding nonmetallated peptide; #, P<0.05. Experiment performed by Dr. Ali Adem Bahar and Dr.
Dacheng Ren (Syracuse).

Cu-p1 and Cu-p3 trigger the SOS response in E. coli persisters
Exposure to DNA damaging agents lead to the induction of the SOS response.
Having shown that Cu-p3 eradicates PA01 persisters, we set out to determine whether
DNA damage is part of its bactericidal mechanism. For this purpose, we used the GFP
fluorescence of the E. coli reporter strain AT15165 (Δattλ::sulApΩgfp-mut2 TetR) as a direct
readout of the SOS response. We exposed E. coli AT15 persisters to varying
concentrations of p1, p3 and their corresponding Cu2+ complex for 2 hours and then
counterstained the cells with propidium iodide (PI). This set-up allowed us to monitor the
number of dead cells bearing a damaged DNA by comparing the levels of doubly
fluorescent cells, that is, both GFP and PI positive cells. Our treatments resulted in a
significant increase in GFP(+), PI(+) cells (Q2 in the scatter plots of Figure 3.15A). At
concentrations greater than 1 µM, we observed an increase in GFP(+), PI(+) cells upon
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metallation of both p1 and p3 (Figure 3.15B). While Cu-p1 and Cu2+ had similar potencies
against PA01 persisters, induction of SOS response in E. coli persisters was significantly
smaller during Cu2+ treatment compared to Cu-p1. This disparity likely arises from
differences in copper-homeostasis pathways67 and in the SOS response166 between the
different bacteria used. The strong SOS response following Cu-p1 and Cu-p3 treatment
suggests that their oxidative DNA cleavage activity is playing a role in E. coli persister cell
death. In addition, p3 also elicited a strong SOS response suggesting two possibilities;
that p3 was able to scavenge Cu2+ and cause direct DNA cleavage; or, that p3 bound
strongly to genomic DNA in the non-metallated form eliciting SOS response as observed
for the non-DNA cleaving fluoroquinolones.167 Indeed, our MD simulation suggests that
the binary complex between piscidin and DNA is intermediary to the more stable
aggregated form (Figure 3.4). It is therefore possible that p3 can non-covalently
“crosslink” DNA strands when they condense to form aggregates which ultimately leads
to induction of the SOS response. Finally, we note that there are no significant differences
in terms of GFP(-), PI(+) cells (dead cells without DNA damage, Q1) between naïve and
metallated piscidin (Figure 3.15B), suggesting that persister cell death pathways induced
by p1 and p3 that are independent of oxidative DNA damage is not a function of copper
binding.
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Figure 3.15. Induction of SOS Response in E. coli Persisters by Piscidins. (A)
Representative scatter plots from flow cytometric analysis of E. coli AT15 persisters
treated with piscidins and stained with propidium iodide. Expression of GFP is a readout
for DNA damage, and influx of PI is a measure of cell death. (B) Quantitative analysis of
the increase in doubly dead cells bearing damaged DNA (Q2, left) or dead cells without
DNA damage (Q1, right) following E. coli AT15 persisters treatment with the indicated
peptide. *, P<0.05.
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Discussion
Thousands of AMPs have been isolated and their activity against bacteria has
been described, but the majority of the literature focuses on their membranolytic activity.
Even though several AMPs have been demonstrated to be non-membranolytic, a detailed
description of AMP-induced cell death is usually lacking. Non-membrane active AMPs
have been shown to bind to intracellular targets, but so far, none have been shown to
covalently damage their binding partners. In this chapter, we illustrate the first
demonstration of a nuclease activity for the natural AMPs, p1 and p3, as a function of
copper binding, and how their relative activities translate to their bactericidal action
against bacteria.
Here, we show that p1 and p3 form strong interactions with DNA in vitro and that
this interaction is not disrupted upon metallation of the peptides as their N-terminal
domain is ordered irrespective of the presence of copper. This is interesting from a
biophysical standpoint because it shows that DNA allows piscidin to adopt a conformation
that is poised to accommodate the metal and is conducive for the nuclease function it has
to perform. Furthermore, we studied p1 and p3’s DNA binding with atomic resolution and
show that Arg7 and Arg14 in p3 engages in more hydrogen bonding interactions with
DNA than Arg7 and Lys14 in p1, reasonably explaining the higher DNA affinity of p3.
Cu-p1 is a stronger oxidizing agent, however, our in vitro DNA cleavage results
show that the reaction with Cu-p3 has a larger rate constant. We believe that the stronger
DNA binding by p3, compensates for the small edge in free energy of oxidation that Cup1 affords from a slightly more positive E°, leading to a more effective nuclease activity
for p3. Indeed, in all biological contexts tested in this study, p3 (or Cu-p3) was superior to
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p1 (or Cu-p1) in cleaving DNA. The trend in nuclease activity mirrored the potency of p1
and p3 against bacteria and biofilms, suggesting that oxidative DNA cleavage plays a
determining role in the bactericidal mechanism of p3. Since p1 and p3 have identical MICs
against a large number of bacteria, a compensatory mechanism that p3 relies on to make
up for its weaker membranolytic effect have been previously hypothesized.146 The
stronger nuclease activity by p3 may very well be the supplemental mode of attack that
p3 uses to “level-off” its potency with p1.
Comparing p1 and p3 according to their relative ability to target the phosphate
containing biomolecules, DNA and phospholipids, it becomes apparent that p1 is more
membrane-active, whereas p3 is more DNA-active.146 While at first glance, contrasting
effects towards these potential targets maybe counterproductive in the context of
homologous peptides, one has to wonder whether a functional complementarity explains
the success of homologous AMP pairs against pathogens. Here, we strengthen this
notion by showing that p1 and p3 have complementary growth inhibition rates. It is logical
for a highly membrane active AMP, like p1, to be able to sterilize a culture rapidly because
of the accessibility of the membrane as its main target. The resumption of growth after 2
hours in p1 + TTM, however, suggests that p1 finds copper in the cellular environment
and utilizes a copper-dependent pathway, independent of membrane disruption, leading
to sustained cell death, possibly because the more versatile mechanism of action of Cup1 relative to naïve p1 is more effective at sensitizing bacteria in the long term. On the
other hand, acting on the DNA not only requires translocation across membranes, but
also circumventing the redundant DNA damage repair pathways. It is therefore sensible
that p3, which has stronger effects than p1 on DNA, exhibits a slower killing kinetics.
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Removal of copper from p3 (and by extension, loss of its nuclease activity) resulted in
attenuation of p3’s bactericidal action, further solidifying the idea that oxidative DNA
damage is central to p3’s antimicrobial mechanism. Collectively, our results suggest that
while Cu-p1 exhibits nuclease activity, it may not be its primary mode of attack simply
because p1 is highly membranolytic, and that bacterial DNA is much less accessible than
the membrane. The alternative mode of attack we propose here highlights the promiscuity
of p1 and p3 (and of other α-helical AMPs) for various targets, and underpins the
challenge of generating a detailed mechanistic account of AMP-induced bacterial death.
We further note that this apparent synergy between copper and both piscidin isoforms
have been previously observed in piscidin 2 (FFHHIFRGIVHVGKTIHKLVTG), which
differs from p1 only through a conservative substitution at position 18, against the fish
parasites Saprolegnia and Tetrahymena.168 It was reasoned that since both agents are
membrane active, their combination resulted in a synergistic effect. We believe that the
copper-binding ability of p2, which affords the peptide oxidative capabilities on critical
cellular components such as the membrane and DNA, logically explains the observed
synergy.
Since the proposed nuclease activity by p1 and p3 is imparted by their metal cofactor, the copper sources of the peptides need to be addressed. We reasoned that the
growth medium or the bacteria themselves contain enough bioavailable and
exchangeable copper for p1 or p3 to sequester. In E. coli, there is an estimated 18 µM of
cell-associated copper.169 Although the reducing environment of the cytosol favors Cu(I),
the presence of multicopper oxidases – that act to detoxify Cu(I) and convert it to Cu(II)
– in several bacteria,51, 69 likely generates a pool of exchangeable Cu(II), the preferred
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oxidation state of the ATCUN motif. While relying solely on intrinsic copper reserves may
not saturate the peptides with the metal, the fact that ROS formation by the Cu-ATCUN
complexes is catalytic, suggests that a small amount of metallated piscidin may be
sufficient to give rise to the observed nuclease activity. However, this still begs the
question: Are p1 and p3 expressed in nature in their metallated form? First, genomic
information indicates that piscidins are expressed as pre-propeptides that need to be
proteolytically cleaved to liberate their active form.135 Second, piscidins were originally
isolated in mast cells134 and were later found to be stored in granules.170 It is known that
both proteolysis and trafficking to cytoplasmic vesicles involve the trans-Golgi network,
an organelle that houses the copper-transporters ATP7A and 7B which metallate newly
synthesized cuproenzymes.171 Therefore, the fundamental processes that act to ensure
proper piscidin expression and localization place these peptides in copper-rich sites of
the cell. For this reason, we propose that both p1 and p3 are likely expressed as
metallopeptides postranscriptionally.
Finally, because of the ability of mast cells and acidophilic granulocytes to circulate
systemically, piscidins were proposed to be involved in the non-specific killing of both
extracellular (via mast cell degranulation) and intracellular (following phagocytosis)
microbes.170 Indeed, previous immunolocalization studies showed a high p1, p2, and p3
expression near the luminal surface of several species of teleost fish, and that p1 was
highly expressed in epithelial cells of the Atlantic cod.140 These surfaces are lined with a
protective layer of mucous which can support bacterial growth.172 It is therefore logical to
express potent and broad-spectrum piscidins at regions that contact pathogens more
often. While expression of all piscidin isoforms may be redundant, the inherent viscosity

95

of the mucous might prevent efficient dispersal of these peptides. Therefore, even though
the pathogens encounter a lower effective piscidin concentration, their combinations
might lead to synergistic effects – a phenotype promoted by a weak DNA repair system,
which likely exists in some aquatic pathogens. We also show here that both Cu-p1 and
Cu-p3 are active in eradicating biofilms, which are more relevant in the external surface
of fish. Conversely, it was shown via qPCR that p3 RNA levels in the gills, intestines and
spleen of hybrid striped bass is higher than those of p1,135 and that an ortholog of p3 is
highly expressed in the gills of the Nile tilapia.138 These are highly vascularized organs in
the fish and therefore, expression of the less hemolytic p3 would be advantageous.
Moreover, in the context of an infection, bacteria that were able to infiltrate the connective
tissue, evade the effects of immune cells and circulate through the bloodstream can
cause recurring infections and persist within the fish. We find here that only Cu-p3 is
active against bacterial persisters, making its expression in highly vascularized organs all
the more profitable.

Methodology
Mass Spectrometry and Cyclic Voltammetry. To determine the stoichiometry of
binding, mass spectrometry was employed. 100 μM of p1 or p3 was mixed with an equal
volume of 100 μM Cu2+ and incubated at room temp for 30 mins. The mixture was diluted
1:500 with 1% formic acid in acetonitrile (ACN) and injected into an electrospray
ionization-mass spectrometer. Resulting spectra was reported without further
manipulation. To determine the standard reduction potential of the respective copper
complexes, we used cyclic voltammetry. A 250 μM solution of p1 or p3 was prepared in
20 mM MOPS, 100 mM KCl pH 7.40, an equal volume of 225 μM Cu2+ was then added
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(slight excess of peptide is present to ensure that no free Cu2+ exists) and incubated for
30 mins. The solution was transferred into a microcell for voltammetry using Ag/AgCl as
reference electrode, glassy carbon as working electrode and a platinum mesh as counter
electrode; a 100 mV/s scan rate over a 1.1 V range was used.
Molecular dynamics simulation of Piscidin and DNA conformations. (Experiment
performed by Dr. Buyong Ma, Dr. Jun Zhao and Dr. Ruth Nussinov, NCI). The initial
Piscidins 1 and 3 conformations were taken from NMR structures (PDB code 2ojm
(piscidin 1) and 2mcx (piscidin 3)). The DNA structure were initially modeled using DNA
response

element

E-box

structure

as

template

and

mutating

sequence

to

AAATACACTTTTGGT. With constraints of hydrogen bonds between base pairs, the DNA
duplex structure was refined using MD simulations, as described below. The piscidinDNA complex structures were searched using Haddock docking and additional manual
adjustment to accommodate/optimize the charge interactions between piscidin and DNA.
Six starting conformations with best initial energy were used to run MD simulations for
p3-DNA complex, and three of them were replaced by p1 to compare their DNA
interactions. The most stable conformation was selected from the MD simulations using
protonated histidines based on free energies. Starting from this select conformation, a
round of MD simulations was performed to test the structural stability of the peptide-DNA
complex at 300 K. The simulations were stopped after confirming the convergence of the
conformation in the MD simulations. For the unstable docking pose, the simulations were
terminated when peptide moves out of docked binding pocket. Images were prepared in
VMD and Pymol.

97

Molecular Dynamics Simulations. (Experiment performed by Dr. Buyong Ma, Dr.
Jun Zhao and Dr. Ruth Nussinov, NCI). Two charged states for piscidins were simulated,
with neutral and protonated histidine residues respectively. The simulation times for the
isolated piscidins were 100 ns at 310 K. For the peptide-DNA complexes, the simulations
were 100 ns for neutral histidine simulation and 30 ns for protonated histidines in the
complexes. MD simulations of the solvated variant models were performed in NPT
ensemble using the NAMD program173 with the CHARMM36 force-field. The models were
explicitly solvated with TIP3P water molecules,174, 175 with a minimum distance of 10 Å
from any edge of the box to any protein atom. Sodium Chloride ions were added at
random locations to neutralize the peptide charge and to maintain the ionic strength at
150 mM salt concentrations. The Langevin piston method173, 176, 177 with a decay period
of 100 fs, and a damping time of 50 fs was used to maintain a constant pressure of 1 atm.
The temperature (300 K) was controlled by Langevin thermostat with a damping
coefficient of 10 ps-1.173 The short-range van der Waals (VDW) interactions were
calculated using the switching function, with a twin range cutoff of 10.0 and 12.0 Å. Longrange electrostatic interactions were calculated using the particle mesh Ewald method
with a cut-off of 12.0 Å for all simulations.178, 179 The equations of motion were integrated
using the leapfrog integrator with a step of 2 fs. The hydrogen atoms were constrained to
the equilibrium bond using the SHAKE algorithm.180 To obtain the relative structural
stability of the variant models, the trajectories were first extracted from the explicit MD
simulation excluding water molecules. The solvation energies of all systems were
calculated using the Generalized Born Method with Molecular Volume (GBMV).181, 182 In
the GBMV calculations, the dielectric constant of water was set to 80.0. The hydrophobic
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solvent-accessible surface area (SASA) term factor was set to 0.00592 kcal/mol∙Å2. Each
variant is minimized 500 cycles and the conformation energy was evaluated by grid-based
GBMV.
Nuclear Magnetic Resonance. (Experiments performed by Prof. Myriam L. Cotten,
College of William and Mary and Dr. Riquiang Fu, NHMFL). Solution NMR: Solution NMR
titration of p3 with Ni2+ was achieved using a buffered solution of either
15

15

N3-His3 p1 or

N3-His3 p3 with a nickel chloride aqueous solution (Fluka). P3 was dissolved at 0.50

mM in Bis-Tris (10 mM, pH 6.8) and aliquots of nickel chloride were added to achieve
specific peptide to nickel molar ratios. Progress of the titrations was monitored using
Heteronuclear Multiple Quantum Coherence (HMQC) solution NMR experiments
previously established.183,

184

The experiments were peformed at the Rensselaer

Polytechnic Institute (Troy, NY) on 800 and 600 MHz Bruker instruments fitted with
cryoprobes. Solid-state NMR: Solid-state samples were made as previously described
(14), with the exception that the peptide (about 2-3 mg) was titrated with an equimolar
amount of Ni2+ prior to binding to DNA. The sequence of the duplex DNA was
AAATACACTTTTGGT, as used in the molecular dynamics simulations. Upon addition of
the peptide to the DNA, aggregation occurred, allowing us to collect hydrated peptideDNA complex for solid-state NMR. The NMR experiments were performed on a midbore
800 MHz magnet equipped with a Bruker Avance III console and fitted with a 3.2 mm lowE triple-resonance biosolids MAS probe at the National High Magnetic Field Laboratory
(NHMFL). Experimental conditions for the NMR experiments were as previously
published.146 Briefly, for each dephasing time (i.e., a multiple of rotor periods), two sets
of data were recorded: one without the train of 15N 180° pulses and one with the train of
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pulses, corresponding to the

13

C signals without (S0) and with (S)

15

N dephasing,

respectively. We collected 10,240 to 30,720 transients depending on the dephasing time.
Since the difference ΔS (S-S0) over S0 depends exclusively on the

13

C−15N dipolar

coupling, we used a MATLAB program to fit the ΔS/S0 ratio as a function of the dephasing
time, and obtained the internuclear

13

C/15N distance. Additional details about fitting the

data and obtaining error bars were previously published.146
In vitro DNA cleavage Assay. The cleavage reactions consisted of 10 μM base pair
pUC19, 100 nM Cu-peptide (or Cu2+), 1 mM sodium ascorbate, and 1 mM H2O2 in 20 mM
HEPES, 100 mM NaCl pH 7.40. Reactions were run at room temperature for the indicated
time points where 10 μL was withdrawn. The reactions were stopped using 3X loading
dye containing 1 mM EDTA. The samples were loaded onto a 1% agarose gel containing
ethidium bromide and ran for 60 mins at 100 V. The gels were imaged using a Bio-Rad
GelDoc XR+ imager and the bands were quantified using the accompanying Image Lab
5.0 software. Due to its diminished capacity to intercalator ethidium bromide, the intensity
of the bands corresponding to the supercoiled form were multiplied by 1.47. Data shown
represent Mean ± SEM obtained from three independent trials. The n1/n2 values were
calculated using equations (1) and (2) from the Poisson distribution and FreifelderTrumbo equation where f(I) and f(III) are the fraction of supercoiled and linearized plasmid
remaining per time point.
f(III)= n2 e^(-n2 )

(1)

f(I)= e^(-(n1+n2))

(2)

Antimicrobial Assay and Time-Kill Kinetics. Antimicrobial susceptibility testing were
done using the broth microdilution method as suggested by Hancock. Gram positive
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Staphylococcus aureus (ATCC 25923); Gram negatives Escherichia coli (MG1655,
TD172 – ΔrecA), and Pseudomonas aeruginosa (PAO1) were grown in Mueller-Hinton
Broth (MHB, Difco) until mid-log phase for 3-5 hrs. Peptide stock solutions were diluted
in PBS (Gibco) pH 7.40, 50 μL two-fold serial dilutions were placed on a sterile 96-well
poplypropylene plate (Greiner). To each well, 50 μL of a bacterial suspension was added
resulting to a final inoculum of 5x105 CFU/mL per well. Plates were incubated at 37°C for
18-20 hrs. Minimum Inhibitory Concentration (MIC) was defined as the concentration that
prevented visual growth of bacteria. MICs reported are the mode obtained from three
independent trials. For time-kill experiments, 350 µL of peptide at 2X the MIC was mixed
with bacteria to yield the same inoculum density as the antimicrobial assay. Every time
point, 10 µL was withdrawn and diluted 1000-fold. Then 100 µL of either the 1:1000 or
the 1:100 dilution was plated on LB agar plates. Colonies were counted manually after
overnight incubation. Curves represent data obtained from two independent trials done in
duplicates.
In cella DNA damage Assay. The Terminal deoxyribonucleotidyl transferase (TdT)mediated dUTP Nick End Labeling (TUNEL) assay was used to assess extent of DNA
damage in live E. coli. A 350 μL aliquot of a 108 CFU/mL E. coli culture was mixed with
an equal volume of the peptides at 2X and 4X its MIC and incubated for 2 hrs. The cells
were pelleted and washed twice with ice-cold PBS. The cells were then fixed with 4%
paraformaldehyde for 30 mins, washed, and permeabilized with 0.1% triton X-100 in 0.1%
sodium citrate for 2 mins. The cells were then pelleted and resuspended in 1X TUNEL
reaction mixture (1 part TdT enzyme, 9 parts label solution; Roche Molecular
Biochemicals, Indianapolis, IN) and were incubated in the dark for 1 hr at 37°C. The cells
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were then pelleted, washed twice with ice cold PBS and resuspended in PBS containing
Propidium iodide for DNA staining. The green and red fluorescence of 100,000 cells were
obtained using a BD FACSCalibur flow cytometer and data were analyzed using FlowJo
v 10 software. Histograms are representative of three independent trials, and bars
represent Mean ± SEM.
Determination of the copper source of p1 and p3. Single colonies of E. coli MG1655
was taken from a LB agar plate and were inoculated into MHB or minimal media, M9
supplemented with glucose. To encourage growth of bacteria in M9, cells were passaged
thrice prior to being used in the experiment. This also ensured infinite dilution of copper
that may have originated from the LB agar plate. Cells were grown in liquid medium to
mid-log phase after which cells were harvested and washed in the corresponding growth
medium they were treated in. A 350 µL, 5x105 CFU/mL suspension was mixed with an
equal volume of peptides (non-metallated or pre-incubated with equimolar concentration
of Cu2+) for 30 mins (for p1 and Cu-p1), 4 hrs (for p3 and Cu-p3) and 2 hrs (for the
untreated controls). The incubation times were selected using the Time-Kill assay as a
guideline and to make sure maximum phenotypic resolution. The cells were incubated at
37°C and diluted up to 1:1000. Then, 100 µL of each dilution were plated into LB agar
plates and incubated overnight for colony enumeration. Bars represent data obtained
from three trials done in duplicates.
Biofilm Inhibition and Biofilm eDNA Cleavage Assay. (Biofilm inhibition experiment
performed by Dr. Ali Alem Bahar and Dr. Dacheng Ren, Syracuse University). An
exponentially growing P. aeruginosa PAO1 culture was used to inoculate 25 mL of fresh
LB broth to an OD600 of 0.05. Biofilms were grown in glass cover slips for 24 hrs at 37°C.
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The cover slips were rinsed by dipping carefully in 20 mM MOPS buffer, pH 7.40, before
transferring to a 10 mm sterile petri plate containing piscidin at varying concentrations.
Following 3 hrs of incubation at 37°C, the coverslips were transferred into conical tubes
containing 10 mL of MOPS buffer, sonicated for 4 mins (at 15 sec intervals), and vortexed.
The cells were concentrated by centrifugation and resuspension in 100 µL of MOPS
buffer. Four 10 µL portions (of each treatment) were then plated into separated LB agar
plates, incubated overnight after which the colonies were counted manually. Bars
represent data obtained from three independent trials. For the eDNA cleavage
experiments, the same treatments were done, following an overnight incubation with the
peptides, coverslips were transferred to conical tubes containing 20 mM Tris-HCl, 5 mM
CaCl2 buffer, pH 8.0 and vortexed for 1 min. the coverslips were removed and 5 µg/mL
Proteinase K was added and incubated at 37°C for 1 hr. After which, the suspension was
centrifuged at maximum speed for 10 mins (to remove planktonic cells and other debris)
and the supernatant was collected. Qiagen spin columns were used to purify extracellular
DNA, using the Qiagen wash buffer provided. The eDNA was eluted using 50 µL of sterile
nanopure water. The DNA was quantified by nanodrop spectroscopy (A260/A280 were all
> 1.80) and a total of 150 µg of DNA was loaded into a 1% agarose gel containing 1X
Sybr Green, ran at 150 V for 2 hrs. Data is representative of three trials done
independently of each other.
Persister Cell Inhibition Assay. (Experiment performed by Dr. Ali Alem Bahar and
Dr. Dacheng Ren, Syracuse University). An overnight P. aeruginosa PAO1 culture was
treated with 200 µg/mL Ciprofloxacin for 3.5 hrs with shaking at 37°C to kill off nonpersister cells. The culture was spun down and washed with MOPS buffer three times
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before resuspending in MOPS buffer at 4°C. A total of 500 µL total volume containing the
indicated peptide concentrations was used, and treatment was done for 3 hrs at 37°C
with shaking. Aliquots were diluted in room temperature MOPS buffer and dilutions were
plated in LB agar plates. After overnight incubation, colonies were counted manually. Bars
represent data from three independent experiments done in triplicates.
Measurement of SOS response via Flow Cytometry. An exponentially growing
culture of E. coli AT15 (a kind gift from Prof Kim Lewis, Northeastern University) was
treated with 50 µg/mL of Ampicillin for 4 hrs at 37°C to kill non-persister cells. The culture
was spun down and cells were washed three times with MOPS buffer before
resuspending to an OD600 of 0.1. A total of 700 µL total volume was used for piscidin
treatment at the indicated concentration. After 2 hrs of exposure to the peptides, the cells
were spun down, washed twice, and resuspended in 15 µL of MOPS buffer containing
0.5 mg/mL of Propidium Iodide (PI). A 10 µL aliquot was used for flow cytometry analysis
in a BD FACSCalibur cytometer, and fluorescence of 100,000 cells were measured. The
gates were established using the Untreated control, and % populations were calculated
(by FlowJo v 10) after applying the same gating parameters through all treatments. Bars
represent data from three independent experiments.
Checkerboard Assay and Synergy Testing. A method analogous to MIC
determinations was used to measure FIC indices. Two-fold serial dilutions of p3 (in MHB
broth) was added to the columns of a sterile 96-well polypropylene plate (except the last
column). Then 50 µL of two-fold serial dilutions of p1 (in MHB) was added to the rows of
the plate (except the last row). The plate was then inoculated with a suspension of 106
CFU/mL of either E. coli MG1655 (WT) or E. coli TD172 (DrecA) and incubated overnight
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at 37°C. The growth was determined by OD600 measurements using a plate reader and
absorbance values were converted to % growth values by dividing it with the untreated
well. The heat map represents Mean ± SEM obtained from three trials done in duplicates.
For visual assessment of synergy, a 3mL culture of 5x105 CFU/mL of bacteria was treated
with ½ MIC of p1 or p3 either alone or in combination. The culture tubes were incubated
in a shaker at 37°C overnight and photographed.
Statistical Analysis. Data were analyzed for statistical differences using Graph-Pad
Prism® v6.0 software. One-Way or Two-Way ANOVA was used to determine statistical
significance and was set at P < 0.05.
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Introduction
The rise of bacterial resistance against small-molecule antibiotics is a growing
global health problem that has led to increased interest in the discovery of agents with a
unique mode of action. Due to their broad-spectrum activity, antimicrobial peptides
(AMPs) have arisen as a paradigm for the design of novel antibiotics. AMPs are a
component of the innate immune system of many organisms, from bacteria and fungi to
vertebrates, invertebrates and plants.1,

6, 185

AMPs have membrane solubilizing, cell

penetrating and DNA/RNA binding abilities.7, 8 Because of their diverse mode of action, a
large effort has been made to develop new classes of anti-infective agents based on
AMPs.6,

7

While some peptides have entered clinical trials, so far, no AMP-based

antibiotics are available in the market right now. Work on the field continues to improve
both efficacy and selectivity against microbes, and prolonging serum stability of
peptides.186, 187
Recent evidence has shown that small molecule bactericidal antibiotics, apart from
their canonical microbial targets, also stimulate the formation of deleterious hydroxyl
radicals. The ROS induction occurs following collapse of the tricarboxylic acid cycle and
subsequent destabilization of iron-sulfur clusters. This liberates free ferrous ions which
catalyze the Fenton reaction, contributing to cell death. 154, 155, 188 While strong arguments
exist against this observation,189, 190 there is generally a consensus in the field that ROS
do play a role in bacterial death by classical antibiotics due to confirmatory work by
several research groups.191, 192 A similar induction of ROS was observed for the AMP
indolicidin, although it was postulated that the •OH radical source was distinct from that
of bactericidal antibiotics.193 In a related note, increasing ROS levels in bacteria either by
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targeting the endogenous ROS-producing mechanism194 or by using silver ions to directly
form ROS,195 have been shown to enhance the bactericidal action of antibiotics in vitro
and in vivo. These studies suggest that synthesis of bactericidal agents with dual actions
– microbial targeting and ROS formation – could lead to the development of clinically
useful molecules.
Numerous peptide-small molecule conjugates have been synthesized to improve
the efficacy of AMPs. Conjugates relevant to this work include amine-based metal binding
groups,196, 197 porphyrins,198-200 and chromophores.200-202 The latter two conjugates are
dual acting in that they directly generate ROS in addition to their classical antibiotic action.
The resulting ROS renders the bacteria more susceptible to the conjugates. Because of
the ability of the ATCUN motif to directly produce ROS, it has also been used to develop
dual-acting antimicrobials. Reports that came out at the same time as the work in this
chapter was being reported have shown that addition of the ATCUN motif to AMPs do in
fact result in higher potencies.203-205 In this chapter, several ATCUN sequences were
assayed for their ability to form ROS when bound to Cu2+ ions. The most active
sequences were added at the amino-terminus of two AMPs with membrane
permeabilizing ability – Anoplin (GLLKRIKTLL-NH2) and the pro-apoptotic peptide (PAP,
KLAKLAKKLAKLAK-NH2).206, 207 We found that addition of the metal-binding motif leads
to a gain-of-function phenotype that affords the resulting conjugate a secondary oxidative
mode of attack.
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Results
Screening for a favorable rate of ROS formation in a small library of tripeptides
A 13-member ATCUN library was prepared by established methods using solidphase peptide synthesis (SPPS) using standard Fmoc protocols. Most of these ATCUN
sequences occur naturally in a variety of proteins (Table 4.1). We first assessed the ability
of these ATCUN sequences to produce ROS after binding copper ions with an assay that
measures the rate at which the Cu-ATCUN complexes undergo multiple turnover redox
process (Table 4.1).91 The rate at which reduced ascorbic acid is consumed was
monitored to measure the turnover rate of the Cu-ATCUN complexes using either O2 or
H2O2 as co-reactant. Initial rates in the presence of H2O2 are higher than in its absence,
a behavior that has been observed in other copper peptide complexes.91 Cu-GGH and
Cu-VIH gave the highest rates for ascorbic acid consumption under both conditions
indicating rapid electrochemical turnover by these complexes. We next examined the rate
at which hydroxyl radicals are formed via reaction with Rhodamine B.117 In agreement
with our ascorbic acid consumption assays, Cu-GGH and Cu-VIH were the most active
complexes (Table 4.1). Taken together, our results indicate that GGH and VIH form ROS
with the fastest kinetics.
Since the four most efficient catalysts for ROS formation were GGH > VIH > RTH
> LKH, these sequences were selected for addition to the AMP sequences. Asp-Ala-His
(DAH) showed slower rates of ROS formation in comparison to the four previously
mentioned, thus, it was selected to serve as a low ROS-producing control sequence.
These tripeptides were appended directly to the N-terminal of Anoplin and PAP without
any amino acid linker. That is, GGH-Anoplin corresponds to GGHGLLKRIKTLL-NH2.
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Table 4.1. Summary of calculated rates for ROS formation by Cu-ATCUN
complexes.

Complex

Source
Protein

Initial Rate of Ascorbic
Acid Consumption
(µM/min)

Initial Rate of Hydroxyl
Radical Formation
(µM/min)

with H2O2

no H2O2

with H2O2

no H2O2

Cu-DAH

Human serum
albumin

1.45 ± 0.07

0.20 ± 0.02

2.44 ± 0.12

0.13 ± 0.03

Cu-DMH

Neuromedin K

1.36 ± 0.02

0.16 ± 0.01

2.57 ± 0.29

0.22 ± 0.02

Cu-DSH

Histatin 5

1.31 ± 0.03

0.13 ± 0.01

2.02 ± 0.06

0.04 ± 0.005

Cu-DTH

Bovine serum
albumin

2.89 ± 0.07

1.28 ± 0.06

2.39 ± 0.23

0.56 ± 0.04

Cu-EAH

Rat serum
albumin

1.14 ± 0.04

0.12 ± 0.02

2.65 ± 0.06

0.47 ± 0.04

Cu-GGH

Simplest
ATCUN

52.54 ± 0.76 19.35 ± 0.43

4.31 ± 0.27

0.92 ± 0.09

Cu-GKH

-

1.21 ± 0.09

0.13 ± 0.01

2.42 ± 0.12

0.19 ± 0.02

Cu-GNH

Neuromedin C

1.15 ± 0.04

0.10 ± 0.002

2.44 ± 0.04

0.07 ± 0.03

Cu-LKH

Xnf7

10.8 ± 0.27

4.52 ± 0.17

3.14 ± 0.14

0.69 ± 0.04

Cu-NGH

Met Lyase

1.29 ± 0.09

0.18 ± 0.01

1.81 ± 0.04

0.14 ± 0.01

Cu-RTH

Human
protamine 2

13.12 ± 0.27

5.67 ± 0.20

2.72 ± 0.08

0.72 ± 0.06

Cu-SMH

Human TBX3

1.39 ± 0.04

0.11 ± 0.01

1.79 ± 0.04

0.07 ± 0.04

Cu-VIH

Designed

39.21 ± 1.08

15.5 ± 0.07

4.08 ± 0.10

0.90 ± 0.09

Cu2+ only

-

57.21 ± 0.81 20.03 ± 0.37

5.03 ± 0.43

0.98 ± 0.09

No CuXXH

-

1.13 ± 0.03

0.10 ± 0.02

0.05 ± 0.003
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0.19 ± 0.02

Antimicrobial activity of the ATCUN-AMP conjugates
The efficacy of the ATCUN-AMPs was assessed by determining their Minimum
Inhibitory Concentration (MIC) against four different bacterial strains: Gram-positive
Bacillus subtilis and Staphylococcus epidermidis and Gram-negative Escherichia coli and
Enterobacter aerogenes. Data obtained using standard antimicrobial susceptibility testing
are shown in Table 4.2. The microbiological characterization showed that the ATCUNAMPs were generally more effective against the Gram-positive bacteria used in this study.
Incorporation of the ATCUN motif to Anoplin and PAP largely resulted in an increase of
their activity, particularly when the ATCUN sequence was VIH. For instance, against E.
coli, VIH-Anoplin was 8-times more active than the parent peptide. GGH was the second
most active ATCUN sequence when bound to the membrane-active peptides Anoplin and
PAP. Since the ATCUN-AMPs bind metal ions, we tested whether the addition of copper
ions could affect its antimicrobial activity. When medium was supplemented with 32 μM
Cu2+, we did not observe a decrease in the activity of the peptides against B. subtilis and
E. coli (Table X). These results suggest that this family of peptides do not induce
starvation for copper ions.
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Table 4.2. Antimicrobial Activity of ATCUN-conjugated AMPs.
Minimum Inhibitory Concentrationa (MIC), µM
Peptide

a

B. subtilis

S. epidermidis

E. coli

E. aerogenes

Anoplin

4 (4)

8

16 (16)

>32

DAH-Anoplin

2 (2)

16

8 (8)

>32

GGH-Anoplin

2 (2)

8

4 (4)

>32

LKH-Anoplin

2

n.d.

4

n.d.

RTH-Anoplin

1

n.d.

4

n.d.

VIH-Anoplin

0.5 (0.5)

2

2 (2)

32

PAP

0.5 (0.25)

4

1 (1)

>32

DAH-PAP

0.25 (0.5)

4

0.25 (0.25)

>32

GGH-PAP

0.125 (0.06)

1

0.125 (0.06)

>32

VIH-PAP

0.125 (0.03)

0.25

0.25 (0.125)

32

Numbers in parenthesis are MICs upon addition of 32 µM to the growth medium.

ATCUN motif conjugation changes the conformation and amphipathicity but not the
cellular localization of Anoplin
We examined the secondary structure adopted by Anoplin and ATCUN-Anoplin
using CD spectroscopy with and without the addition of the membrane mimicking agent,
2,2,2-trifluoroethanol. Figure 4.1 shows that Anoplin and ATCUN-Anoplin adopts a
random coil conformation in buffer. However, when TFE is added to a final concentration
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of 50% (v/v), characteristic curves indicative of an α-helix is observed. This suggests that
Anoplin and ATCUN-Anoplin adopt a helical conformation when interacting with the
bacterial membrane. The resulting curves were used to calculate the percent α-helical
content of each peptide from the observed ellipticity at 222 nm. We found a minor
decrease in the helical content when the ATCUN motif was added to the N-terminal of
Anoplin (Table 4.3). Since protein and peptide function is highly tied to its propensity to
adopt a functional secondary structure, we believe that the activity of ATCUN-Anoplin is
not due to its formation of structured conformations. Since Anoplin has been shown to
adopt an α-helical conformation, its amphipathicity can be analyzed using a helical wheel
diagram (Figure 4.2). An increase in amphipathicity is not expected for the RTH and LKH
derivatives, due to the presence of the helix breakers, Lys 2 and Thr 2 in the hydrophobic
phase of the helix. This explains why the addition of the ATCUN motifs LKH and RTH
resulted in lower percent α helical content for the ATCUN-Anoplin conjugates.

Figure 4.1. Secondary Structure of ATCUN-conjugated Peptides. Circular dichroism
spectra of Anoplin and ATCUN-Anoplin in 25 mM phosphate buffer pH 7.40 (dashed lines)
and in 50% trifluoroethanol in phosphate buffer (solid lines). Spectra show that all
peptides adopt a helical conformation in membrane mimicking solvents.
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Figure 4.2. Helical Wheel Diagram of ATCUN-conjugated Anoplin. Amphipathicity is
shown here as clusters of amino acids having similar hydrophobicities when viewed along
the helical axis. Thr 2 and Lys 2 in ATCUN-Anoplin break the continuum of hydrophobic
residues in each helix. The Eisenberg concensus hydrophobicity scale was used.

Table 4.3. Calculated Percent a-Helix for ATCUN-containing Peptides.
% a-helix
Peptide
PBS 50% TFE
Anoplin

0

56

LKH-Anoplin

0

45

RTH-Anoplin

0

51

To evaluate whether the addition of the ATCUN motif changes the localization of
Anoplin, we used laser confocal microscopy to visualize the fluorescently-labeled
peptides upon incubation with E. coli. The 5(6)-carboxyfluorescein-labeled peptides were
synthesized by coupling the fluorescent probe to the ε-amino group of an extra Lys
residue placed between the ATCUN motif and Anoplin domains. Laser confocal
microscopy showed that fluorescent peptides localized in the bacterial membrane and
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that addition of LKH and RTH to the sequence of Anoplin does not change its localization
(Figure 4.3). This result also suggests that the major target of Anoplin is retained. A similar
localization was observed for PAP (Appendices, Figure S4.1).

Figure 4.3. Cellular Localization of ATCUN-conjugated Peptides. Laser confocal
microscopy (middle) and differential interface contrast (DIC, right) images of live E. coli
cells exposed to fluorescein-conjugated peptides for 30 mins. Micrographs show that
peptides localize in the bacterial membrane.

The ATCUN motif increases the membrane-permeabilizing activity of Anoplin and PAP
Since the addition of the ATCUN motif could affect the ability of the AMPs to turn
the bacterial membranes permeable and allow the cellular contents to leak out, we
assayed membrane permeabilization in E. coli by measuring the amount of β-
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galactosidase leakage from the bacterial cytoplasm after exposure to the ATCUN-AMPs.
After isolating the leaked β-galactosidase, its activity was monitored by adding 2nitrophenyl-β-D-galactopyranoside and measuring the increase in absorbance at 405 nm.
Upon addition of the DAH motif to Anoplin, we found that the membrane lytic activity of
the AMP was improved (Figure 4.4). The addition of GGH and VIH to Anoplin did not
result in an enhancement of the membrane-permeabilizing property of the peptide. In
contrast to the ATCUN-Anoplin peptides, the addition of the GGH and VIH motifs to PAP
increased its membrane-permeabilizing activity, while DAH conjugation to PAP did not
result in increased lytic activity. These results are to be expected as ATCUN motif
conjugation adds three extra residues, one of which contributes to the overall cationic
charge of the peptide, which potentially increases membrane binding affinity.

Figure 4.4. Membrane Permeabilizing Activity of ATCUN-AMPs. E. coli cells were
treated with peptides at their MIC and levels of b-galactosidase that leaked out as a result
of peptide treatment was quantified using a colorimetric assay at 405 nm. *, P<0.05.
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ATCUN-AMPs bound to copper ions can peroxidize phospholipids
Since ROS formation can induce damage to bacterial membranes (Chapter 2), we
next evaluated whether the diffusible and short-lived ROS generated by the ATCUNAMPs bound to copper ions (Cu-ATCUN-AMP) could potentially destabilize the bacterial
membrane through oxidative stress. The oxidative damage brought about by ROS
production was assessed by measuring lipid peroxidation in either small unilamellar
vesicles (SUVs) that mimic the E. coli outer membrane or live E. coli MWF1 (a strain that
contains elevated levels of unsaturated fatty acids in its membrane). The Cu-ATCUNAMP complexes were prepared by mixing 1.5 equivalents of peptide with 1 equivalent of
Cu2+ and pre-incubating at room temperature for 30-45 minutes. The slight excess of
ATCUN-AMP is used to ensure no free copper ions are present. Cu-ATCUN-AMPs were
incubated with 80:20 DOPE:DOPG SUVs in the presence of H2O2 and sodium ascorbate
or with live E. coli in complex media. The malonyldialdehyde formed was then tested via
a standard thiobarbituric acid test.
As can be seen in Figure 4.5, the Cu-ATCUN-PAP complexes showed no
differences among themselves in the amount of peroxidized lipid formed. Interestingly,
the Cu-ATCUN-Anoplin peptides show a trend that trails the observed MICs of the
ATCUN-AMPs, i.e. Cu-VIH-Anoplin and Cu-GGH-Anoplin being more active than CuDAH-Anoplin. Moreover, lipid peroxidation was observed in live bacteria, suggesting
relevance of this mechanism in the activity of this family of ATCUN-AMPs. These results
taken together suggest that the increased antimicrobial action of the ATCUN derivatives
of the membrane-disrupting peptide Anoplin is largely influenced by the oxidative stress
caused by the peptides on the microbial membrane.
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Figure 4.5. Lipid Peroxidation Activity of ATCUN-AMPs. Oxidation of fatty acyl lipid
chains in the bacterial membrane as a result of peptide treatment was assessed by
measuring levels of malonyldialdehyde (MDA) – a product of lipid peroxidation. Percent
lipid peroxidized was normalized against activity of free Cu2+, whose activity was assigned
the value of 100%. Data show that ATCUN-AMPs peroxidize phospholipids both in (A)
purified vesicles and (B) live bacteria. *, P<0.05.

ATCUN-AMPs exhibit low hemolytic activity against human erythrocytes
To assess the selectivity of the tested compounds towards bacteria over
mammalian cells, their hemolytic activity was investigated. Release of hemoglobin from
packed human red blood cells (RBCs) was measured spectrophotometrically and
hemolysis of the peptides was normalized against the hemolytic activity of Triton X-100.
As observed in Table 4.4, all the synthesized peptides had low hemolytic activity at the
observed MIC for E. coli as all of the peptides had less than 10% hemolysis (with the
exception of VIH-PAP with 13%), suggesting a selectivity of these peptides to lyse
bacterial cells instead of RBCs. The data also showed that upon addition of the ATCUN
motif to Anoplin and PAP, general membrane lytic activity increased.
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Table 4.4. Hemolytic Activity and Selectivity Parameters of ATCUN-AMPs.

a

Peptide

% Hemolysis
(@ MIC vs E. coli)

HD10 (µM)a

Therapeutic
Indexb

Anoplin

6±1

> 64

>4

DAH-Anoplin

7±3

64

8

GGH-Anoplin

6±2

16

4

LKH-Anoplin

6±1

64

4

RTH-Anoplin

6±2

16

4

VIH-Anoplin

7±1

4

2

PAP

3±1

64

64

DAH-PAP

4±1

8

32

GGH-PAP

4±1

4

32

VIH-PAP

13 ± 5

<1

<1

Peptide concentration that results in lysis of 10% of red blood cells.

b

The therapeutic

index was calculated by dividing the MIC (vs E. coli) by the HD10 values.

Discussion
This study presents the development of bifunctional antimicrobial agents that
combine the bactericidal/bacteriostatic action of AMPs with the ROS-forming ability of a
CuII-ATCUN complex. We hypothesize that the new ATCUN-AMPs will take advantage
of the presence of the existing pool of labile copper ions in bacteria that flux in response
to environmental stimuli. The large affinity of the ATCUN motif for copper ions (log K ~
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14-15) would allow successful competition for this endogenous pool of copper.91 For this
purpose, the ability of certain ATCUN sequences to form ROS was initially assessed by
monitoring consumption of reduced ascorbic acid. In the presence of the oxidant H2O2
and reductant ascorbic acid, hydroxyl radicals (•OH) and other ROS are produced via the
Fenton reaction, as the bound copper cycles back and forth between its +2 and +3
oxidation states.91, 92 Our experiments showed that both Cu-GGH and Cu-VIH produced
ROS at the highest rates, and as such were chosen to be added at the N-terminus of
Anoplin, and PAP. The DAH derivatives were used as a control for sequences that weakly
form ROS.
When the ATCUN-AMPs were tested for their potency against a panel of four
different bacteria the ATCUN motif was found to increase the activity of Anoplin and PAP
up to a maximum of 16-fold (in the case of VIH-PAP against S. Epidermis). Some AMPs
use metal-chelation as their mechanism of action and do not involve the production of
ROS.83 In those cases, the addition of metal ions such as Cu2+ to the medium affects
negatively their antimicrobial activity. This is not the case for the ATCUN-AMPs presented
in this study, since when 32 μM of Cu2+ ions were deliberately added to the peptide before
incubation with the bacteria, the antibacterial activity of the ATCUN derivatives of all
peptides were retained. This clearly indicates, that metal depletion due to the chelating
ability of the ATCUN-AMPs synthesized in this work is not the mechanism of action used
by these peptides. The ATCUN-AMPs have a low toxicity towards mammalian cells, as
tested by an assay that measures their hemolytic activity. Although the ATCUN
derivatives are slightly more hemolytic than their parent peptides, none of them cause
more than 33% hemolysis at a concentration as high as 32 μM.
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Anoplin is a membrane-acting AMP isolated from the venom of the wasp Anoplius
samariensis with a broad-spectrum antimicrobial activity.206 The fluorescently labeled
Anoplin and ATCUN-Anoplin localize on the bacterial membrane, indicating that the
addition of the ATCUN motif does not change to a major extent the affinity of the Anoplin
sequence for its target. The highest antibacterial activity in the four bacterial strains tested
was observed for VIH-Anoplin. The pore-forming ability of the ATCUN derivatives seems
to be larger than that of Anoplin; however, no correlation between the membranepermeabilizing activity and the MIC values is found. Importantly, ROS-mediated damage
of lipids by the ATCUN-Anoplin peptides in combination with copper ions correlates with
the antimicrobial activity. Thus, it is reasonable to suggest that the increased antimicrobial
activity of the Anoplin derivatives has as origin the nonenzymatic oxidative damage of
membrane phospholipids.208 The process is likely initiated by hydroxyl radicals since
peroxyl radicals are unable to react with fatty acids with rates that are biochemically
important.209 The •OH produced via the ATCUN-CuIII/ ATCUN-CuII cycling can initiate
membrane peroxidation through a hydrogen atom abstraction from a –CH2 group alpha
to a carbon-carbon double bond of an unsaturated fatty acid (Equation (1)). Next, a lipid
peroxyl radical can be formed from the reaction of dioxygen with the lipid radical (Equation
(2)). The radical can then be propagated via reaction 3.
RH

+

HO•

→

R•

+

R•

+

O2

→

ROO•

RH

+

ROO•

→

R•

+

HOH

(1)
(2)

ROOH

(3)

The de novo peptide PAP was designed to be amphipathic in its helical
conformation and strongly interact with bacterial membranes.207 Initial studies have
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established that PAP is a highly active AMP with low toxicity towards mammalian cells.207,
210

Overall, the addition of the ATCUN motif increased the antimicrobial activity of PAP.

The addition of both GGH and VIH doubled the membrane-permeabilizing activity of PAP,
whereas no significant difference was observed with the DAH derivative. The larger ability
to disrupt the membrane structure by the VIH and GGH derivatives can be explained by
analyzing the helical wheel diagram of the three peptides (Figure 4.6). If a peptide adopts
an α-helical conformation, as expected for PAP, the helical wheel diagram provides a
simple tool for the analysis of amphipathicity.211 As observed in Figure 4.6, VIH-PAP can
potentially have the highest amphipathicity, followed by GGH-PAP. The Asp residue in
DAH-PAP is detrimental to the amphipaticity of the peptide, since it would appear
surrounded by hydrophobic residues. The close correlation between the membranepermeabilizing activity and antimicrobial activity is an indication that the main mechanism
of action of the ATCUN-PAP peptides is the disruption of the prokaryotic cell membrane.

Figure 4.6. Helical Wheel Diagram of ATCUN-conjugated PAP. The better
membranolytic activity of ATCUN-PAP may be related to an increased amphipathic
character. Shown here are the clusters of hydrophobic residues in ATCUN-PAP making
a significant hydrophobic phase of the helix. Eisenberg hydrophobicity values are used.
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The present study reveals that the addition of the ATCUN motifs leads to an
increase in antimicrobial activity of the parental AMPs Anoplin, and PAP. Although the
ATCUN-AMPs can induce the formation of ROS, the mechanistic mode of action differs
among peptides and depends largely on the parental peptide. The addition of the ATCUN
motif to Anoplin and PAP results in an increase of their membrane-permeabilizing activity.
In the case of Anoplin, the membrane-permeabilization is caused by ROS-mediated
damage to the lipids; whereas the activity of the PAP derivatives is related to the increase
in amphipathicity. In the field of drug design, it is well accepted that the ability to attack
microbes with multiple mechanisms of activity may have better chances of generating
new antibiotics with broader-spectrum and enhanced antimicrobial activity. Therefore,
agents such as the ATCUN-AMPs synthesized in this work are promising lead
compounds that deserve further studies to fully describe their mechanism of action and
their potential therapeutic applications.

Methodology
Peptide Synthesis, Purification, and Quantification. Peptides in their C-terminal
amidated forms were synthesized manually on a Rink Amide resin (ChemPep Inc,
Wellington, FL) using standard Fmoc-protected L-amino acids (Matrix Innovation,
Quebec, Canada). Coupling reactions were done with 4 eq of amino acids and 4 eq of
HBTU, deprotection using 20% piperidine in DMF and cleavage using 95:2.5:2.5
TFA/H2O/TIS. Free peptides were purified via RP-HPLC (Schimadzu LC-20AD) on a C18
semi-prep 250x10mm column (Grace Davison, Deerfield, IL) using 0.1% TFA in H2O
(Buffer A) and 0.1% TFA in ACN (Buffer B). Tripeptides were subjected to a linear gradient
of 5-95% Buffer B over 20 mins and ATCUN-AMPs were purified using a linear gradient
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of 30-60% Buffer B over 30 mins. 5(6)-Carboxyfluorescein (Sigma Aldrich) labeled
peptides were synthesized by attaching the fluorophore to the ε-amino group of an
additional Lysine residue and were purified in the same way as the ATCUN-AMPs. Pure
fractions were collected and the identities confirmed by ESI-MS ran on a positive
ionization mode. All purified Peptides were subsequently reinjected on a C18 analytical
250x4.6 mm column (Grace Davison, Deerfield, IL) and were found to be ≥ 95% pure. All
peptides were quantified using a method suggested by Gruppen. Briefly, lyophilized pure
peptides were dissolved in nanopure water and a small aliquot was diluted in 80:20:0.1
H2O/ACN/Formic Acid and absorbance of this solution was read using a Varian Cary
50Scan UV-Vis Spectrometer at 214 nm. Molar extinction coefficient of each peptide was
calculated on a sequence-specific manner based on the reported values for each amino
acid and the peptide bond.
Peptide Handling and Preparation. All water used in this study was obtained from
a Barnstead NANOpure Diamond filtration system with a 0.2 μm pore size filter. Purified
peptides dissolved in nanopure water were stored at 4°C, and were diluted to the required
concentration on the day of use. Concentrations were regularly checked via UV-Vis
spectrophotometry. To form CuII-peptide complexes, 1.5 eq of peptide was mixed with 1
eq of Cu2+ (to ensure no free metal ion is present) and were pre-incubated at room
temperature for 30-45 mins.
Determination of Ascorbic Acid Consumption. The rate at which ascorbic acid was
consumed by the CuII-ATCUN complex was measured by the decrease in absorbance of
reduced ascorbic acid. Reaction mixture contained 10 μM CuII-XXH complex with 1 mM
Ascorbic acid with and without 1 mM H2O2 in 20 mM HEPES, 100 mM NaCl at pH 7.40.
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Absorbance at 300 nm was measured on a clear 96-well plate using a Molecular Devices
FlexStation 3 Plate Reader. Absorbance was plotted versus time and the slope of the
linear portion of the curve was used to determine the rate constant of reaction. Ascorbic
acid molar absorptivity was used to convert units of rate to μM ascorbic acid/min. Average
values were taken from three trials and presented as Mean ± SD.
Antimicrobial Assay. Antimicrobial susceptibility testing was done using the broth
microdilution method as suggested by Hancock. Gram-positives Bacillus subtilis (PS832),
Staphylococcus epidermidis (ATCC 12228) and Gram-negatives Escherichia coli (DL7),
and Enterobacter aerogenes (ATCC 13048) were grown in Mueller-Hinton Broth (MHB,
Difco) until mid-log phase for 3-5 hrs. Peptide stock solutions were diluted in PBS (Gibco)
pH 7.40, 50 μL two-fold serial dilutions (starting from 32 μM) were placed on a sterile 96well poplypropylene plate (Greiner). To each well, 50 μL of a bacterial suspension was
added resulting to a final inoculum of 5x105 CFU/mL per well. Ampicillin (Sigma Aldrich)
was used as positive control and PBS as negative control. Plates were incubated at 37°C
(30°C for E. aerogenes) for 18-20 hrs. For experiments with the Cu-ATCUN-AMP
complexes, the same dilutions and bacterial manipulations were done using MHB
containing Cu2+. A small aliquot of a concentrated Cu2+ solution was added to the MHB
to bring the final Cu2+ concentration to 32 μM (well below the toxic level of Cu2+ in E. coli
which is 3.5 mM). Minimum Inhibitory Concentration (MIC) was defined as the
concentration that prevented visual growth of bacteria, and results were confirmed by
matching to a plate reader OD600 nm measurement. MICs reported here is the average of
three independent trials.
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β-Galactosidase Leakage Assay. The membrane disruption caused by the
peptides was assessed by measuring the amount of leaked β-galactosidase. Overnight
cultures of E. coli were inoculated in fresh LB broth and were grown to OD600 nm ≈ 0.6.
Overexpression of β-galactosidase was induced for 1 hr by addition of isopropyl-β-Dthiogalactopyranoside (IPTG, Fisher) at 1 mM final concentration. The cells were washed
three times with PBS and resuspended in fresh LB broth. 75 μL of the bacterial
suspension was mixed with 75 μL of two-fold serial dilutions of the peptides (starting from
32 μM) in sterile microcentrifuge tubes. The mixture was incubated at 37°C for 1 hr. After
incubation, tubes were spun down at 4400 rpm at 4°C for 10 mins, then 100 μL of the
supernatant was transferred to a clear 96-well plate. 50 μL of 2-nitrophenyl-β-Dgalactopyranoside (ONPG, Thermo Scientific) in PBS was added at 0.8 mg/mL final
concentration. The β-galactosidase activity was monitored by measuring the increase in
absorbance at 405 nm every 5 mins for a period of 1 hr. Data shown are the final
absorbance readings for three independent trials and presented as Mean ± SD.
Lipid Peroxidation Assay. The extent of Oxidative damage in the surface of the cell
was measured by quantifying the peroxidation products of unsaturated phospholipids. A
model E. coli membrane was made from an 80:20 mole percent mixture of 1,2-dioleoylsn-glycero-3-phosphoethanolamine (DOPE, Avanti Polar Lipids, Alabaster, AL) and 1,2dioleoyl-sn-glycero-3-phospho-1’-rac-glycerol sodium salt (DOPG, Avanti Polar Lipids,
Alabaster, AL). The chloroform was evaporated by a steady stream of N2 and was dried
further overnight in a high vacuum line. The lipid cake was rehydrated with 20 mM
HEPES, 100 mM NaCl at pH 7.40 for 1 hour, vortexed 5 times and was sonicated for 20
mins to generate Small Unilamellar Vesicles (SUV). A 100 μM total lipid solution of SUV
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was incubated with 10 μM of CuII-ATCUN-AMP complexes with 1 mM H2O2 and 1 mM
sodium ascorbate in rehydration buffer for 1 hour. Then 50 μL of Butylated
Hydroxytoluene was added followed by 1.5 mL of 0.44 M H3PO4. The mildly acidic mixture
was incubated for 10 mins prior to addition of 500 μL of 2-thiobarbituric acid (TBA). The
mixture was then heated on a dry block heater set at 90°C for 30 mins. After cooling down
to room temperature, the amount of malonyldialdehyde-TBA adduct was quantified by
injecting 50 μL of the final reaction mixture in a C18 analytical column. Elution was done
at 35% methanol and 65% 50 mM KH2PO4/KOH buffer at pH 7.00 and monitored at 532
nm. The peak at ~4.6 mins represents the amount of the pink MDA-TBA adduct. The
average of the peak area obtained from three independent trials are reported and
presented as Mean ± SD.
Confocal Fluorescence Microscopy Imaging. Images were acquired on Zeiss LSM510 confocal microscope using a 63X (1.4 N.A.) oil immersion objective at a pixel
resolution of 512 × 512, and then processed utilizing ImageJ (National Institutes of
Health).
Hemolytic Assay. To assess selectivity of the peptides towards bacterial
membrane disruption, extent of hemolysis was measured. Packed Human Erythrocytes
(ZenBio Inc, Research Triangle, NC) with anticoagulant Citrate Dextrose were washed
three times with sterile PBS. A small aliquot of washed cells were resuspended in fresh
PBS to make a 0.8 % (v/v) solution of RBC. Then 75 μL of RBC was mixed with 75 μL of
a two-fold serial dilution series of the peptides and incubated at 37°C for 1 hr. Triton X100 and PBS were used as positive and negative controls, respectively. The tubes were
then spun down at 4400 rpm at 4°C for 10 mins and 100 μL of the supernatant was
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transferred to a clear 96-well plate. The absorbance at 414 nm was measured and was
normalized against the absorbance of the positive and negative controls. Data are
obtained from four independent trials presented as Mean ± SD.
Statistical Analysis. Data were analyzed for statistical differences using Graph-Pad
Prism® software. The Mann–Whitney asymptotic U-test was used for comparison
because a Gaussian distribution could not be assumed. Whenever ties were present,
comparison was done using Chi-square test. Statistical significance for all tests was set
at P < 0.05.
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Chapter 5

The ATCUN Motif in General Antimicrobial Drug Development – Part II
ATCUN motif Conjugation to AMPs Results in a Gain-of-Function Phenotype
Imparting the Ability to Oxidatively Cleave Microbial DNA
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Introduction
In chapter 4, we appended the ATCUN motif to the membrane active AMPs
Anoplin and PAP to address the influence of an exogenously added ATCUN motif to the
activity of AMPs. The resulting ATCUN-AMP conjugates were found to be more active
compared to the parental AMPs. We proposed that this increase in activity arises from
the endogenous capability of the ATCUN-AMPs to inflict oxidative stress (when they bind
to labile copper ions) on top of the classical antimicrobial action of the parent peptide. Our
initial mechanistic evaluations lead us to believe that the ATCUN-AMPs ultimately cause
membrane damage by lipid peroxidation on the natural target of the parent AMP.
The success of the ATCUN motif conjugation to Anoplin made us wonder whether
the same phenotype can be observed on an AMP that naturally targeted the bacterial
DNA. Cowan and Long have shown that Cu-ATCUN complexes possess nuclease activity
via formation of ROS when the metal cycles back and forth its +2 and +3 oxidation states
under physiologically relevant conditions.90, 91, 212-215 In this regard, we conjugated ATCUN
motifs to the DNA-binding AMP, Buforin II. We aimed at developing a conjugate that could
bring the ATCUN motif in close proximity to bacterial DNA and generate ROS in the
vicinity to effect DNA cleavage.
The rational design of AMPs largely depends on the understanding of the
molecular characteristics responsible for the antimicrobial action. Here, to address the
influence of a basic residue in the ATCUN motif in AMPs that target DNA, we have
appended the RTH motif to sh-Buforin and compared it to a derivative containing a VIH
motif. We hypothesize that the addition of a positively-charged ATCUN motif will allow a
stronger interaction with DNA resulting in an AMP with increased antimicrobial activity.
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We have also investigated the effects of a change in stereochemistry to the bioactivity of
ATCUN-sh-Buforin conjugates. We hypothesize that increased antimicrobial activity of
ATCUN-sh-Buforin is expected since L-to-D amino acid substitution have been shown to
increase the ROS-generating activity of the ATCUN motif.91 The results provided in this
chapter are important information for the further optimization of ATCUN-based
antimicrobial agents.

Results
Initial ATCUN motif conjugation to sh-Buforin generates a peptide-based nuclease
sh-Buforin is a truncated analogue of buforin II (TRSSRAGLQFPVGRVHRLLRKNH2), a potent AMP that kills bacteria without cell lysis and has a strong affinity for
oligonucleotides.11, 114, 216, 217 The N-terminal random structure (residues 1-4) does not
appear to be important to the antibacterial activity of buforin II,114 thus the addition of the
ATCUN motif was not expected to perturb its mode of action. Driven by the calculated
rates of ROS formation from Chapter 4, we proceeded to append the ATCUN motifs DAH,
GGH and VIH to sh-Buforin (RAGLQFPVGRVHRLLRK-NH2). A structure-activity
relationship study showed that sh-Buforin had increased translocation activity across
bacterial membranes relative to the full peptide.114 ATCUN motif conjugation resulted in
a two- to four-fold decrease in MIC against E. coli and B. subtilis. We postulated that this
increase was likely a result of oxidative DNA cleavage being afforded by the exogenous
ATCUN motif and we tested this hypothesis using an in vitro model of DNA cleavage.
Damage to the DNA plasmid pUC19 by ROS was monitored after 30 mins and 2 hours of
incubation with the Cu-ATCUN-sh-buforin complexes. Figure 5.1A shows a time-
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dependent cleavage of plasmid DNA with the supercoiled form decreasing overtime and
the linearized form simultaneously building up. We then measured the degree to which
the peptides can affect general oxidative stress in live bacteria by monitoring the increase
in fluorescence of an ROS-responsive fluorophore – 2’,7’-dichlorofluoresceindiacetete.
Figure 5.1B shows that ATCUN-sh-buforin can generate >3-fold amount of ROS within
cells and this activity mirrored the rates of ROS formation by the isolated tripeptides.
These evidences point to a capability of Cu-ATCUN-sh-buforin to induce generalized
oxidative stress within bacteria, generating DNA nicks that could be responsible for the
antibacterial action.

Figure 5.1. Initial Assessment of ATCUN-sh-Buforin Activity. (A) pUC19 plasmid
DNA was used to monitor in vitro nuclease activity of ATCUN-sh-Buforin derivatives.
Reactions were quenched at two time points showing a time-dependent cleavage of DNA
promoted by the peptides. (B) General oxidative stress in E. coli was measured using the
fluorescent reporter dichlorofluorescein. Cells pre-loaded with the dye were treated with
the peptides and the indicated controls for 2 hrs. *, P<0.05.
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Design principles to optimize nuclease activity of ATCUN-sh-buforin
We selected the ATCUN motif RTH not only because it has moderately high initial
rates of ROS production, but also due to the structural similarities of the metal-bound
ATCUN motif to DNA binding agents such as Netropsin and Hoescht 33258 as illustrated
by Long.218 We reasoned that these two factors could lead to an added interaction with
DNA, generating a more potent antimicrobial. In addition, we synthesized ATCUN-shbuforin peptides containing D-enantiomers since we wanted to explore the influence of
amino acid stereochemistry in the activities of the peptides as it has been previously
reported that changes in the stereochemistry can tune the reactivity of the copper-bound
ATCUN motif.91

L-to-D amino acid substitution positively affects the potency of ATCUN-sh-buforin
To assess the relative efficacy of the synthesized peptides, the minimum inhibitory
concentration (MIC) was determined against E. coli, and E. aerogenes. Our data shows
that addition of the ATCUN motif generally leads to an increase in antimicrobial activity
against all strains used. For the case of E. coli MG1655 (a wild type K-12 strain), a twofold increase was observed when RTH was added to L-sh-buforin and a four-fold increase
when RTH and VIH were added to D-sh-buforin. Table 1 also shows that the D-peptides
are more active compared to the L-peptides. An 8-fold increase in activity was seen when
the stereochemistry of L-sh-buforin was changed and up to a 32-fold increase was seen
for the case of L-VIH-L-sh-buforin. Interestingly, the data also shows that changing the
stereochemistry of the ATCUN motif does not affect the antimicrobial activity (L-ATCUNL-sh-buforin vs D-ATCUN-L-sh-buforin) and that MIC seem to be largely dictated by the
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stereochemistry of the parental peptide, sh-buforin. It is also worth noting that while all
the other peptides exhibited MIC values in the high micromolar range, D-VIH-D-sh-buforin
had an MIC of 16 μM against the problem pathogen E. aerogenes, the causative agent
of many nosocomial infections. Buforin II and sh-buforin has been shown to exert its
action by penetrating the bacterial membrane and interacting with both DNA and RNA.
We hypothesize that ATCUN-sh-buforin can interact and directly damage the DNA via
ROS formation. Because of this, a bacterial strain incapable of repairing DNA damage is
expected to be more susceptible to ROS relative to the wild type strain. This phenomenon
has been observed on several occasions. In this regard, we determined the MIC of our
peptides against E. coli TD172, a strain wherein the DNA repair protein RecA has been
deleted. Most of our peptides exhibited a two-fold increase in activity (Table 5.1) when
tested against the recA deletion mutant compared to the wild type; this hints at the
possibility that ATCUN-sh-buforin acts by damaging the DNA. We used as a control, the
membrane active peptide, magainin 2, which generates tension-induced pores on the
surface of bacterial membranes. We found that activity of magainin 2 was the same in
both E. coli strains, further implicating DNA as the major target for sh-buforin and ATCUNsh-buforin.
Chelating agents like the ATCUN motif can devoid cells of essential copper ions,
perturbing metabolic functions, which can cause cell death. Notably, the Cu(II)-chelating
antimicrobial peptide microplusin exerts its action by copper starvation. Excess Cu2+ in
the medium was found to rescue the growth of bacteria exposed to microplusin. We
determined the MIC of our peptides when the growth medium was supplemented with 32
μM (Table 5.1, +Cu2+) and found that the additional Cu2+ does not reduce the activity of
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our peptides. Interestingly, we observed a two-fold increase in activity for L-RTH-D-shbuforin and D-VIH-D-sh-buforin when Cu2+ was supplemented, which might indicate full
activity during a copper-saturated state for these peptides.
Table 5.1. Antimicrobial Activity of sh-Buforin and ATCUN-sh-Buforin Analogs.
Minimum Inhibitory Concentration (MIC)a, µM
Peptide

E. coli MG1655 (WT)

E. coli TD172 (DrecA)

E.
aerogenes

no Cu2+

+ Cu2+

no Cu2+

+ Cu2+

L-sh-Buforin

64

64

32

32

>64

L-RTH-L-sh-Buforin

32 *

32 *

16 *

16 *

64

L-VIH-L-sh-Buforin

64

64

32

32

64

D-RTH-L-sh-Buforin

32 *

32 *

16 *

16 *

64 b

D-VIH-L-sh-Buforin

64

64

32

32

64 b

D-sh-Buforin

8#

8#

4#

4#

64

L-RTH-D-sh-Buforin

2*

2*

2*

1 *,**

32

L-VIH-D-sh-Buforin

2*

2*

1*

1*

32

D-RTH-D-sh-Buforin

4 *,#

4 *,#

2 *,#

2 *,#

32 b

D-VIH-D-sh-Buforin

2 *,#

4 *,#

2 *,#

1 *,#,**

16

Magainin 2

8

8

8

8

N.D.

Ampicillin

2

N.D.

2

N.D.

16

Kanamycin

0.125

N.D.

0.125

N.D.

1
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a

+ Cu2+ runs represent supplementation of growth medium with 32 µM of Cu2+.

b

Significant reduction in growth was observed until 16 µM. *, P<0.001 compared to shBuforin; #, P<0.001 compared to their enantiomer (pure L vs pure D); **, P<0.001 when
compared to trials without Cu2+.

D-sh-buforin have bactericidal activity against E. coli
To study the dynamics of bacterial killing, we quantified the number of viable cells
for a specified period of time following exposure to the peptides. Since a change in
stereochemistry of the ATCUN motif did not show a difference in MIC, we decided to
study only the pure L- and pure D-enantiomers. Our data shows that the D-peptides are
bactericidal at their MIC (exhibiting about four orders of magnitude decrease in
population), in contrast to the bacteriostatic effects of the L-peptides. For the wild type
(Figure 5.2), killing starts 2 hours after exposure to the peptide, whereas it only takes 1
hour to start killing off the recA mutant (Figure 5.2). This corroborates our MIC values,
indicating that the peptides are more effective against the recA mutant. For both L-RTHL-sh-buforin and L-VIH-L-sh-buforin, the rate of growth of bacteria seemed to exceed the
rate of growth of inhibition by the peptides 4 hours post-exposure. This phenomenon has
been observed for the all-D-enantiomer of the antimicrobial peptide KLAKLAKKLAKLAK
at its MIC against P. aeruginosa,219 and recently for a Vancomycin analog at its MIC
against MRSA.220 This suggests that bacterial clearance is incomplete at the MIC for LATCUN-L-sh-buforin.
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Figure 5.2. Bactericidal Activity of ATCUN-sh-Buforin. Time-kill kinetics curves
following exposure to peptides at their MIC against E. coli WT (left) and recA mutant
(right). Viable cells were enumerated at the indicated time points via spreading dilutions
in LB agar plates.

Spectroscopic studies reveal that metalation of ATCUN-sh-buforin does not change its
secondary structure
To determine the secondary structure adopted by the peptides we obtained the
circular dichroism spectra of each peptide from 190 to 250 nm in a 50% (v/v) 2,2,2trifluoroethanol (TFE) in 100 mM phosphate buffer pH 7.40. TFE mimics the bacterial
membrane, hence, under these conditions; the functionally relevant conformations of the
peptides can be determined. Figure 5.3 (and Appendices, Figure S5.1), shows that L-shbuforin and L-ATCUN-L-sh-buforin adopts an alpha-helical conformation as evidence by
the minimum negative peak at around 208 and 222 nm, and the maximum positive peak
at 190 nm. The spectra of D-sh-buforin and D-ATCUN-D-sh-buforin were observed to be
the exact mirror images of their respective enantiomers. We also determined the effect of
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Cu2+ binding to the conformation of peptide and we found that complex formation does
not affect the overall helicity (blue and green curves in Figure 5.3).

Figure 5.3. Spectroscopic Characterization of ATCUN-sh-Buforin Secondary
Structure. CD Spectra of VIH-sh-Buforin with and without Cu2+ in 50% (v/v)
trifluoroethanol and phosphate buffer. Spectra show characteristic curve for an a-helical
peptide.

The amount of α-helix present was calculated based on the mean residue ellipticity
at 222 nm using eqn 2 (Methodology). Our results show that all our peptides contain 3543% α-helix, and counter intuitively, the addition of an ATCUN motif (of any
stereochemistry) leads to a slight decrease in α-helical content. Buforin II contains three
structured domains separated by a proline hinge at position 11 – the N-terminal random
coil, an extended helical domain from the 5th to 10th amino acid, and a C-terminal regular
helix.114 In a structure-activity relationship study of buforin II, it was found that sh-buforin
contained about 9% more helical content compared to the complete peptide.114 The
observed increase in helicity is probably due to the loss of the random coil domain of
buforin II when the first four amino acids are truncated. When the ATCUN motif is added,
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it occupies the region where a random coil is expected, which explains the decrease in
helicity. No significant difference in values was observed when the stereochemistry of the
peptides was changed, nor did it change upon addition of copper (Table 5.2).
Table 5.2. Calculated percent helicity for the synthesized peptides.
% α helix
Peptide
- Cu2+ + Cu2+
L-sh-Buforin

42

-

L-RTH-L-sh-Buforin

36

38

L-VIH-L-sh-Buforin

40

41

D-RTH-L-sh-Buforin

39

39

D-VIH-L-sh-Buforin

40

39

D-sh-Buforin

43

-

L-RTH-D-sh-Buforin

40

40

L-VIH-D-sh-Buforin

36

36

D-RTH-D-sh-Buforin

35

37

D-VIH-D-sh-Buforin

37

39

ATCUN-sh-buforin does not exhibit a membranolytic activity
The extent to which sh-buforin and its analogs disrupt bacterial membranes was
measured by quantifying the amount of leaked enzyme after exposure to the peptides.
The β-galactosidase content of the supernatant was determined by a colorimetric reaction
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monitored at 405 nm. When E. coli cells are exposed to sh-buforin and ATCUN-sh-buforin
at their MIC, we observed very minimal membrane damage (four to five fold less) relative
to the membrane active peptide, magainin 2 (Figure 5.4). No significant difference was
found with either a change in stereochemistry or a change in the ATCUN motif. This
suggests that both sh-buforin and ATCUN-sh-buforin (of either stereochemistry) exert
very little perturbations in the integrity of bacterial membranes, in conjunction with the fact
that buforin II is a cell-penetrating peptide able to kill bacteria without cell lysis.

Figure 5.4. Membranolytic Activity of ATCUN-sh-Buforin. Hydrolysis of O-nitrophenylb-D-galactopyranoside (ONPG) to o-nitrophenol was used to quantify amount of leaked
enzyme from E. coli exposed to peptides at their MIC. *, P<0.001 compared to L- and Dsh-Buforin.

ATCUN-sh-buforin induces oxidative stress in bacteria
Since the ATCUN-sh-buforin can form ROS when bound to Cu2+ ion, and because
sh-buforin has been shown to traverse the membrane and localize in the cytoplasm, we
studied the amount of ROS formed inside bacterial cells. We used the pro-fluoresent
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probe 2’,7’-dichlorofluorescein diacetate (dCFdA) to study generalized oxidative stress
inflicted by our peptides. dCFdA can cross membranes, once inside, it gets deacetylated
by cellular esterases. This non-fluorescent derivative is polar enough that it is essentially
trapped inside the cell. When it gets oxidized by ROS, it generates the highly fluorescent
2’,7’-dichlorofluorescein. We incubated E. coli MG1655 cells with the peptides at MIC (no
Cu2+ added) for two hours – at which point killing has not started yet (as evidenced by the
time-kill kinetics experiment) – and then we measured the fluorescence of 100,000 cells
using a flow cytometer. Our treatments did not lead to a significant change in the cellular
morphology as shown by the scatter plots (Appendices, Figure S5.2). Our results (Figure
5.5) indicate that there is a buildup of ROS inside the cell preceding cell death. A threeto seven-fold increase in intracellular ROS was observed when the bacteria were treated
with our peptides. This may be related to the fact that antibiotics can induce formation of
hydroxyl radicals via a pathway involving the tricarboxylic acid cycle and a transient
destabilization of iron-sulfur clusters, a phenomenon that has been repeatedly reported
by Collins.155,

221, 222

This has also been observed for antimicrobial peptides, and

respiratory proteins.223,

224

Figure 5.5 shows that there is a greater amount of ROS

induced by D-sh-buforin compared to L-sh-buforin. Curiously, The ATCUN-sh-buforintreated cells formed the same amount of ROS as the sh-buforin-treated cells. A logical
explanation for this observation is the model proposed by Cowan and Dervan where the
ROS is intimately bound to the copper center and is not released to the surroundings.
Thus, we believe that the ROS detected in this assay arises solely from the classical
pathway as proposed by Collins and not from direct formation via the Cu-ATCUN
complex.
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The most accessible ROS, the superoxide anion (O2-•) – arising from a single
electron reduction of molecular oxygen – can release iron from iron-sulfur clusters from
metalloenzymes. The Fe2+ released can then undergo Fenton reaction to produce
hydroxyl radicals, essentially amplifying the amount of ROS. To eliminate this effect, we
repeated the ROS experiment with pre-incubation of the bacteria with the iron chelator,
2,2’-bipyridine (bpy). Our results show no significant difference when bpy is added
indicating that the measured ROS is not due to endogenous ferrous ions.

Figure 5.5. Intracellular ROS production of ATCUN-sh-Buforin. General oxidative
stress was monitored using the ROS-responsive probe dichlorofluorescein. To study the
effect of iron released from {4Fe-4S] clusters by ROS, the iron chelator 2,2’-bipyridine
was added. a formation of Cu(bpy)3 leads to less availability of copper to undergo redox
cycling. *, P<0.05 and **, P<0.01 when compared to L- or D-sh-Buforin.

Next, we wanted to determine the extent to which ROS production is involved in
the death of cells exposed to our peptides. We incubated E. coli MG1655 with the
peptides at their MIC with and without the radical scavenger, thiourea for three hours and
compared the survival rate. Thiourea has been shown to rescue the growth of bacteria
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exposed to ROS-generating agents.155,
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Our results indicate that ROS is indeed

contributing to the antibacterial action of the peptides and that quenching the ROS formed
inside the cell diminishes their efficacy to varying degrees. Figure 5.6A shows a visible
reduction in the number of colonies when thiourea (TU) is present. We also observed a
greater difference in survival with thiourea when cells were incubated with ATCUN-shbuforin (Figure 5.6B), which suggests that ROS production plays an important role in the
mechanism of the conjugates.

Figure 5.6. Involvement of ROS in ATCUN-sh-Buforin Activity. (A) Representative
agar plates showing different bacterial susceptibility towards L-VIH-L-sh-Buforin in the
presence of the radical scavenger, thiourea. (B) Presence of thiourea rescues survival of
peptide-exposed E. coli. A greater degree of protection was observed during ATCUN-shBuforin treatments. *, P<0.01.
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Positively charged ATCUN motifs promote DNA binding in vitro
Buforin II is found in the N-terminal region of Histone H2A of Xenopus,226 and
hence has DNA-binding capability as shown by previous in vitro experiments.11, 227 We
determined how the addition of the ATCUN motif changes the affinity of sh-buforin to DNA
by employing a competition assay between Ethidium bromide (EtBr) and our peptides.
We titrated a mixture of pUC19 plasmid and EtBr with the peptides (or pre-formed CuATCUN-sh-buforin) and then measured the decrease in fluorescence after every addition.
We observed no statistically significant difference in binding when the ATCUN motif is
added (Figure 5.7A). This result was counterintuitive as addition of the tripeptide
sequence increases the net charge, Z by 0.1 (for VIH) and by 1.1 (for RTH). On the other
hand, when we utilized a 15-mer dsDNA oligonucleotide whose sequence was extracted
from the portion of the DNA directly bound to the buforin II segment of Histone H2A (5’AAATACACTTTTGGT-3’),217 we observed an increase in binding when RTH is added to
sh-Buforin (Figure 5.7B). Changing the stereochemistry of the peptides also did not give
rise to a change in DNA binding. This suggests that the interaction between DNA and shbuforin is largely ionic in nature. When pUC19 was titrated to pre-formed CuII-ATCUN-shbuforin, a dramatic increase (up to four-fold) in binding affinity was observed. CuII-RTHsh-buforin showed higher binding compared to CuII-VIH-sh-buforin (for both
stereochemistries); this is likely a result of the key interactions between the guanidinium
group of Arg and the nitrogenous bases in the DNA as mapped out by Long and coworkers for the CuII-Arg-Gly-His complex.218 The CuII-ATCUN complex has high affinity
towards A/T-rich regions of the DNA minor groove.228, 229 We hypothesize that the large
difference in binding affinity is caused by a change in binding mode – without Cu2+,
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ATCUN-sh-buforin binds through the buforin portion, but with Cu2+, it binds through both
the buforin domain and the metal complex greatly increasing the formation constant of
the peptide-DNA complex.

Figure 5.7. In vitro DNA binding of ATCUN-sh-Buforin. (A) Peptide-plasmid pUC19
association constant was calculated by measuring the decrease in ethidium bromide as
a function of added peptide. Calculated values were normalized against L-sh-Buforin
whose Ka = 1.00. A dramatic increase in binding was observed when Cu2+ is added. (B)
Association constant defined as the concentration of peptide required to reduce initial
fluorescence of ethidium bromide by half. RTH-sh-Buforin were found to bind tighter to a
15-mer oligonucleotide whose sequence was extracted from the portion of DNA directly
bound to the Buforin II portion of Histone H2A. *, P<0.05; **, P<0.01; ***, P<0.005; and
****, P<0.001.

ATCUN-sh-buforin have catalytic nuclease activity in vitro
Since the ATCUN motif can form ROS and subsequently cleave DNA when bound
to Cu2+, we studied the extent of DNA linearization promoted by the Cu-ATCUN-shbuforin complexes. We used as a model DNA target, a solution of the plasmid pUC19.
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Our results showed a time-dependent decrease in the supercoiled form with a
concomitant increase of the linearized form (Figure 5.8A, and Appendices Figure S5.3).
We quantified the amount of supercoiled and linearized pUC19 at each time point and
plotted it against time (Appendices Figure S5.3). The resulting curves show that rate of
DNA cleavage is faster for ATCUN-D-sh-buforin compared to ATCUN-L-sh-buforin as
evidenced by their slope. Our data show that the VIH-sh-buforin peptides cleave DNA
faster compared to RTH-sh-buforin. This is not surprising because the oxidative nuclease
activity is largely influenced by the sequence and stereochemistry of the ATCUN motif
alone.90, 91 Results also show that there is generally a smaller amount of supercoiled form
that remains when it is incubated with ATCUN-D-sh-buforin, and that an L-to-D amino
acid substitution in the ATCUN motif alone leads to a smaller (however statistically
insignificant) amount of supercoiled DNA (Figure 5.8B). Taken together our results
indicate that DNA cleavage is controlled largely by the stereochemistry of the parent
peptide and to a smaller extent the stereochemistry of the ATCUN motif. Even though we
did not study the rate of ROS formation of the D-ATCUN motifs alone, our DNA cleavage
results agree with what Cowan and his co-workers pointed out that an L-to-D amino acid
substitution leads to a greater rate of ROS-promoted DNA cleavage.91
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Figure 5.8. In vitro Nuclease Activity of ATCUN-sh-Buforin. (A) DNA cleavage was
monitored using agarose gel electrophoresis at the indicated time points following
incubation with the copper complexes of the peptides. N = nicked, L = linearized, and S
= supercoiled form of the plasmid pUC19. (B) Amount of supercoiled plasmid remaining
at the end of the experiment (a reporter of degree of reaction completion) shows that
ATCUN-D-sh-Buforin cleaves DNA more efficiently compared to their enantiomer. *,
P<0.05; **, P<0.01.

A closer examination of the cleavage patterns show a propensity for linearization,
that is, the intensity of the bands corresponding to the nicked form seem to plateau out
(around 60 mins) while that of the linearized form seem to continue increasing (Figure
5.8A). This suggests that double strand breaks are preferred over single strand breaks.
Single-strand (ss) nicks in opposite strands of DNA can occur sufficiently close such that
the forces stabilizing the double helix is weakened resulting to a double-strand (ds) break.
Rationally, when the metallopeptide binds to a specific region on the DNA, the ROS
produced diffuses to nearby regions resulting in a greater degree of dsDNA breaks. In
light of this, we wanted to determine whether DNA cleavage occurs via a random process
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or a concerted one using a standard statistical test.230 The average number of ssDNA (n1)
and dsDNA (n2) breaks per molecule was calculated from the fraction of linearized and
supercoiled plasmid remaining after each time point. We then calculated the ratio n1/n2.
The Freifelder-Trumbo relationship indicates that under completely random conditions,
100 ssDNA breaks occurs for every one dsDNA break, that is n1/n2 ≥ 100 for a random
cleavage event. Our calculations revealed n1/n2 values that were much less than 100
(Table 5.3) indicating that the ROS responsible for cleavage attack the DNA locally. The
n1/n2 values were generally smaller for RTH-sh-buforin and for the L-peptides.
Table 5.3. Freifelder-Trumbo Analysis of in vitro DNA Cleavage by ATCUN-shBuforin.
Peptide Complex

n1 / n2

Peptide Complex

n1 / n2

L-RTH-L-sh-Buforin

2.1

L-RTH-D-sh-Buforin

2.7

L-VIH-L-sh-Buforin

2.1

L-VIH-D-sh-Buforin

4.2

D-RTH-L-sh-Buforin

1.8

D-RTH-D-sh-Buforin

3.7

D-VIH-L-sh-Buforin

2.6

D-VIH-D-sh-Buforin

4.9

ATCUN-sh-buforin cleave DNA in live E. coli
To determine whether the observed in vitro nuclease activity occurs in bacterial
cells, we employed the Terminal deoxyribonucleotide transferase (TdT)-mediated dUTP
Nicked End Labelling (TUNEL) Assay. The assay involves cell fixation and
permeabilization with subsequent labeling of DNA strand breaks using an enzymatic,
template-independent reaction. The TdT transfers a fluorescein-conjugated nucleotide to
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free 3’-OH groups present in DNA strand breaks, hence, greater cell fluorescence means
a greater amount of DNA damage. This assay has been used to assess DNA damage in
E. coli and H. volcanii brought about by H2O2.231 The data we obtained from measuring
the TUNEL fluorescence of 100,000 cells proves the existence of DNA strand breaks in
E. coli brought about by the peptides at their MIC (Figure 5.9). Moreover, the ATCUN-shbuforin conjugates exhibited greater TUNEL fluorescence compared to sh-buforin alone,
trailing the observed trend in MIC. It is worth noting that MIC of the D-peptides were about
one-eighth those of the L-peptides, indicating that it requires a smaller amount of Dpeptides to generate the same amount of DNA strand breaks. The D-ATCUN-D-shbuforin analogs seem to have a higher nuclease activity in cella, consistent with our in
vitro assay.

Figure 5.9. In cella DNA Cleavage by ATCUN-sh-Buforin. Representative histograms
for detection of DNA damage in E. coli via the TUNEL assay. E. coli cells were treated
with peptides at their MIC for 2 hrs. ATCUN-sh-Buforin showed higher nuclease activity
relative to sh-Buforin alone.
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ATCUN-sh-buforin are minimally cytotoxic to mammalian cells
Hemolysis assays were performed in PBS. Our data (Table 5.4) suggests that the
synthesized peptides exhibit very low hemolytic activity at their MIC against E. coli.
Addition of the ATCUN motif to sh-buforin does not seem to increase the peptide’s
hemolytic activity. All of the tested peptides were found to have less than 8% hemolysis
at MIC, suggesting high selectivity towards bacterial cells. We calculated the
concentration required to lyse 5% of the cells (Table 5.4) and used it to determine
therapeutic indices, which were in the range of 0.14 through 13 suggesting good
therapeutic potential. HeLa and HEK293 cells were used for the cytotoxicity studies of the
peptides. The results depicted in Figure 5.10 indicate that all ATCUN-sh-buforin peptides
showed very low toxicity or no toxicity to these cell lines up to 128 μM, a concentration
well above their MIC values.

Figure 5.10. In vitro Cytotoxicity of ATCUN-sh-Buforin Against Mammalian Cells.
HeLa and HEK293 cells were treated with peptides at varying concentrations for 24 hrs
and viability was assessed by quantification of the insoluble formazan product from MTT
oxidation. All tested peptides exhibit minimal toxicity.
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Table 5.4. Hemolytic Activity and Calculated Therapeutic Indices of the Peptides.
Peptide

% Hemolysis HD5, µM Therapeutic Index

L-sh-Buforin

5.5 ± 0.9

44

7

L-RTH-L-sh-Buforin

5.8 ± 0.6

26

4

L-VIH-L-sh-Buforin

5.9 ± 0.8

10

2

D-RTH-L-sh-Buforin

4.9 ± 0.5

54

11

D-VIH-L-sh-Buforin

7.4 ± 0.7

1

0.14

D-sh-Buforin

3.7 ± 0.1

45

11

L-RTH-D-sh-Buforin

4.2 ± 0.3

51

13

L-VIH-D-sh-Buforin

6.6 ± 0.9

1

0.14

D-RTH-D-sh-Buforin

5.4 ± 0.9

11

2

D-VIH-D-sh-Buforin

5.3 ± 1.0

3

0.60

Magainin 2

7.5 ± 2.4

2

0.25
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Discussion
Buforin II and sh-buforin have been shown to exert their antimicrobial activity by
traversing the bacterial membrane and binding to nucleic acids.216, 217, 226 DNA is also the
main target of the ATCUN-sh-buforin derivatives. The ΔrecA mutant E. coli TD172 was
more susceptible to the ATCUN-sh-buforin peptides than wild-type E. coli MG1655. In
this chapter, we studied the effect to the bioactivity of ATCUN-sh-buforin conjugates
(XaaXaaHRAGLQFPVGRVHRLLRK-NH2) upon: (1) inclusion of a basic amino acid in the
ATCUN motif and (2) L-to-D amino acid substitution. The Arg-Thr-His (RTH) motif is
expected to increase the affinity of the copper-bound ATCUN motif for the bacterial DNA;
whereas the change in ATCUN stereochemistry is anticipated to result in an increased
nuclease activity by metal complexes of this motif.91
sh-buforin has high affinity towards bacterial DNA. The addition of a positively
charged ATCUN motif is expected to increase the binding affinity of the peptide for the
negatively charged DNA. When we used a 15-mer sequence from a DNA sequence
known to interact strongly with buforin II and its derivatives, our fluorescent intercalator
displacement assay revealed that the RTH derivatives have larger affinities than the VIH
peptides. The larger affinity displayed by the RTH peptides disappeared when pUC19
was used indicating that the peptide-nucleic acids interaction depends on the DNA
sequence. Interestingly, the affinity towards pUC19 by the copper-bound peptides (CuIIATCUN-sh-buforin) was three- to four-times larger than that of the apopeptide and a
larger affinity was observed for the CuII-RTH-sh-buforin derivatives. The antimicrobial
assays, however, showed that L-sh-buforin derivatives benefit from the positive charge,
whereas the D-sh-buforin peptides had the same or lower activity when the RTH motif is
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used. Thus, the charge of the ATCUN motif alone does not determine the overall activity
of the peptide.
Results from our antimicrobial susceptibility testing revealed that the D-peptides
are more active compared to the L-peptides. Within the same family, a change in
stereochemistry of the ATCUN motif did not affect the antimicrobial activity (L-ATCUN-Lsh-buforin vs D-ATCUN-L-sh-buforin). Interestingly, the stereochemistry of the sh-buforin
moiety dictates the potency (MIC of ATCUN-L-sh-buforin > MIC of ATCUN-D-sh-buforin,
and DNA cleavage by ATCUN-D-sh-buforin > DNA cleavage by ATCUN-L-sh-buforin).
Previous reports of L-to-D amino acid substitutions on membrane active peptides,
wherein the key interactions are not chiral in nature, resulted in little to no increase in
activity.219,

232-235

However, in apidaecin and drosocin – AMPs thought of having

intracellular targets – the antimicrobial activities of the all-L peptides differ from the all-D
enantiomer.236, 237 In both cases, the all-D peptides are less active than the all-L AMPs. It
is interesting to note that the all-L and all-D enantiomers of the peptide WRWYCR, an
AMP that induces DNA damage through Holliday junction-trapping, showed the same
MIC values against a panel of bacteria.238 Therefore, the observed eight-fold to 32-fold
increase in activity for the all-D-ATCUN-sh-buforin peptides is to our knowledge
unprecedented. This increase in activity is the result of the combined increased stability
and higher DNA cleavage activity by the all-D peptides.
ROS formation plays a major role in the bacterial killing by ATCUN-sh-buforin. This
was established by rescuing the bacterial population through the addition of the radical
scavenger thiourea. When intracellular Cu2+ binds to ATCUN-sh-buforin, the resulting
complex forms ROS, which then targets the major biomolecules in the cell causing the

161

bacteria to die of excessive oxidative stress. No significant difference in ROS production
is observed when the ATCUN motif is added. This is likely due to the fact that the
intermediate ROS formed by Cu-ATCUN complexes are non-diffusible; that is they are
bound to the copper center.90,

239

A scheme proposed by Cowan involves molecular

oxygen undergoing a two-electron reduction, wherein two Cu-ATCUN complexes
dimerizes via a peroxo bridge, and subsequently forms a hydroperoxyl anion. The
resulting hydroperoxyl is reduced to form hydroxide ion and a copper-bound hydroxyl
radical (Equations 1-3 in Chapter 1).90
In summary, the experiments described in this study allow us to better understand
the role of the ATCUN motif in ATCUN-sh-buforin peptides. Comprehending the key
factors that play a fundamental role in ATCUN-containing peptides is not only important
to develop more potent AMPs but it will also allow us to understand the role of ATCUN
motifs in AMPs found in nature. We found a strong correlation between the in vitro DNA
cleavage results and the MICs (Figure 5.11A). For the group of D-peptides, we observed
a strong correlation between the median TUNEL fluorescence and the MIC (Figure
5.11B), that is, a greater TUNEL fluorescence corresponds to a lower MIC. The same
correlation was also observed for the L-peptides. Therefore, direct DNA damage plays a
large and central role in the antimicrobial activity of ATCUN-sh-buforin peptides. A
positively charged ATCUN motif contributes towards the DNA binding affinity but does
not always result in an increased antimicrobial activity. We also found that changing the
stereochemistry of the ATCUN-sh-buforin peptide leads to an increase in antimicrobial
activity, as a result of the larger stability and enhanced nuclease activity of the peptides.
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Figure 5.11. Nuclease and Antibacterial Activity Correlations of ATCUN-sh-Buforin.
(A) Correlation between in vitro DNA cleavage and MIC of peptides. (B) Correlation
between in cella DNA damage and observed MICs. Both panels show strong correlation
between nuclease and antimicrobial activity of peptides, suggesting a strong involvement
of DNA damage by ATCUN-sh-Buforin peptides.

Methodology
Peptide Synthesis, Purification, Quantification and Handling. Peptides were
manually synthesized using standard Fmoc protocols and purified (≥95%) via reversed
phase-HPLC on a C18 column. The purified fractions were characterized by ESI-MS ran
in positive ion mode. The peptides were quantified using sequence-specific molar
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extinction coefficients using reported values for each amino acid and the peptide bond as
reported by Gruppen.240 All purified peptides were dissolved in nanopure water and were
stored at 4°C and were diluted to the required concentration on the day of the experiment.
Finally, to form the Cu2+-peptide complexes, 1.5 eq of peptide was mixed with 1 eq of
Cu2+ (to ensure no free copper remains) and incubated at room temperature for 30-45
mins.
Antimicrobial Assay. Single colonies of E. coli (MG1655, WT), E. coli (TD172,
recA)241 and E. aerogenes (ATCC 13048) were grown in Mueller-Hinton Broth (MHB;
Difco) for 3-5 hrs until mid-logarithmic phase. The peptide stock solutions were diluted in
1X sterile phosphate buffered saline (PBS; Gibco), pH 7.40 starting at 128 μM. Then 50
μL aliquots of a two-fold serial dilution series were placed on a sterile 96-well
polypropylene plate (Greiner). To each well, 50 μL of a bacterial suspension was added
to yield a final inoculum of 5x105 CFU/mL per well. Ampicillin and Kanamycin (mixed
isomers) were used as positive control. The plates were incubated at 37°C (30°C for E.
aerogenes) for 18-20 hrs. For the experiments involving addition of Cu2+, the same
dilutions and manipulations were done using MHB containing 32 μM Cu2+, but allowing
for a 30 min incubation time prior to addition of bacteria. This concentration is well below
the toxic level of Cu2+ for E. coli, which is 3.5 mM).242 For both cases, the Minimum
Inhibitory Concentration (MIC) was defined as the lowest concentration that prevent visual
growth of bacteria. MIC values reported here is the mode of three independent trials.
Time-Kill Kinetics Experiment. The number of viable cells was determined 1, 2, 4,
and 8 hrs after exposure. A 350 μL aliquot of peptide at concentration 2X the MIC was
mixed with 350 μL of 106 CFU/mL bacterial suspension (E. coli MG1655 or E. coli TD172)
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in MHB, to yield a final inoculum containing 5x105 CFU/mL and peptide at the MIC. At
each specified time point, 10 μL of the mixture was withdrawn and was serially diluted up
to 1:1000. Then, 100 μL of the 10-3 dilution was spread on LB agar plates (the 10-2
dilutions were used when no colonies were detected from the 10-3) and allowed to grow
for an additional 16 hrs. The number of single colonies was counted and was plotted
against time. The curves represent the average obtained from three independent trials.
Circular Dichroism Spectra. CD spectra were recorded on a Jasco J-710
Spectropolarimeter. Samples used were 100 μM of peptide in 50% (v/v) TFE in 50 mM
sodium phosphate (NaPB), pH 7.40 in a 1 mm cuvette. Each spectrum was the average
of 5 accumulations, and the spectra were recorded twice using peptides prepared at
different time points to ensure reproducibility. The two average spectra showed <5%
deviation from each other. For spectra of Cu-ATCUN-AMP, a 2 μL aliquot of a
concentrated Cu2+ stock was added to the peptide sample to yield [Cu-ATCUN-AMP]final
= 90 μM. Solution was allowed to equilibrate for 5 mins before obtaining CD spectra. The
mean residue ellipticity, [θ] was calculated using eqn 1, where θ is the measured ellipticity,
l is pathlength in cm, c is concentration in millimolars, and n is the number of residues in
the peptide.232
[θ]= (100

θ) / (l

c

n)

(1)

The percent alpha helical content was calculated using eqn 2, where [θ]222 is the
mean residue ellipticity calculated at 222 nm.
% α helix= ([θ]222 – 3000) / 33000

(2)

β-galactosidase Leakage Assay. Overnight cultures of E. coli transformed with
pUC19 were subcultured in fresh Luria-Bertani (LB) broth and were allowed to grow to
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OD600 nm ~ 0.6. Overexpression of β-galactosidase was induced for 1 hr by addition of
isopropyl-β-D-thiogalactopyranoside (IPTG; Fisher) at 1 mM final concentration. The cells
were washed three times with PBS and resuspended in fresh LB. Then, a 75 μL aliquot
of the bacterial suspension was mixed with 75 μL aliquot of a two-fold serial dilutions of
the peptides (starting from 64 μM) in sterile microcentrifuge tubes. The mixture was
incubated for 1 hr at 37°C. The tubes were then spun down at 4400 rpm at 4°C for 10
min, then 100 μL of the supernatant was transferred to a clear 96-well plate. A 50 μL
aliquot of 2-nitrophenyl-β-D-galactopyranoside (ONPG; Thermo Scientific) in PBS was
added at 0.8 mg/mL final concentration. Color was allowed to develop for 1 hr in the dark,
and then absorbance of each well was measured at 405 nm. Data shown are the average
of three independent trials presented as Mean ± SD.
Measurement of Intracellular ROS Formation.243 E. coli MG1655 cells in midlogarithmic phase were washed twice with M9+glucose minimal media and resuspended
in

fresh

M9+glucose

containing

10

μM

of

the

profluorescent

probe

2’,7’-

dichlorofluorescein diacetate. The dye was loaded for 1 hr before washing the cells twice
to remove unloaded dye. The cells were then suspended in fresh M9+glucose and were
allowed to grow for an additional 30 mins, after which the cells were incubated with the
peptides at MIC for 2 hrs. For experiments with the iron chelator, 2,2′-bipyridine, a small
aliquot was added to the loaded cells to yield a 500 μM final concentration of bipyridine
prior to incubation with the peptides. The fluorescence of 100,000 cells was read using a
BD FACSCalibur flow cytometer with the following PMT voltage settings: E00 (FSC,
primary collection parameter), 350 (SSC), and 600 (FL1). Data were analyzed using
FlowJo 10.0 and the mean fluorescence intensity (MFI) of each experimental run was
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normalized against the MFI of the negative control (PBS), which was set to 1.0. Results
shown are obtained from three independent trials and presented as Mean ± SD.
Viable Colony Counting with Thiourea. Equal volumes of bacterial suspension
containing 106 CFU/mL were mixed with peptide solution at 2X its MIC. This mixture was
split into two portions, and to one of which were added thiourea to a final concentration
of 100 μM. The cells were incubated at 37°C for 1 hr, after which a 10-μL aliquot was
diluted 1:1000 using fresh MHB. Then 100 μL of the 10-3 dilution were spread onto fresh
LB Agar plates and incubated overnight. The number of colonies was counted the next
day. Results shown are obtained from two independent trials presented as Mean ± SD.
Fluorescent Intercalator Displacement Assay. sh-buforin, ATCUN-sh-buforin and
preformed CuII-ATCUN-sh-buforin (1.2 eq of peptide with 0.9 eq of Cu2+) were titrated into
a 200 μL mixture containing 15 μM bp pUC19 and 7.5 μM Ethidium bromide in 10 mM
NaCl and 10 mM sodium cacodylate buffer, pH 7.50. All measurements were done in a
Molecular Devices FlexStation 3 with λex = 545 nm and λem = 595 nm. All fluorescence
readings were corrected for dilution, and then fluorescence was plotted with
concentration. The curves were fitted to a linear equation (all R2 > 0.91) and C50 was
calculated and defined as concentration of peptide required to decrease the fluorescence
to half its original value. The Association constant Ka was the inverse of C50. Calculated
values were normalized relative to L-sh-buforin which was assigned a value of 1.00. Data
shown here are obtained from three independent experiments and presented as Mean ±
SD.
In vitro DNA Cleavage Assay. The reaction mixtures contained 10 μM base pair
pUC19, 100 nm CuII-ATCUN-AMP, 1 mM sodium ascorbate, and 1 mM H2O2 in 20 mM

167

HEPES, 100 mM NaCl pH 7.40. Reactions were run at room temperature for the indicated
times and were stopped using 3X loading dye containing 1 mM EDTA. Then a 15 μL
aliquot was loaded on a 1% agarose gel containing Ethidium bromide (EtBr) and ran at
100 V for 40 mins. The gels were imaged using a Bio-Rad GelDoc XR+ Imager, and
bands were quantified using the accompanying Image Lab 5.0 software. A correction
factor of 1.47 was applied to the intensity of supercoiled DNA due to its diminished ability
to intercalate EtBr. Data shown here is the average of four trials reported as Mean ± SD.
Freifelder-Trumbo Analysis. The fraction of linearized DNA, f(III), is related to the
number of double strand breaks, n2, per molecule and can be calculated from the first
term of the Poisson distribution (eq 3).
f(III)= n2 e^(-n2 )

(3)

The number of single strand breaks, n1, was then calculated from the fraction of
supercoiled DNA, f(I), remaining after treatment with the CuII-ATCUN-AMP complexes
using the Friefelder-Trumbo equation (eq 4).
f(I)= e^(-(n1+n2))

(4)

This statistical test shows that the number of double-strand breaks arising from
random single-strand nicks is less than 0.01, that is (n1/n2) > 100. Hence, by calculating
the ratio of n1 and n2, one can determine whether linearization resulted from a random or
concerted cleavage event.
TUNEL Assay. To assess the extent of in cella DNA damage brought about by the
peptides, the Terminal deoxyribonucleotide transferase (TdT)-mediated dUTP Nick End
Labelling (TUNEL) Assay was employed. An overnight culture of E. coli TD172 was
subcultured 1:20 in fresh MHB and was allowed to grow for an additional 90 mins (~107
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CFU/mL). A 350 μL aliquot of peptide at 2X the MIC was mixed with 350 μL of the bacterial
suspension. The mixture was incubated at 37°C for 2 hrs, after which, the cells were
pelletized and washed twice with ice-cold PBS. The cells were then fixed using 100 μL of
4% paraformaldehyde in 1X PBS for 30 mins. The cells were pelleted and resuspended
in 100 μL of permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) then
incubated on ice for 2 minutes. The pellets were kept on ice. The positive control was
resuspended in 50 μL of digestion buffer (CutSmart; New England Biolabs) containing 20
U of EcoR1 to generate single strand breaks. The digestion was allowed to proceed for 1
hr at 37°C, after which, the cells were pelleted. All tubes were resuspended in 50μL of 1X
TUNEL reaction mixture (9 parts label solution, 1 part TdT enzyme; Roche Molecular
Biochemicals, Indianapolis, IN) and were incubated in the dark at 37°C for 1 hr. The cells
were then pelleted and washed once with ice-cold PBS. Cells were counterstained using
the nuclear dye Propidium Iodide (PI). The PI staining was allowed to proceed for 10
mins, then 5 μL of the mixtures were diluted with 1 mL of PBS and the green and red
fluorescence of 100,000 cells were analyzed using a BD FACSCalibur flow cytometer.
Results shown are representative of three trials performed independently.
Hemolytic Assay. To assess the selectivity of the peptides against bacterial
membranes, extent of hemolysis was measured in human red blood cells (RBCs). Packed
human erythrocytes (ZenBio, Inc, Research Triangle, NC, USA) with anticoagulant citrate
dextrose were washed three times with sterile PBS. A small aliquot of washed cells was
resuspended in fresh PBS to yield a 0.8% (v/v) suspension of RBCs. Then 75 μL of RBCs
were mixed with 75 uL aliquots of a two-fold serial dilution series of the peptides (starting
from 64 μM). The mixture was incubated at 37°C for 1 hr. Triton X-100 and PBS were

169

used as positive and negative controls, respectively. The cells were then pelleted and
100 μL of the supernatant were carefully removed and transferred to a clear 96-well plate.
The absorbance of each well at 414 nm was measured and was normalized against the
positive and negative controls. Results shown are the average from three independent
trials shown as Mean ± SD.
MTT Cell Viability Assay. HeLa and HEK293 cells were grown in DMEM
supplemented with 10% Fetal Bovine Serum and incubated in a humidified atmosphere
at 37°C and 5% CO2. Cytotoxicity studies were done using the MTT Assay (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Invitrogen). Breifly, 5000 cells
were seeded in each well of a sterile 96-well plate and incubated for 20 hours to allow
cells to adhere. The media were aspirated and replaced with 200 uL of media containing
serial dilutions of the peptide (starting from 128 uM). The cells were incubated for 24
hours after which 10 uL of 5 mg/mL solution of MTT was added to each well. The color
development was allowed to proceed for 4 hours. The media was then removed and the
purple formazan product was solubilized using pure DMSO. The absorbance of each well
at 595 nm was recorded and used to calculate % viability.
Statistical Analysis. Data were analyzed for statistical differences using GraphPad
Prism 6.0. One-Way or Two-Way ANOVA was used to determine statistical significane.
The Sidak’s or Turkey’s multiple comparisons test was used as post-test. Statistical
significance for all tests was set at P < 0.05.
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Chapter 6

The ATCUN Motif in Targeted Antimicrobial Drug Development
Copper-binding and Cell-penetrating Antimicrobial Peptidomimetic Utilizes
Phagosomal Copper to Target Intracellular M. tuberculosis
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Libardo, M.D.J., Anand, K., Krishnamoorthy, G., Kaiser, P., Dietz, C., Smith, M.B.,
Kaufmann, S.H.E., Singh, A.S., Angeles-Boza, A.M., 2017, submitted
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Introduction
Resulting in close to two million deaths and more than 10 million new cases
annually and with about two billion latent infections worldwide, tuberculosis (TB) remains
the deadliest infectious disease known to humankind.244 This problem is exacerbated by
the alarming rate at which multidrug-resistant (MDR) and extensively drug-resistant
(XDR) M. tuberculosis (Mtb) strains are emerging, extinguishing the efficacy of current
anti-TB drugs. There is therefore an urgent need to develop medicines that target this
pathogen in novel ways and a pressing demand to understand their mechanism of action.
It is widely known that transition metal trafficking within primary macrophages is
altered in response to infection. In keeping with the concept of nutritional immunity, iron
and manganese are limited within the phagosomes to deprive pathogens of these
essential micronutrients.41, 245 On the other hand, as substrate to the transporter ATP7A,
copper is deliberately enriched in phagosomes and contributes to the macrophage
microbicidal effect.53 Considering its redox cycling, ability to displace metal cofactors of
enzymes, iron-sulfur cluster targeting, and its thiophilic nature,50, 246 it becomes apparent
why reallocating this toxic metal to sites containing bacteria is advantageous. Indeed,
Mtb-infected macrophages contain 25 – 400 µM of copper in the phagosome.57 However,
there exist redundant defense mechanisms which protect Mtb from copper-related
toxicity. The bacilli express CtpV and MctB, membrane-bound copper efflux pumps that
transport copper back to the phagosomal lumen.60, 247 In addition, it expresses cytosolic
metallothionein (MymT) which sequesters up to six Cu(I) ions,68 and a periplasmic
oxidase (MmcO) that converts Cu(I) to the less toxic Cu(II).73 Together, these proteins
whose expression is controlled by transcriptional repressors (CsoR and RicR) that bind
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to Cu(I) in sub-attomolar (<10-18) levels,248-250 form an arsenal of defenses that confer Mtb
resistance towards phagosomal copper stress.
The profusion of copper ions in the host-Mtb interface therefore represents an axis
that can be exploited for therapeutic purposes. Indeed, several reports have shown that
Mtb can be resensitized to copper by using small molecules that act as shuttles to boost
the intracellular concentration of the metal. Compounds like thiolated semicarbazones,251
disulfiram,252 8-hydroxyquinoline,253 and cyclams254 rely on a Trojan Horse strategy to
inundate Mtb with copper and restore the metal’s toxicity.
Whereas Mtb can withstand high copper concentrations, it is susceptible to
reactive oxygen species (ROS). The pro-oxidant activity of ascorbic acid is responsible
for the rapid and complete sterilization of an Mtb culture via perturbations in the
NADPH/NADP+ ratio resulting in accumulation of hydroxylated fatty acids in the
membrane.255 Moreover, ROS induced by bactericidal antibiotics and inhibitors of sulfur
metabolism were demonstrated to be effective in eradicating mycobacterial persisters.163,
256

Reactive nitrogen species (RNS) liberated from intrabacterial reduction of PA-824 (a

bicyclic nitroimidazole) and hydroquinone-based small molecules that generate
superoxide radicals were shown to efficiently kill nonreplicating and drug-resistant Mtb.257,
258

These studies suggest that ROS-forming compounds are potent alternatives to

sterilize an Mtb infection, and perhaps shorten the treatment regimen in patients.
In this chapter, we utilized the peptidomimetic DAB-10 (D-VIH-D-sh-buforin from
Chapter 5), composed of an Amino Terminal Copper and Nickel (ATCUN) binding motif,
and a C-terminal domain from a cell-penetrating antimicrobial peptide (AMP) as an antimycobacterial agent. The Cu-ATCUN complex is known to produce ROS under
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physiologically relevant conditions.91, 204 By coupling it to a cell-permeable peptide, we
aimed at developing a conjugate that could potentially bind intracellular copper (which
Mtb is resistant to) and harness the chemical reactivity of the resulting metallopeptide to
generate ROS (which Mtb is susceptible to). We demonstrate here that DAB-10 requires
copper ions to kill mycobacteria via an oxidative stress mechanism and present the first
unambiguous evidence that phagosomal copper plays a critical role in eliminating
intracellular Mtb.

Results
Design principles and antimycobacterial activity of DAB-10
Our work on the ATCUN motif lead to the generation of D-ATCUN-D-sh-buforin10 (DAB-10, Chapter 5), an all-D amino acid peptide with the sequence
DVIHRAGLQFPVGRVHRLLRK-NH2.

The ATCUN binding motif, Val-Ile-His (selected due

to its high ROS forming activity, Chapter 4) was coupled to residues 5 through 21 of the
AMP buforin II. Derived from Histone H2A, buforin II binds isolated DNA and is
hypothesized to inhibit bacterial growth through the same manner.114 Conversion from Lto D-amino acids served to increase oxidative turnover of the ATCUN motif91 and to confer
protease resistance to DAB-10. Previous chapters have shown that DAB-10 can
oxidatively cleave DNA in vitro and in live E. coli (Chapter 5). Here we focus on its antimycobacterial activity and assess its potential to be activated by host-derived copper ions.
As an internal control, we utilized DAB-6 (DRAGLQFPVGRVHRLLRK-NH2), a peptide
identical to DAB-10 which lacks the ATCUN motif (and by extension, lacks direct oxidative
capabilities), to determine the relevance of copper-binding to the mechanism of DAB-10.
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We started by measuring the minimum inhibitory concentration (MIC) of both
peptides against several Mycobacterium species in a standard broth microdilution assay.
Across all species tested, we found that DAB-10 was more active than DAB-6 (Table 6.1).
Pre-incubating DAB-10 with copper did not alter its MIC (Appendices, Table S6.1), hence,
to examine the role of copper, we utilized the selective, cell-permeable copper chelator,
tetrathiomolybdate (TTM).151 In the presence of 100 µM TTM, DAB-10 activity against M.
smegmatis was significantly attenuated as its MIC increased 16-fold while that of DAB-6
remained unchanged (Table 6.1). Supportive of this phenotype is our observation that the
bactericidal activity of DAB-10 at its MIC is diminished in the presence of TTM (Figure
6.1). Taken together, our results show that DAB-10 indeed uses copper for its antimycobacterial activity.
Table 6.1. Antimycobacterial Activity of Peptidomimetics.
Minimum Inhibitory Concentration (MIC), µM
Mycobacterial Species
DAB-6 (+TTM)

DAB-10 (+TTM)

M. smegmatis mc2155

0.5 (0.5 – 1)

0.125 (1 – 2)

M. bovis BCG (SSI 1331)

4–8

0.5 – 1

M. tuberculosis H37Rv

8

2

M. tuberculosis BND320a

8

4

M. tuberculosis Jal2287a,b,c

16

4

M. tuberculosis MYC431a,b,c,d

8

4

Resistance:

a

Isoniazid,

b

Streptomycin,

c

Rifampicin,

d

Ethionamide. TTM =

Tetrathiomolybdate. Experiments with M. tuberculosis were performed by Dr. Kushi
Anand and Dr. Amit Singh (Indian Institute of Science).
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Figure 6.1. Copper-dependent Bactericidal Activity of DAB-10. Time-kill curves of M.
smegmatis cells treated with DAB-10 in the presence or absence of 100 µM copper
chelator, tetrathiomolybdate (TTM). Results show a strong copper-dependence of DAB10 activity as bactericidal action is significantly attenuated upon co-treatment with TTM.

DAB-10 promotes copper-dependent oxidative stress, contributing to its potency
Following confirmation of the copper-dependence in the activity of DAB-10, we set
out to determine whether it induces oxidative stress. For this purpose, we employed the
genetically encoded, ratiometric, fluorescent probe Mrx1-roGFP2259 – a fusion of
mycoredoxin-1 and redox-sensitive GFP – to report on the redox state of DAB-10-treated
mycobacteria. Oxidation of Mrx1-roGFP2 results in a decrease in the 488 nm excitation
with a concomitant increase in the 405 nm excitation. The 405/488 ratio is therefore a
direct readout of the relative amounts of oxidized and reduced mycothiol (MSH) which
can then be converted to potential values (EMSH) using the Nernst Equation (Appendices,
Figure S6.1). We first generated a calibration curve using Mrx1-roGFP2-expressing M.
smegmatis (Msm) treated with varying ratios of the oxidized and reduced form of
dithiothreitol (DTT, 10 mM total) corresponding to known EMSH values (Figure 6.2B).
Treatment of Msm with DAB-10 at its MIC resulted in a population-wide shift in
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fluorescence consistent with probe oxidation, while the fluorescence of DAB-6-treated
cells virtually resembled the untreated ones (Figure 6.2A). Using DTT as reductant and
cumene hydroperoxide (CHP) as oxidant controls, we confirmed that a shift towards more
positive EMSH values suggests that cells experience oxidative stress upon exposure to
DAB-10, but not during DAB-6 treatment (Figure 6.2C). To confirm the copper
dependence of DAB-10-induced oxidative stress, we utilized the TUNEL Assay as
supplementary measure of oxidative DNA damage. We observed a two- to three-fold
increase in TUNEL-positive cells upon DAB-10 treatment (Figure 6.2D). More importantly,
we observed a statistically significant decrease upon addition of TTM, implying that
intracellular oxidation by DAB-10 resulted from copper binding.
To determine whether oxidative activity of DAB-10 is a determining factor for its
anti-mycobacterial activity, we tested the survival of Msm in Middlebrook 7H9 with or
without catalase. Removal of catalase did not affect the potency of DAB-6 across all
Mycobacterium species tested. On the other hand, DAB-10 activity increased six- to eightfold upon removal of the enzyme, indicating that in the absence of an ROS scavenging
system, DAB-10 activity was potentiated (Figure 6.3). Because catalase affects the
potency of DAB-10 without gaining access to the mycobacterial cytosol, our results also
suggest that extracellularly generated ROS by DAB-10 also plays a role in mycobacterial
killing. Altogether, these results from three independent procedures demonstrate that
DAB-10 induces copper-dependent oxidative stress in vitro which likely plays a major role
in its bactericidal mechanism.
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Figure 6.2. Oxidative Stress in Mycobacteria Induced by DAB-10. (A) Representative
scatter plots obtained from flow cytometric determination of DAB-10-treated Msm,
demonstrating oxidation of the probe Mrx1-roGFP2 indicating that only DAB-10 has
oxidative activity. (B) Calibration curve relating 405/488 ratio to corresponding EMSH value.
Curve was obtained by titrating varying ratios of DTTox and DTTred to Msm corresponding
to known EMSH values from the Nernst equation. (C) The 405/488 ratio of Mrx1-roGFP2
resulting from DAB-10 treatment were converted to EMSH values using the calibration
curve in (B). Results show that DAB-10 shifts EMSH to more positive values, similarly to
the oxidant control, cumene hydroperoxide, CHP. *, P<0.05. (D) TUNEL assay was used
to quantify extent of genomic DNA damage arising from oxidative activity of DAB-10.
Results show that oxidative stress is a function of copper binding because levels of
TUNEL positive cells decreased upon addition of TTM. *, P<0.05.
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Figure 6.3. Effect of Catalase in the Oxidative Activity of DAB-10. Change in activity
of the peptidomimetics as a result of removal of catalase from Middlebrook 7H9 was
obtained from a ratio of MIC values with and without the enzyme. Results show that DAB10 activity is positively affected by removal of catalase.

It was recently reported that silver ions potentiate the activity of bactericidal
antibiotics through disruption of iron homeostasis eventually leading to production of
ROS.195 We therefore hypothesized that the ROS formed by copper-bound DAB-10 can
enhance the activity of other antibiotics. To this end, we tested whether DAB-10 exhibits
synergistic interactions with known anti-TB drugs. Of the four first-line drugs we tested,
we observed synergistic interactions between DAB-10 and Rifampicin against both M.
tuberculosis and M. bovis (Figure 6.4), suggesting the potential use of DAB-10 in
combination chemotherapy.
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Figure 6.4. DAB-10 Synergy with Rifampicin. The checkerboard assay was used to
assess interactions between DAB-10 and rifampicin. Heat maps show % survival
determined via measurement of alamar blue fluorescence following overnight incubation.
Values inside the heat maps are the fractional inhibitory concentration (FIC) indices for
the corresponding well at which they appear in. FIC index < 0.50 indicates synergy.

Partial random transposon mutagenesis of Msm unravels networks necessary for DAB10 resistance and provides hints to the nature of the ROS
To determine direct or indirect targets of DAB-10, we performed partial random
transposon mutagenesis screen of Msm isolate DAB-10-resistant mutants (Figure 6.5).
We failed to isolate truly resistant mutants from 7H11 plates containing DAB-6 or DAB10 at 10X their MIC. Because AMPs are known to interfere with a wide range of biological
functions (multi-hit mechanisms of action), we believe that pleiotropic effects dominate at
this concentration making isolation of resistant clones challenging. However, we were
able to isolate three mutants in 7H11 plates containing DAB-10 at 5X MIC. These mutants
exhibited a markedly higher MIC relative to the wild type (WT) (Figure 6.6A). To determine
the transposon insertion sites, we performed rescue cloning followed by DNA sequencing.
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Briefly, genomic DNA of the resistant mutants were isolated, digested, religated, and
reintroduced into E. coli. The rescued plasmids, containing the transposon (Tn::KanR)
were sequenced using primers that annealed to the transposon termini. A BLAST search
of the sequencing data identified transposon insertions in MSMEG_6617, MSMEG_4041,
and MSMEG_6091; all comprise uncharacterized products but nevertheless express
putative functions. Genetic complementation of these genes restored susceptibility of
these mutants to DAB-10 similar to WT levels, confirming interactions of DAB-10 with the
gene products. Surprisingly, when we tested the ROS resistance of the transposon
mutants, all of them were equally susceptible as the WT strain to either 5 mM Menadione,
1 mM CHP, or 1 mM tert-butylhydroperoxide (tBHP) (Figure 6.6B). Despite its
counterintuitive nature, our results are supported by the fact that the oxidative DNA
cleavage of the ATCUN motif is not inhibited by DMSO, NaN3, or superoxide dismutase
(SOD)

which

scavenges

hydroxyl

radicals,

singlet

oxygen,

and

superoxide,

respectively.90 Our results therefore suggest that none of the three aforementioned ROS
is implicated in DAB-10 activity, and that the peptide likely generates an ROS of unknown
nature. Indeed, a non-diffusible, copper-bound hydroxo species has been proposed as
the formal ROS in this context.90
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Figure 6.5. Schematic Representation of Msm Transposon Mutagenesis Screening.
The library of Msm transposon mutants were plated in 7H11 plates containing indicated
concentrations of peptidomimetics. The corresponding number of mutants were isolated
and tested on liquid culture for determination of truly resistant mutants. Truly resistant
mutants were used for MIC determination and rescue cloning.

Figure 6.6. Genetic Screening for DAB-10 Target Identification. (A) Alamar blue
viability assay of Msm Tn mutants truly resistant to DAB-10. Red wells indicate bacterial
growth. (B) ROS susceptibility of the isolated Msm transposon mutants were tested by
treatment with 5 mM Menadione, 1 mM CHP, or 1 mM tBHP. Results show that mutants
were equally susceptible to superoxide and hydroxyl radicals as the WT.
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We hypothesized that genetic interruptions that ultimately lead to hyperactive ROS
scavenging systems (that detoxify the ROS formed by DAB-10) or proteases (that
degrade oxidized proteins which become toxic in abundance) could reconcile the
observed DAB-10 resistance in spite of the mutants’ ROS susceptibility. Using the online
database SmegmaList,260 we found that none of the interrupted genes encoded for
putative reductases or proteases (Table 6.2).

However, a STRING analysis261 of

MSMEG_4041 shows phylogenetic co-occurrence and genetic fusion with a putative
reductase and that of MSMEG_6091 showed functional associations with the chaperone
DnaK and three Clp protease subunits (Appendices, Figure S6.2). Therefore, our analysis
suggests that while a direct interaction of DAB-10 to the products of the interrupted genes
are unlikely, the resulting mutant proteins interact with downstream effectors that can
neutralize the toxicity of DAB-10.
Table 6.2. Msm Transposon Mutants Resistant to 5X MIC of DAB-10 vs WT.
Tn insertion site

Gene Product

Mtb
ortholog

DAB-10
MIC, µM

WT

-

-

0.25 – 1

MSMEG_6617

NUDIX hydrolase

None

8

MSMEG_4041

Hydroxyquinol dioxygenase

None

8

MSMEG_6091

Negative regulator of Genetic
Competence

clpC1

8

DAB-10 co-localizes with intracellular Mycobacteria
Since access to the mycobacteria-containing phagosome is imperative for efficient
Mtb eradication, we next tested whether DAB-10 co-localizes with intracellular
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Mycobacteria. We first incubated RAW264.7 macrophages with 4 µM of a
tetramethylrhodamine (TMR)-labeled version of DAB-10. We observed distinct punctate
localization reminiscent of cytosolic vesicles (Figure 6.7), indicating a possible mode of
internalization involving endocytosis. When we co-treated macrophages with 50 µM
Amiloride, a macropinocytosis inhibitor, we observed a DAB-10 localization similar to that
of the untreated one. However, in the presence of 80 µM Dynasore which inhibits COP1mediated endocytosis, DAB-10 was found to localize in the mitochondria. This
observation suggests that while DAB-10 can translocate across biological membranes, it
is preferably internalized by macrophages via COP1-mediated endocytosis.

Figure 6.7. DAB-10 Internalization into Murine Macrophages. RAW264.7 cells were
incubated with rhodamine-labeled DAB-10 and its localization was followed by confocal
microscopy. Micrographs show cellular uptake of DAB-10 into distinct cytoplasmic
vesicles dependent on COP1-mediated endocytosis. Scale bars = 10 µm.
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We then infected RAW264.7 cells with Msm (multiplicity of infection, MOI 1:100)
prior to incubation with 4 µM of DAB-10-TMR. We found co-localization of bacteria and
DAB-10 as early as 30 mins post-exposure to the peptide (Figure 6.8). This co-localization
was observed even at DAB-10 concentrations as low as 1 µM (Appendices, Figure S6.3).
Figure 6.8 also shows that intracellular Msm was homogenously stained by DAB-10,
indicating that DAB-10 also translocates across the mycobacterial membrane. Indeed,
treatment of isolated Msm with DAB-10-TMR resulted in the same phenotype (Figure 6.9).
We assume that the DAB-10-containing and Msm-containing phagosomes fuse at the
stage of early to late endosomes because neither the bacteria nor the peptide co-localize
with lysosomes after 30 mins (Appendices, Figure S6.4). However, because Msm cannot
arrest phagosomal maturation like Mtb, both bacteria and peptide find their way to the
lysosomes after 3 hours (Appendices, Figure S6.4). Overall, our data demonstrate that
DAB-10 co-localizes with intracellular mycobacteria.

Figure 6.8. DAB-10 Colocalization with Intracellular Mycobacteria. GFP-expressing
Msm was used to infect RAW264.7 cells (multiplicity of infection 1:100) prior to incubation
with 8 µM of rhodamine-labeled-DAB-10. Images show peptidomimetic colocalizing with
bacteria 30 mins post-exposure. Scale bar = 10 µm.
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Figure 6.9. Bacterial Localization of DAB-10. Msm cells were exposed to 4 µM of
rhodamine-labeled DAB-10 and imaged in a confocal microscope to follow DAB-10
localization. Micrograph shows DAB-10 intrabacterial staining. Scale bar = 5 µm.

DAB-10 binds to phagosomal copper
We next sought to determine whether DAB-10 can competitively sequester copper
in the intracellular milieu. For this purpose, we synthesized CS-1 (Appendices, Figure
S6.5), a copper-selective fluorescent probe262 to determine whether DAB-10 co-localizes
with the metal. Because the emission spectra of CS-1 significantly overlaps with that of
TMR, we synthesized fluorescein (FL)-labeled DAB-10. Incubation of RAW264.7 cells
with 8 µM DAB-10-FL and 2 µM of CS-1 showed fluorescence co-localization within
distinct puncta (Figure 6.10). Activation of RAW264.7 cells with either IFN-g or LPS
resulted in overexpression of the copper transporters Ctr1 and ATP7A effectively
increasing intracellular copper content.53 When we used LPS-activated macrophages, not
only did we see a stronger signal at the red channel, but also co-localization of the metal
with the peptide. Our results indicate that DAB-10 and copper are within proximity of each
other making metal binding possible.
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Figure 6.10. DAB-10 Colocalization with Intracellular Copper. Resting and activated
RAW264.7 cells were incubated with fluorescein-labeled DAB-10 and 2 µM of the
fluorescent copper sensor, CS-1. Images show co-localization of DAB-10 with
intracellular copper in regions highlighted by white arrowheads. Scale bar = 10 µm.

We next examined whether direct metal binding occurs within macrophages. For
this purpose, we exploited the fluorescence quenching properties of copper262 and
designed DAB-10 derivatives that differed in the position of the fluorophore with respect
to the ATCUN motif. We attached TMR (a pH insensitive fluorophore) to the ε-amino
group of either Lys-20 (DAB-10-K20(TMR)) or an extra Lys placed immediately after the
ATCUN motif (DAB-10-K4(TMR)), and reasoned that since TMR is closer to the metal in
the K4 derivative, DAB-10-K4(TMR) should exhibit fluorescence quenching upon copper
binding. Not surprisingly, we observed ~35% decrease in emission intensity in vitro when
1 equivalent of copper was added to DAB-10-K4(TMR) but not when added to DAB-10-
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K20(TMR) (Figure 6.11A). When incubated with macrophages (figure 6.11B), we observed
intracellular fluorescence for DAB-10-K20(TMR) with a similar intensity upon macrophage
activation. On the other hand, DAB-10-K4(TMR) exhibited minimal fluorescence
(irrespective of LPS addition) which was later rescued upon addition of TTM. This result
proves that quenching of the DAB-10-K4(TMR) intracellular fluorescence is a function of
copper binding.

Figure 6.11. Intracellular Copper binding of DAB-10. (A) 1 eq of Cu2+ was added to
rhodamine-labeled DAB-10 derivatives differing in the position of the fluorophore. In vitro
fluorescence quenching was confirmed for the K4 derivative. (B) 4 µM of DAB-10-TMR
derivatives were added to resting or activated RAW264.7 cells in the presence or absence
of TTM. Quenched fluorescence of DAB-10-K4(TMR) suggests direct copper binding to
the ATCUN motif of DAB-10. Images were acquired using the same instrument settings.
Scale bars = 10 µm.

To ensure that the differences in fluorescence intensity is not a result of decreased
peptide uptake, we quantified the intracellular concentration of both DAB-10 derivatives
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(Figure 6.12A). We found that at 4 µM, the concentration at which the microscopy
experiments were done, both DAB-10-K20(TMR) and DAB-10-K4(TMR) were taken up by
RAW264.7 cells to similar extents (~0.1 nmol/mg of protein). Thus, the weaker
fluorescence intensity by DAB-10-K4(TMR) is not an experimental artifact, but rather a
result of direct copper binding within the cell. Note that a similar fluorescence intensity
and cell uptake profile was observed for the same set of DAB-10 derivatives labeled with
fluorescein (Appendices, Figure S6.6 and S6.7), indicating that the observed phenotype
is independent of the identity of the fluorophore.

Figure 6.12. Measurement of Copper binding Constant of DAB-10. (A) Analytical
quantification of cellular uptake of DAB-10 derivatives used in Figure 6.11B shows that at
the concentration used in the experiment, both K4 and K20 derivatives of DAB-10 had
similar intracellular concentration. (B) Isothermal titration calorimetry (ITC) was used to
determine binding constant of DAB-10 to Cu2+ at pH 6.40, resembling pH of
Mycobacterium-containing phagosome.
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Finally, using isothermal titration calorimetry (ITC), we found that DAB-10 binds to
Cu2+ with a sub-micromolar affinity (Kd = 547 ± 123 nM, Figure 6.12B) under pH 6.40,
simulating arrested acidification of the Mtb-containing phagosome.263, 264 Together with
the fact that following infection with Mtb, intraphagosomal copper reaches concentrations
well above the observed Kd,57 our data thus far indicates that DAB-10 is likely copperbound inside Mtb-infected macrophages.

Phagosomal copper is essential for eradicating intracellular M. tuberculosis
Having confirmed copper-dependent oxidative activity and intracellular copper
scavenging of DAB-10, we proceeded to determine whether it uses the metal for its
activity against intracellular Mtb. We first examined the toxicity of DAB-10 in naïve
macrophages using a standard viability assay. We found that DAB-10 has negligible
toxicity against THP-1 and RAW264.7 cells up to 256 µM (Figure 6.13), in line with the
reported minimal toxicity against other mammalian cell lines including HeLa and HEK293
cells (Chapter 5).

Figure 6.13. Peptidomimetic Cytotoxicity against Macrophage Cell Lines. The
cytotoxicity of DAB-6 and DAB-10 against macrophages in vitro was assessed through
the MTT assay. Data shows minimal toxicity up to 128 µM.
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We next infected differentiated THP-1 cells with M. tuberculosis H37Rv (MOI 1:5)
and measured the bacterial survival following peptide treatment (at 10X MIC) for 24 and
48 hours. We found minimal bactericidal activity after 24 hours of incubation (Appendices,
Figure S6.8), however, both peptides effected ~50% bacterial killing after 48 hours (Figure
6.14B). Furthermore, we observed almost a complete sterilization of intracellular Msm
after 24 hours of peptide incubation (Figure 6.14A). We conclude that DAB-10 is active
against intracellular Mycobacteria. To unambiguously determine whether phagosomal
copper is involved, we co-treated infected macrophages with DAB-10 and either TTM
(cell-permeable) or BCS (bathocuproinedisulfonate, cell-impermeable). We hypothesized
that by using copper chelators with varying permeability profiles, we could determine,
without bias, whether intracellular or extracellular copper is utilized by DAB-10. DAB-6
activity was unaffected by the presence of the chelators indicating that it does not utilize
copper for its activity. However, we observed a significant decrease in DAB-10 activity
only in the presence of TTM. Taken together with the fact that DAB-10 is restricted within
endosomes, our results demonstrate that it is indeed the phagosomal copper that is
utilized by DAB-10. Note that at 100 µM of the chelators, neither the intracellular survival
of Mtb nor the THP-1 viability is affected (Appendices, Figure S6.9). Overall, our results
emphasize that DAB-10 utilizes phagosomal copper to kill intracellular Mycobacteria.
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Figure 6.14. Activity of Peptidomimetics against Intracellular Mycobacteria. (A)
Resting RAW264.7 cells were infected with Msm (MOI 1:100) and treated with
peptidomimetics at the indicated concentration for 24 hrs. (B) Differentiated THP-1 cells
were infected with Mtb H37Rv (MOI 1:5) prior to treatment with DAB-6 (80 µM) and DAB10 (20 µM) corresponding to 10X the in vitro MIC for 48 hrs. Results show bactericidal
activity against intracellular mycobacteria for both peptides, however, only DAB-10
efficacy was attenuated upon addition of the chelator TTM. *, P<0.05.

Discussion
The need to develop novel antimicrobials and understand their mechanism of
attack is becoming increasingly urgent due to the rise of bacterial strains resistant to
conventional antibiotics. For TB, multiple strategies involving bacterial enzyme
targeting265 and modulation of host-immune response266, 267 were proven to be effective
in proof-of-concept studies, whereas use of agents that exploit factors in the hostpathogen interface have been limited. The influx of copper ions into the mycobacterial
phagosome, resulting from the concerted action of copper transporters (Ctr1 and ATP7A)
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and chaperones (Atox1),268 represents an untapped resource for novel therapeutic
interventions. Agents that harness this exchangeable metal pool would circumvent the
copper resistance of Mtb246 without requiring secondary exogenous factors. Furthermore,
because copper tends to accumulate during infection,269,

270

it was suggested that

compounds which turn into potent antimicrobials in the presence of copper can be used
to control bacterial loads in situ.253 The promise of this approach has been tested using
small organic molecules that become anti-mycobacterial upon binding to copper.251-253
However, these studies lacked evidence for a direct phagosomal copper involvement and
conclusions made from ex vivo models of infection were reasonable yet inferential.
Herein, we present explicit evidence of a peptidomimetic utilizing phagosomal copper for
its anti-mycobacterial activity. Our approach combines exploitation of host-derived copper
ions with susceptibility of Mtb to ROS, to generate an activatable oxidant for inhibition of
intracellular Mtb.
Central to our strategy is the ATCUN motif, which performs both copper-binding
and oxidative chemistry in DAB-10. When in vitro MIC measurements were done, DAB10 was neither pre-incubated nor was the medium supplemented with copper. While most
of the copper in Middlebrook 7H9 (~6.3 µM) is sequestered by albumin (which incidentally
also contains an ATCUN motif), we assumed that not adding exogenous copper simulates
conditions of metal competition that are relevant physiologically. Indeed, DAB-10 MICs
were in the low micromolar range, below the total copper content of 7H9, rendering
existence of metallated DAB-10 plausible. Furthermore, depletion of copper in 7H9 via
addition of the high affinity chelator TTM271 attenuated DAB-10 potency, signifying
copper-dependence of its activity. While DAB-10 in our experiments may not be saturated
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with copper, the fact that the ROS formation by the Cu-ATCUN motif is catalytic90, 91
suggests that a small population of metallated DAB-10 can effect a similar, albeit weaker
oxidative activity.
The observation that DAB-10, but not DAB-6, exhibits copper-dependent redox
cycling supports the notion that addition of the ATCUN motif results in a gain-of-function
phenotype that affords DAB-10 a secondary mode of attack. Indeed, DAB-6 displays a
weaker potency relative to DAB-10, which we believe is stemming from its DNA binding
ability, possibly resulting in inhibition of nucleic acid metabolism.11, 114 Conversely, we
propose that a major contributor to the activity of DAB-10 is its redox cycling. However,
without comprehensive investigations, we cannot completely exclude the possibility that
it also inhibits growth in a manner similar to DAB-6. The Msm transposon mutants we
isolated were paradoxically resistant to DAB-10 but susceptible to ROS. Apart from the
aforementioned neutralization of DAB-10 toxicity by the proteins that form functional
associations with the products of the interrupted genes, this paradox can likely be
explained by a secondary, non-oxidative mode of attack which is probably a function of
the C-terminal domain of DAB-10, exclusive of the ATCUN motif. This supplementary
mechanism likely involves direct binding of DAB-10 to the products of MSMEG_6617,
MSMEG_4041, and MSMEG_6091; with the transposon insertion preventing interaction
with the peptidomimetic. This suggests that not only can DAB-10 overwhelm the bacteria
with ROS, but it can also elicit an inhibitory effect independent of its oxidative ability, a
route it can take when surrounding copper levels are not sufficient for binding.
It has been repeatedly shown that bactericidal antibiotics – both small molecules
and AMPs – induce formation of deleterious hydroxyl radicals by liberating ferrous ions
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(from iron-sulfur clusters) that promote the Fenton reaction.154, 155, 188, 272 The observation
of a copper-dependent oxidative stress experienced by DAB-10-treated cells therefore
suggests that instead of inducing the formation of ROS, metallated DAB-10 is directly
producing it. While the exact mechanism of ROS formation by Cu-ATCUN complexes is
still a matter of debate, the accepted pathway proposed by Cowan and co-workers91
involves initial formation of a peroxo-bridged Cu-ATCUN dimer that then forms a
hydroperoxide anion (technically a deprotonated H2O2). This hydroperoxide anion is then
involved in the reduction of another Cu-ATCUN complex to form a copper-bound hydroxyl
radical, the actual ROS in this context (Eqns 1-3 in Chapter 1). From this scheme, it can
easily be seen why catalase attenuates DAB-10 activity, because in the presence of the
H2O2 scavenging enzyme, reaction 3 cannot occur, terminating the scheme prior to
formation of the active oxidant. Moreover, this scheme also supports the susceptibility of
our Msm transposon mutants to superoxide, singlet oxygen and hydroxyl radicals
because none of these three canonical ROS is proposed to be formed by the Cu-ATCUN
complex in metallated DAB-10.
Because the oxidative activity of DAB-10 is a function of its copper co-factor, the
question of where DAB-10 acquires the metal becomes relevant. As previously
mentioned, we assume that DAB-10 sequesters copper from 7H9 because it contains
micromolar levels of the metal, well above the measured Kd of Cu-DAB-10. Since copper
is supplied as CuSO4, and because of the relative instability of Cu(I) under aerobic
conditions, there is likely a sufficient amount of copper in the preferred oxidation state of
the ATCUN motif. Moreover, binding constants to Cu(II) previously measured for the
ATCUN motif of Ctr1273 are close to those of Human Serum Albumin (HSA)126 indicating
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that competition for the metal between ATCUN motifs of varying sequences is possible
and bidirectional. Therefore, DAB-10 can competitively sequester copper from albumin in
the supplement as well. In the intracellular milieu, DAB-10 co-localized and bound directly
to copper regardless of whether resting or activated macrophages were used. The Cu(I)
selective probe CS-1 used here was shown to have endosome-like localization (termed
copper “hotspots”) in primary macrophages52 similar to DAB-10 distribution in RAW264.7
cells. Taken together with the fact that the ATCUN motif also has considerable affinity
toward Cu(I) as previously described for Ctr1,273 DAB-10 is most-likely copper bound
within naïve macrophages. Moreover, endosomal Cu(I) can disproportionate, or can be
oxidized to Cu(II) as the phagosome matures and the lumen becomes increasingly
oxidizing. In addition, even though it is widely known that the reductive conditions in the
cytoplasm favor Cu(I), the fact that endosomes are topologically equivalent to the
extracellular environment274 suggests that any copper taken up during endocytosis is
likely in the +2 state. These conditions generate a transient pool of Cu(II) which can serve
as metal source for DAB-10 making formation of metallated DAB-10 probable. Finally,
within macrophages infected with Mtb, it is even more plausible that DAB-10 is copperbound for the following reasons. First, naïve macrophages infected with M. avium, or
macrophages activated with IFN-g prior to or following infection were shown to contain 17
µM, 82 µM, and 177 µM of copper in the phagosome, respectively.57 All of these reported
concentrations are well above the measured Kd of Cu-DAB-10. Second, Mtb expresses a
periplasmic multicopper oxidase (MmcO) that possibly converts Cu(I) to Cu(II).73
Therefore, in the context of an infection, not only is there an abundant copper supply in
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the phagosome, this labile pool also contains copper in the oxidation state preferred by
DAB-10.
Pooling our results together, we propose a pathway through which DAB-10
oxidatively targets intracellular Mtb (Figure 6.15). Infected macrophages, regardless of
activation, contain micromolar levels of copper due to transport pathways involving Ctr1,
Atox1 and ATP7A. During DAB-10 treatment, the peptidomimetic is taken up via COP1mediated endocytosis and the resulting vesicle is uncoated in the cytosol. At this stage,
a fraction of DAB-10 is probably already bound to copper, but because of the depletion
of reductive equivalence in a progressively maturing endosome, minimal redox cycling
occurs. It was shown that intracellular Mtb acquires extracellular iron by gaining access
to the transferrin recycling pathway57,

275, 276

suggesting that the Mtb-containing

phagosome can likely fuse with early endosomes.

Therefore, bacteria and

peptidomimetic co-localization occurs following fusion of the DAB-10-containing and Mtbcontaining endosomes. Vesicular fusion affords DAB-10 access to high levels of copper
upon which metal sequestration ensues. DAB-10 probably translocates across the
mycobacterial membrane in the metallated form, if not, apo-DAB-10 can get metallated
in the mycobacterial periplasm where Cu(II) is formed by MmcO. Finally, the biological
reductants present in the mycobacterial cytosol triggers oxidative activity of DAB-10
resulting in Mtb death.
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Figure 6.15. Proposed Mechanism of Action of DAB-10 against Intracellular
Mycobacteria. Following intermalization to macrophages, DAB-10-containing vesicles
fuse with the Mtb-containing phagosome allowing access to high levels of copper. Copper
binding triggers oxidative activity of DAB-10 against Mtb resulting in bacterial death.

In conclusion, our work describes a new drug candidate which does not only target
susceptible, but also drug-resistant Mtb for control of the devastating threat of TB. We
build upon the proof-of-concept studies that exploit the profusion of copper ions in the
host-Mtb interface by using a system that not only binds copper but also leverages the
metal’s redox properties to generate ROS.
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Methodology
Antimicrobial Susceptibility Testing and Time Kill Kinetics. (MIC measurements
against M. tuberculosis were performed by Dr. Kushi Anand and Dr. Amit Singh, Indian
Institute of Science). Activity testing was done using the broth microdilution method as
suggested by Hancock. Mycobacteria were grown until exponential phase in Middlebrook
7H9 broth with 10% OADC (Oleic acid, Albumin, Dextrose, Catalase) supplement and
0.05% Tween 80. For experiments without catalase, media contained 4.7 g/L of 7H9
base, 5 g/L BSA, 0.85 g/L NaCl, 2 g/L glucose, 0.4% glycerol, and 0.05% Tween-80.
Peptidomimetic stock solutions were diluted in growth medium and 50 µL of a 2-fold serial
dilutions were placed on separate wells of a sterile 96-well polypropylene plate
(polystyrene plates were used for M. tuberculosis and M. bovis). To each well, 50 µL of
bacterial suspension was added to yield a final inoculum of 5x105 CFU/mL per well. Plates
were incubated in seal plastic bags at 37°C for 24 hrs for M. smegmatis, and 7 days for
M. bovis and M. tuberculosis. Following incubation, 10 µL of Alamar Blue was added and
the color was allowed to develop for an additional 4 hrs for M. smegmatis and 24 hrs for
M. bovis and M. tuberculosis. Fluorescence of the plate was read using a microplate
reader and was converted into percent growth inhibition. The Minimum Inhibitory
Concentration (MIC) was defined as the lowest concentration that resulted in 90% growth
inhibition. Data shown was obtained from three independent trials done in duplicates. To
test synergy of DAB-10 with isoniazid and rifampicin, a similar method was adopted,
except that DAB-10 was added to the rows of the 96-well plate while the anti-TB drugs
were added to the columns. Heat maps represent data obtained from three independent
trials done in duplicates. The time kill kinetics experiments were done by mixing M.
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smegmatis with the indicated concentration of DAB-10 with or without 100 µM
tetrathiomolybdate (TTM) in a total volume of 500 µL. At each time point, a 20 µL aliquot
was withdrawn and diluted 100- and 1000-fold. Then 100 µL of the dilutions were plated
in 7H9 plates and incubated for three days. Colonies were enumerated manually and
results show Mean ± SEM from three trials done in duplicates.
Measurement of Intramycobacterial Reduction Potentials. Calibration curves were
first generated by treating M. smegmatis mc2155 expressing Mrx1-roGFP2 with varying
ratios of DTTox and DTTred corresponding to known potential values based on the Nernst
Equation with a fixed total concentration of 10 mM. Bacilli were suspended in degassed
PBS and the DTT mix was added. After a 5-min treatment, cells were pelleted and
immediately fixed with 4% paraformaldehyde for 15 mins. Cells were washed and
resuspended in 10 µL of degassed PBS for flow cytometry measurements. For bacteria
treated with DAB-10, M. smegmatis was incubated with DAB-10 at its MIC and 2X MIC in
Middlebrook 7H9 at 37°C for 1 hour. Afterwards, the cells were washed and fixed with 4%
paraformaldehyde for 15 mins and analysed using a BD FACSCalibur flow cytometer.
The fluorescence of 100,000 cells were measured and the data analyzed using FlowJo
v.10. The fluorescence intensity values at 405 nm and 488 nm was obtained and the ratio
converted to EMSH values using the previously generated Calibration Curves. Data
shown represent Mean ± SEM obtained from three independent trials done in duplicates.
TUNEL Assay. M. smegmatis mc2155 was treated with DAB-10 at the indicated
concentration in the presence or absence of 100 µM tetrathiomolybdate (TTM) for 1 hour
at 37°C. Following treatment, cells were prepared for TUNEL labeling according to a
procedure described in Chapter 5. The cells were then analyzed using a BD FACSCalibur
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flow cytometer to which fluorescence of 100,000 cells were measured and data were
analyzed using FlowJo v.10. The events were gated first for propidium iodide (PI)
fluorescence to differentiate the cells from debris and then gated for green fluorescence
to select for TUNEL positive cells. Total TUNEL (+) cells were divided with the total
number of PI (+) cells to determine % TUNEL (+) cells. Bars represent data obtained from
two independent trials done in triplicates.
Generation of M. smegmatis Transposon Mutant Library. A two-day old, 200 mL
M. smegmatis culture was pelleted and washed twice with 20 mL of 7H9 base medium
(no supplements, no Tween 80). Then the cells were resuspended in 10 mL of 7H9 base
medium. A 1 mL aliquot of MycoMar phage was added and the suspension was mixed
gently by inversion. Infection was allowed to proceed for 90 mins at 37°C without shaking.
The cells were then pelleted at 4000g for 10 mins at 37°C and resuspended in 10 mL of
7H9 base medium. The suspension was triturated to minimize cell clumps. A 1 mL aliquot
of the transposon mutant library was then plated onto large 7H11 plates containing 20
µg/mL of Kanamycin and either 2.5 µM, or 5 µM of DAB-6 or 1.25 µM, or 2.5 µM of DAB10. The plates were incubated at 37°C until visible colonies appeared.
Transposon Mutant Library Screening, Rescue Cloning and ROS Susceptibility
Testing. The transposon mutants isolated were expected to be resistant to DAB-10. This
resistance was confirmed in liquid culture by performing a microdilution broth assay
similar to the one described above. Three truly resistant mutants were isolated and
propagated. The genomic DNA of the resistant clones (including that of the WT) were
extracted and digested with BamH1 overnight and then treated with T4 DNA ligase to
circularize the DNA fragments. The DNA was then transformed into chemically competent
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E. coli Pir cells and plated onto LB agar plates containing 50 µg/mL Kanamycin. The
resulting colonies were isolated and propagated in LB medium containing Kanamycin.
The rescued plasmid from the transformants were extracted and sequenced using
primers that recognized the transposon termini to determine the insertion site. The
sequencing was supplemented with genotyping PCR using primers recognizing the
termini of the WT gene to validate site of transposon insertion. The ROS susceptibility of
the transposon mutants were tested using known superoxide and hydroxyl radical
generating agents. Mutants were treated with 5 mM Menadione, 1 mM cumene
hydroperoxide or 1 mM tert-butyl hydroperoxide for 1 hr at 37°C. Ten-fold serial dilutions
were plated onto 7H11 agar plates and incubated at 37°C overnight. Colonies were
enumerated manually and converted to CFU/mL. Bars represent data obtained from two
independent trials done in duplicates.
Macrophage Cell Culture. RAW264.7 cells were grown in 10% FBS in DMEM with
200 U/mL each of Penicillin and Streptomycin. THP-1 cells were cultured in RPMI-1640
with 10% FBS, 200 U/mL each of Penicillin and Streptomycin, and 0.05 mM 2mercaptoethanol. THP-1 cells were differentiated prior to infection by addition of phorbol
12-myristate 13-acetate (PMA) to a final concentration of 40 ng/mL and incubation for 72
hours. Cells were grown in a 37°C incubator with 5% CO2.
Laser Confocal Microscopy. 30,000 RAW264.7 cells were seeded into each well
of a chambered cover glass and allowed to adhere overnight. For peptidomimetic
localization; 1, 2, 4, and 8 µM of tetramethylrhodamine-labeled DAB-10 (TMR-DAB-10)
was added to each well and peptide labeling was allowed to proceed for 30 mins at 37°C.
For endocytosis inhibitor experiments, cells were pre-treated with either 50 µM Amiloride
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or 80 µM Dynasore (both inhibitors were from stock solutions in DMSO and final DMSO
concentration was <0.5%) for 1 hr. The cells were then washed once with growth medium
and replaced with fresh media containing the inhibitors and desired concentration of DAB10. For co-localization experiments, M. smegmatis constitutively expressing GFP were
grown in Middlebrook 7H9 + 10% ADC with 50 µg/mL Kanamycin was washed twice with
PBS, and resuspended in 10% FBS in DMEM. The bacteria were quantified via OD600
measurements. The RAW264.7 cells were then infected (MOI 1:100) for 1 hr, washed
exhaustively with PBS and fresh growth medium was added. Infected cells were then
treated with TMR-DAB-10 for 30 mins and then washed and replenished with fresh media.
For copper co-localization studies, cells were simultaneously treated with 1 µM CS-1 and
4 µM TMR-DAB-10 for 30 mins. Whenever activated RAW264.7 cells were used, 100
ng/mL of Lipopolysaccharide (LPS) from E. coli was added 24 hours prior to cell staining.
Cellular organelles were labeled with MitoTracker Deep Red and/or LysoTracker based
on the manufacturer’s instructions. Samples were analyzed using a Nikon A1R Laser
Confocal Microscope using the appropriate filter sets.
Quantification of DAB-10 Uptake by Macrophages. 50,000 RAW264.7 cells were
seeded into 24-well polystyrene plates and allowed to adhere overnight. TMR-DAB-10 or
fluorescein-labeled DAB-10 (FL-DAB-10) was added at the indicated concentration and
allowed to incubate for 30 mins at 37°C. After incubation, cells were washed exhaustively
and lysed with 200 µL RIPA lysis buffer. The fluorescence of the lysate was measured
using a Molecular Devices FlexStation 3 microplate reader via a top-read mode. The
absolute quantity of fluorescent peptide in the lysate was established by using a
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calibration curve generated from peptide standards dissolved in the lysis buffer. Data
represent Mean ± SEM obtained from three independent trials done in duplicates.
Isothermal Titration Calorimetry. Binding constants were measured on a TA
instruments NanoITC calorimeter with the peptidomimetic being titrated into a solution of
Cu2+ at 25°C. Solutions used were 2 mM DAB-10 (in the ITC syringe) and 400 µM
Cu(NO3)2 (in the ITC cell) both in 20 mM MES buffer at pH 6.40. Blank titrations were run
to determine heats of dilution. Data were analyzed using TA Instruments NanoAnalyze
software and represent values obtained from three independent titrations.
Mammalian Cell Viability. 10,000 RAW264.7 or THP-1 cells were seeded and
differentiated (for the case of THP-1 cells) in 96-well polypropylene plates. 100 µL of
media containing 2-fold serial dilutions of the test agent was added to each well and the
cells were incubated for 24 hrs at 37°C. Then, the cells were washed with PBS twice and
replaced with fresh media containing 5 mg/mL of MTT. The color was allowed to develop
for 4 hrs in the incubator afterwhich, the cells were washed with PBS twice. 200 µL of
DMSO was then added to each well to lyse the cells and quantify degree of MTT
oxidation. The absorbance of each well at 595 nm was recorded and used to calculated
% cell viability. Data shows Mean ± SEM obtained from three independent trials done in
duplicates.
Activity against Intracellular Mycobacteria. (Experiment performed by Dr. Gopinath
Krishnamoorthy, Dr. Peggy Kaiser, and Dr. Stefan H.E. Kaufmann, Max Planck Institute
for Infection Biology) 50,000 THP-1 cells were seeded into 24-well plates and PMAdifferentiated for 72 hrs. M. tuberculosis H37Rv was grown until exponential phase and
was used to infect fully differentiated THP-1 cells at an MOI of 1:5. The infection was
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allowed to proceed for 4 hours after which the macrophages were washed with PBS
exhaustively. Then fresh medium was replaced into the cell containing either 80 µM of
DAB-6 or 20 µM of DAB-10 in the presence or absence of 100 µM of either
bathobuproinedisulfonate (BCS) or TTM. The cells were incubated for 24 and 48 hours
after which macrophages were lysed and the lysate serially diluted and plated in 7H11
agar plates. The plates were incubated for four weeks and colonies were enumerated
manually. Data shows values obtained from two trials done in duplicates.
Statistical Analysis. Data were plotted and analyzed for statistical differences using
GraphPad Prism 7.0. One-way or Two-way ANOVA was used to determine statistical
significance which was set at P<0.05.
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Chapter 7

Concluding Remarks
The Bigger Picture, Outstanding Questions, and What Lies Ahead

“The task is…not so much to see what no one has yet seen; but to think what nobody
has yet thought, about that which everybody sees.”
– Erwin Schrödinger
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Looking Back and Connecting the Dots
The host immune system employs a plethora of antimicrobial factors that act in
concert either amongst themselves or with other chemical components present to
eradicate invading microbes. The competition for essential metal micronutrients between
microbes and host-derived factors represent a long-standing battle in the host-pathogen
interface.1, 2 While several intervention strategies involving metal ions at sites of infection
are currently being explored, most, if not all focus on interfering or overriding the bacterial
metal acquisition mechanisms.3-6 Unlike iron, zinc, and manganese that are depleted
during microbial challenge, copper is deliberately trafficked into regions containing
bacteria.7,

8

While it may be advantageous to boost the copper concentration during

infection due to its inherent antimicrobial properties, bacteria have developed clever ways
to evade the toxic effects of copper. Be that as it may, spending cellular currency to
redistribute copper during infection must be auspicious, otherwise, evolution would have
selected against it.
To address this conundrum, we looked at what else is present in the site of
infection: cells, proteins, etc. Professional phagocytes flood the region containing
bacteria. These cells contain or secrete several antimicrobial effectors which include hostdefense peptides (some of which are known to bind metals) and reactive intermediates.
We postulated that copper exhibits a dynamic interplay with the subset of HDPs that
contain an ATCUN motif to elicit synergistic effects. That way, copper can exert direct
bactericidal effects that circumvent bacterial resistance mechanisms. We set out to study
the subset of HDPs that contain an ATCUN motif and asked the question: how is copper
binding beneficial to the bioactivity of these peptides? More importantly, we wondered
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how copper-mediated bacterial targeting is leveraged or exploited by other antimicrobial
effectors. Finally, in an effort to contribute to the development of novel intervention
strategies against resistant strains of bacteria, we also wondered whether the ATCUN
motif can be used to improve the potency of other peptides.
The results described in this dissertation span four aspects that when taken
together allow us to define the biological significance and advantage of the ATCUN motif.
First, the ATCUN motif is necessary for the oxidative mechanism of naturally
occurring AMPs. We demonstrated in Chapter 2 that whereas a His-to-Ala substitution or
an ATCUN deletion generated derivatives that were equally as potent, those mutants lack
the oxidative capability of the WT peptide. This suggests that the inherent oxidative
capacity of the resulting Cu-ATCUN complex is used by these AMPs to effect oxidative
stress into their targets. Biomolecular oxidation is largely dictated by the affinity of these
peptides toward different structures in bacteria. For instance, ixosin has a great affinity
towards the bacterial membrane and thus can cause membrane lipid peroxidation and
piscidin 3 binds nucleotides and can therefore oxidatively cleave DNA. Ultimately, what
this implies is that ATCUN-containing AMPs and HDPs can covalently damage their
targets, instead of just relying on electrostatic and steric contributions. Covalently
damaging the target generates new functionalities that either has to be degraded and
recycled, or can be toxic on its own.
Second, we observed direct target oxidation in Chapters 2 and 3 without preloading the peptides with copper. Because oxidative capacity is a phenotype expected
only if the peptides are metallated, these observations suggest a competitive ability of the
ATCUN-containing peptides to scavenge copper ions and utilize it for their oxidative
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mechanism. Copper can come from extracellular sources or from the endogenous pool
of labile copper inside bacteria. Together with the fact that the ATCUN motif has a high
affinity towards copper ions, it doesn’t seem surprising that these peptides actually
sequester copper. In chapter 3, we dissected where the copper can come from, and found
that both extracellular and intracellular copper reserves can supply piscidins with copper.
Moreover, because a significant level of oxidation was observed, it seemed like the soup
of chemical effectors in the cellular milieu is sufficient in promoting the redox cycling to
the metal center. This generates a catalytic oxidant that is likely the major driving force
for bacterial death.
Third, copper-binding and the subsequent target oxidation paves the way for
synergistic interactions between homologous and/or co-expressed peptides to occur. In
chapter 2 we showed that the oxidized phospholipids generated by Cu-Ixosin-mediated
membrane oxidation is a target for ixosin B. This phospholipid targeting by ixosin B likely
involves imine group formation between the amine groups of the peptide and the carbonyl
groups of the oxidized lipids, effectively anchoring the peptide into the membrane.
Therefore, in the presence of ixosin, a smaller amount of ixosin B is required for bacterial
killing. In chapter 3, we discussed how the homologous peptides p1 and p3, who both
have considerable yet contrasting activity towards the bacterial membrane and DNA
exhibit synergistic interactions with each other in the absence of a robust DNA repair
pathway. More importantly, their synergy is likely more relevant in terms of their functional
complementarity. Taken together, these results suggest that ATCUN-containing peptides
sensitize bacteria toward the effects of other AMPs, leading to a cooperative interaction.
This represents a case where expression of ATCUN-AMPs may be selected for because
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it offers a pathway not only for direct protection against microbes but also for boosting the
activity of other effectors in situ.
Finally, the redox cycling is a function of the ATCUN moiety alone and is therefore
a transferrable trait. In Chapters 4, 5, and 6, we were able to integrate the oxidative
capability of the ATCUN motif to peptides that normally would not have it. While the
tripeptide alone is not a sufficient antimicrobial, exogenously adding this sequence to
other AMPs affords the latter a secondary mode of attack resulting in a gain-of-function
phenotype. We were able to observe a similar nucleotide or membrane targeting in the
conjugates. More importantly, we developed an in situ activatable peptidomimetic which
can exploit the transition metal trafficking in macrophages to target intracellular M.
tuberculosis. Apart from its oxidative capabilities, the small size of the ATCUN motif lends
itself amenable for bioconjugations – one gets an entirely new mode of attack from these
peptides at the small expense of adding three extra amino acids. The pharmaceutical
industry is dominated by molecules that target one specific protein or pathway in the cell,
with the hope of minimizing side-effects arising from off-target toxicity. However, this
seems to ignore the question of what happens when mutations in these proteins or
pathways occur? Resistance mechanisms oftentimes abolishes target recognition step,
effectively rendering antibiotics ineffective. While combination therapy gets around this
problem, treating bacteria with two single-acting drugs which may have varying serum
half-lives leads to the slow emergence of multidrug resistant strains. One has to wonder
whether a new paradigm – one that is based on developing multiple modes of inhibition
by a single agent is more advantageous. After all, it seems to be the method of choice by
our immune systems.
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The Bigger Picture
The results presented in this dissertation shed light on the small and ubiquitous
ATCUN motif, a tripeptide sequence whose chemistry has long been established but
whose biology is largely unexplored. Although we initially set out to study a specific subset
of HDPs and AMPs, the results we obtained through the years lead us to paint a bigger
picture of the interface between bioinorganic chemistry and immunology – one which
expands the catalog of mechanisms by which AMPs and HDPs utilize metal ions for their
activity. The underlying theme to every chapter in this dissertation is the demonstration
of copper-binding and oxidative damage by ATCUN-containing peptides. Our data show
that these peptides leverage the chemical reactivity of the Cu-ATCUN complex in their
biological activity. Therefore, it is clear that HDPs – apart from sequestering metal ions
from bacteria or using metals as structural scaffolds – also utilize transition metals as
direct chemical co-factors. This suggests that copper trafficking into sites of infection likely
is advantageous because it generates a pool of exchangeable copper for some of these
HDPs to exploit. We show here that ATCUN-containing peptides likely utilize a
generalized mechanism of attack – one that directly generates oxidative stress in their
target. Moreover, since ATCUN-AMPs have been isolated from diverse sources, it
represents a common defense mechanism by seemingly unrelated organisms.

Which Questions Remain Unanswered?
While most of the AMPs studied in this dissertation come from non-mammalian
sources, there are a number of human HDPs that contain the ATCUN motif and can
therefore utilize a similar mechanism of attack. First, the histatin family of salivary AMPs
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consists of three ribosomally-synthesized parent peptides and nine proteolytic
degradation products, all of which have antifungal activity.9, 10 Of this 12-member family,
eight of which contain the ATCUN motif.9 One has to wonder why there is a need for such
a large number of antifungal peptides in a region where bacterial invaders pose a greater
threat. Moreover, histatins have always been screened for antibacterial activity alone and
never in combination with other members of their family. It is therefore a likely possibility
that the narrow-spectrum activity reported doesn’t take into consideration the possibility
that histatins act in concert when they target bacteria. From their narrow-spectrum activity
and the sheer number of members in this family, it seems reasonable to question whether
these peptides exhibit synergistic interactions among them.11
Further support to the notion of ATCUN-AMPs boosting the antimicrobial effects
of other peptides in its family have been alluded to by reports published a decade ago.
For instance, antimicrobial peptide expression in Drosophila is differentially induced by
specific microbes. Infection with Gram-negative bacteria induces expression of
metchnikowin, diptericin, cecropin A, and drosocin; whereas Gram-positive infections
leads to expression of metchnikowin and drosomycin. Fungal infections cause
metchnikowin, diptericin, attacin, and drosomycin to be expressed.12 From these
expression profiles, one can see that regardless of the pathogen, the AMP metchnikowin
is always expressed. Metchnikowin contains His-Arg-His (HRH) in its N-terminal, and
does not exhibit any antimicrobial activity up to 512 µM (data not included in this
dissertation). Because of the ATCUN-mediated synergy between Ixosin and Ixosin B
(which were isolated from insects as well) presented in Chapter 2, it seems logical to
propose that metchnikowin might be acting as an adjuvant AMP to other AMPs in
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Drosophila eliciting synergistic interactions from other AMPs which are differentially
induced. This is likely because the ROS formed by the ATCUN motif is non-specific and
can therefore be used to sensitize any microbe to the attack of other AMPs.
Some peptides that exists within mammalian (phagocytic) cells also contain the
ATCUN motif. In particular, ubiquicidin, an AMP derived from proteolytic degradation of
ubiquitin contains a Lys-Phe-His (KFH) in its N-terminal.13, 14 Given the abundance of
copper ions in the Mycobacteria-containing phagosome and the trafficking of ubiquitin
derived fragments into the phagosome, one has to wonder whether there is involvement
by the ATCUN motif in the killing of Mtb. Indeed, the ubiquitin pathway has been shown
to play a role in the mycobactericidal activity of activated macrophages.15, 16 Moreover,
hepcidin, an ATCUN-AMP that partakes in iron homeostasis also plays a role in
mycobacterial eradication in macrophages.17
Indeed, even though the peptides studied here are not derived from humans, the
fact that copper-binding and oxidative capacity is less-sequence independent than it is
donor-atom-dependent, suggests that human-derived ATCUN-HDPs can also deliver a
mode of attack similar to the ones described in this dissertation. That is, the properties
that make the Cu-ATCUN complex antimicrobial is the three-dimensional arrangement of
nitrogen atoms around the copper center that are able to support the metal’s trivalent
state. Therefore, it seems reasonable to posit that all ATCUN-AMPs likely have an
oxidative mode of attack.

The Future of Metalloimmunology
While this dissertation focused on how host-derived AMPs utilize copper for their
activity, differential trafficking during infection is not unique to copper. For instance, two
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paradigms exist for zinc in the host-pathogen interface – sequestration and intoxication.18
We know which antimicrobial effectors are involved in each mechanism, but the reason
why contrasting zinc regulation exist during infection is not clear. The Zn2+ ion, owing to
its small size and high-position in the Irving-Williams series can also effect metal co-factor
replacement. However, the ion is redox-silent unlike Fe2+ and Cu+. Considering its inability
to form ROS, the question of what other toxic effects does Zn2+ have remains
unanswered.
The concept of nutritional immunity dictates that metals are sequestered away
from pathogens to inhibit their growth. However, what happens after the bacteria dies?
Do the metals get recycled? If so, what mechanisms exists to remove the metal out of the
high-affinity S100 proteins?19 Moreover, does the host leverage the sudden surge in
extracellular metals to recruit other immune effectors given the emerging role of transition
metals in cell signaling?
Finally, a model of the immune response that focuses on late first-row transition
metals biases against their lighter congeners, which are also abundant in other
organisms. In particular, Vanadium is highly enriched in tunicate hemocytes, immune
cells that also express AMPs.20-22 Does V have a role in the immune system of
invertebrates? If so, how is the metal utilized? These questions, among many others,
promise to make keep the field of metalloimmunology dynamic. Answering these
questions will bring us one step closer to an understanding of the metallobiology of the
immune system, and help us build a detailed narrative of its bactericidal activity.
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Chapter 8

Appendices
Supplementary Figures and Tables

“Simple ingredients can be used to make elegant dishes with just a little
extra attention to detail.”
– Marcus Samuelsson
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Figure S2.1. Cytotoxicity of Peptides under study. MTT Assay was used to determine
extent of Mammalian cell toxicity of peptides. IC50 could not be determined with
confidence since at the concentration range used for the experiment, complete inhibition
and complete growth was not seen.
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Figure S2.2. Helical Wheel Projection and CD Specta of Ixosin in TFE. (A) Helical
wheel diagram of ixosin WT and Ixosin-pch using the Eisenberg consensus
hydrophobicity scale. (B) The CD spectra of the peptides were obtained in 50% TFE in
sodium phosphate buffer. Ixosin glh refers to a derivative (not included in main text)
containing D-Leu, and D-His.
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Figure S2.3. Mass Spectra of Ixosin copper complexes. (A) ESI-MS unreconstrcuted
Spectra of Ixosin and its copper complex showing multiply charged species +3 through
+6. (B-C) Unreconstructed ESI-MS Spectra of Cu-Ixosin focusing on the +3 and +4
charged states. Insets show peaks for the corresponding Cu-Ixosin zoomed in and
stretched out to highlight similarity of actual peaks with simulated peaks. (D) Simulated
isotopic distribution pattern for the +5 and +6 charged states for Cu-Ixosin showing that
peaks converge into one broad peak making it difficult to resolve given the resolution of
the mass spectrometer used.
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Figure S2.4. Mass Spectra of Ixosin-H3A with and without Cu2+. (A) Ixosin-H3A and
(B) Ixosin-H3A pre-incubated with Cu2+ were injected in an ESI-MS. Both spectra show
that No apparent 1:1 copper complex is formed, suggesting the H3A mutation effectively
abolishes Cu2+ binding.
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Figure S2.5. Localization of Ixosin WT with respect to DNA. Laser Confocal
Micrograph of Ixosin WT (green channel) and DNA (false colored red to enhance
contrast). Ixosin WT accumulate in the bacterial membrane. E. coli cell in the middle is
filamentous probably showing a defect in cell division most likely a downstream effect of
Ixosin WT treatment.
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Figure S2.6. Time-Kill Curves of D-amino acid containing derivates. Dynamics of
bacterial growth inhibition caused by Ixosin-glh and Ixosin-pch-glh (containing D-Leu and
D-His instead of the L-stereoisomer).

231

Figure S2.7. Bacterial Survival on media depleted of O2 or Cu2+. Colonies survival
after treatment with Ixosin and derivatives in oxygen- and copper-starved conditions.
Each colony was counted and done over three trials. For TETA and PenNH2 treatment,
10-3 dilution was used for Control whereas 10-2 dilution was used for treated cells.
Numbers shown below each plate image corresponds to Bacterial Titer in CFU/mL
obtained from the specific trial shown (which may or may not represent the average).
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Figure S2.8. Lipid Peroxidation of Ixosin and Derivatives. (A) Analytical HPLC traces
of MDA external standards used to quantify thiobarbituric acid reactive substances
(TBARS). (B) Calibration Curve for lipid peroxidation experiments. Peak Height from
HPLC was used to quantify TBARS. (C) HPLC traces of TBARS obtained from Ixosintreated cells.

Figure S2.9. Size distribution of native and oxidized LUVs. Dynamic Light Scattering
of native and oxidized LUVs showing no significant change in diameter is observed upon
lipid oxidation. Cu-Ix A oxLUV = native LUVs pre-oxidized using copper complex of Ixosin
A before using in quenching experiments.
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Figure S2.10. Complete assignments of 1H-15N Correlations in Ixosin. H-N
correlations and crosspeak assignment of Ixosin WT. 23X refers to Arg-23. Spectra was
collected in 20 mM acetate buffer pH 7.4 with 7% D2O using a 600 MHz Varian
Spectrometer.
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Figure S3.1. Atomic Resolution of Piscidin-DNA Interaction. Molecular Dynamics simulations
reveal Arg14 in p3 forms two hydrogen bonds with the phosphate backbone of the DNA whereas
Lys14 forms only one.

Figure S3.2. in vitro DNA Cleavage Promoted by Cu-p1 and Cu-p3. Agarose Gel
Electrophoresis was used to monitor time-dependent cleavage of the plasmid pUC19 in response
to ROS formation by Cu-p1 or Cu-p3. Loss of the supercoiled form is accompanied by a
concomitant increase in the nicked and linearized form.
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Figure S3.3. TUNEL Assay Tetrathiomolybdate Control. In cella DNA damage promoted by
piscidin was studied using the TUNEL Assay (Terminal deoxynucleotidyl transferease (TdT)mediated dUTP Nicked End Labeling). Figure above shows that addition of tetrathiomolybdate
(TTM) to the bacteria had negligible effect in the TUNEL fluorescence, indicating that observed
decrease in TUNEL (+) cells upon cotreatment with piscidin and TTM is a result of decreased
copper bioavailability.

Figure S3.4. Cyclic Voltammetry of Piscidin Copper Complexes. To ensure no free Cu2+ was
left in solution, we mixed piscidin and Cu2+ in a 1.1:1.0 molar ratio. Our voltammogram showed a
cathodic peak current (~100 µA) at potentials (vs an Ag/AgCl reference electrode) of 0.796 V (for
Cu-p1) and 0.778 V (for Cu-p3) characteristic of a Cu3+/2+ couple.
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Figure S3.5. ESI-MS Spectra of Copper-Piscidin Complexes. Cu2+ and piscidin were mixed in
a 1:1.2 molar ratio and subsequently injected to an electrospray ionization MS. Peaks
corresponding to a 1:1 stoichiometry of binding appear in the mass spectra. Peaks at m/z 499.8,
624.5, and 832.5 in the bottom panel corresponds to the +5, +4, and +3 charged states of nonmetallated p3.
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Figure S3.6. Piscidin-Induced Lipid Peroxidation. Calibration peaks of lipid peroxidationderived products via RP-HPLC using the external standard tetraethoxypropane. The product
malonyldialdehyde (MDA) was detected at 512 nm. The peak heights were used to generate a
calibration equation for the analysis of piscidin-treated bacteria.

Figure S4.1. Localization of labeled ATCUN-AMPs. Fluorescence images of live E.coli
cells exposed to 5(6)-carboxyfluorescein-labeled Anoplin (4 μM), VIH-Anoplin (0.5 μM),
PAP (0.25 μM), VIH-PAP (0.06 μM), sh-Buforin (8 μM) and VIH-sh-Buforin (2 μM) for 60
min.
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Figure S5.1. Circular Dichroism Spectra of sh-Buforin and ATCUN-sh-Buforin
conjugates showing characteristic alpha helical curves. Addition of ATCUN motif and
Cu2+ do not induce a significant change in helical content.
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Figure S5.2. Scatter plots obtained from flow cytometry experiments. Data reveal no
significant morphological changes in the cells when treated with all the synthesized
peptides.
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Figure S5.3. Kinetic curves of pUC19 cleavage. The exponential decrease in the amount of
supercoiled pUC19 when incubated with CuII-ATCUN-sh-Buforin is due to oxidative DNA
cleavage. The black curve is the same for both graphs.
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Figure S5.4. Concentration-dependence of RBS Hemolysis. A hyperbolic relationship exists
between RBC hemolysis and L-sh-Buforin concentration. The equation of the best-fit line was
used to calculate HD5, which is defined, as concentration causing hemolysis of 5% of RBCs.

Figure S5.6. Proteolytic Stability of tested peptides. Equal volumes of 256 uM purified
peptides (in PBS) and 0.2 ug of trypsin were mixed in a sterile microcentrifuge tube. At each time
point, a 10 uL aliquot was withdrawn and the reaction was stopped using 10 uL of 20% TFA. A
15 uL aliquot was then injected in an analytical C18 HPLC column. The products of degradation
were monitored at 214 nm, and relative concentrations were obtained from peak areas arising
from respective chromatograms.
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Figure S5.7. ESI-MS Spectrum of a 1.0:0.8 mixture of Cu2+ and ATCUN-sh-Buforin.
We observed a 1:1 stoichiometry of binding evidenced by the doubly and triply charged
species.
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Figure S5.8. Cytotoxicity of synthesized peptide was assessed using the MTT
Assay. Cells treated with the peptide were incubated for 24 hours and viability was
determined by quantification of the insoluble formazan product. All tested peptides
exhibited minimal cytotoxicity even at the highest tested concentration, 128 uM.
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Figure S6.1. Real-Time Measurement of Oxidative Stress in Msm. (A) top, schematic
representation of changes occurring in the Mrx1-roGFP2 sensor as a result of oxidation
by intracellular ROS; bottom, Nernst Equation used to convert concentrations of oxidized
and reduced forms of DTT to EMSH values. (B) Calibration curve for EMSH
determinations. Msm were treated with varying ratios of DTTred and DTToxd
corresponding to calculated EMSH values (in mV) using the Nernst equation. These
EMSH values were plotted against 405/488 fluorescence ratios obtained from flow
cytometry. Plot represents data obtained from three independent experiments and shown
as Mean ± SEM.
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Figure S6.2. STRING Analysis for Functional Associations of Interrupted Genes Identified
from Msm Tn Screen. Top, the network of functional associations predicted for MSMEG_6091
(clpC) and MSMEG_4041. Nodes of the network represent proteins; colored nodes are proteins
within the first shell of interaction whereas white nodes are within secondary shell of interactions;
large nodes mean that some 3D structure is known or predicted. Green lines indicate gene
neighborhood, red line for gene fusions, blue lines for gene co-occurrence, black lines for coexpression, and purple lines for protein homology. Bottom, names of proteins to whom
MSMEG_6091 and MSMEG_4041 form functional associations with. STRING scores closer to
1.0 mean a better quality prediction.
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Figure S6.3. DAB-10 Intracellular Localization. 1 µM of DAB-10-TMR was incubated with
RAW264.7 cells for 1 hr at 37°C and localization was followed using laser confocal microscopy.
Localization observed here is similar to localization when 4 µM of DAB-10-TMR was used. Image
is a composite of the red, blue and DIC channels. Scale bar = 5 µm.

Figure S6.4. Co-localization of Msm and DAB-10 with Lysosomes. RAW264.7 cells were
infected with Msm (MOI 1:100) for 2 hours and extracellular Msm were washed away with PBS.
The macrophages were then incubated with media containing DAB-10 and LysoTracker for 30
mins in the dark. The cells were washed and fresh media was added. The peptidomimetic,
bacteria and lysosomes were tracked using confocal microscopy. Results show that DAB-10 colocalization with bacteria occurs prior to fusion with lysosomes. Scale bars = 5 µm.
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Figure S6.5. Synthesis of the Fluorescent Copper Probe, CS-1. Chemical structure
of CS-1 is shown. 1H NMR (top) and 13C NMR (bottom) spectra of synthesized CS-1.
All peaks are accounted for based on literature procedure.
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Figure S6.6. Probing the in vitro Copper binding of DAB-10-FL derivatives. The same
experimental conditions as in Fig S9 was used but with excitation wavelength set at 495 nm.
Quenching of fluorescein (FL) fluorescence in the K4 and not in the K20 derivative suggests direct
copper binding to the ATCUN motif. Both S9 and S10 shows that emission suppression
phenotype is independent of the identity of the fluorophore and is only a function of its position
relative to the copper-binding site.
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Figure S6.7. Probing Intracellular Copper Binding of DAB-10. (A) Analytical
quantification of DAB-10-FL uptake in RAW264.7 cells. Results show that across all
concentrations (from 4 – 32 µM) both DAB-10-K4(FL) and DAB-10-K20(TMR) was taken
up to the same extent. Comparison with Fig 4C (in the main text) shows a lower uptake
of fluorescein-labeled DAB-10 relative to rhodamine-labeled version. Data represent
Mean ± SEM (n = 3 duplicates) (B) Fluorescence quenching phenotype similar to that
observed in vitro (Fig S6.6) for DAB-10-K4(FL) but not for DAB-10-K20(FL) upon
incubation with LPS-activated RAW264.7 cells suggests that DAB-10 directly binds to
copper within the cell. The fluorescence of the K4 derivative was rescued via addition of
the high affinity copper chelator, TTM; suggesting that lower fluorescence was not a result
of impaired peptidomimetic uptake. Scale bar = 5 µm.
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Figure S6.8. Activity of DAB-10 against Intracellular Mtb. Differentiated THP-1 cells were
infected with Mtb (MOI 1:5) for 1 hour and extracellular bacteria were washed off via extensive
PBS rinsing. DAB-6 (80 µM) and DAB-10 (20 µM) was added to the cells in the presence or
absence of 100 µM BCS (cell impermeable) or TTM (cell permeable). Peptidomimetic treatment
was allowed to proceed for 24 hour prior to CFU enumeration. Data represent Mean ± SEM (n =
3 duplicates).

Figure S6.9. Cytotoxicity of Copper Chelators towards Macrophages. Differentiated THP-1
cells were incubated with the indicated concentration of tetrathiomolybdate (TTM) or
bathocuproinedisulfonate (BCS) for 24 hrs. Cellular viability was determined using the MTT assay.

251

Table S2.1. Sequence and physicochemical properties of the designed peptides.
Peptide Name

Sequence

<H>a

<μH>b

ixosin

GLHKVMREVLGYERNSYKKFFLR

0.282

0.382

ixosin4-23

GLHKVMREVLGYERNSYKKFFLR

0.232

0.36

ixosin-H3A

GLAKVMREVLGYERNSYKKFFLR

0.290

0.383

ixosin1-12

GLHKVMREVLGYERNSYKKFFLR

0.460

0.573

ixosin12-23

GLHKVMREVLGYERNSYKKFFLR

0.160

0.199

ixosin1-18

GLHKVMREVLGYERNSYKKFFLR

0.178

0.478

ixosin4-18

GLHKVMREVLGYERNSYKKFFLR

0.091

0.462

ixosin7-18

GLHKVMREVLGYERNSYKKFFLR

-0.008

0.370

GLHKVMRKVLGYLRNVYK

0.358

0.664

GLAKVMRKVLGYLRNVYK

0.368

0.663

GLHKVMRKVLGYLRNVYK

0.308

0.685

ixosin1-18 E8K, E13L,
S16V / ixosin-pch
ixosin1-18 H3A, E8K, E13L,
S16V / ixosin-pch-H3A
ixosin4-18 E8K, E13L,
S16V / ixosin-pch4-18
a

Hydrophobicity and b Hydrophobic Moment were calculated using HeliQuest 2 (an online

resource tool available from www.expasy.org) using α-helix as conformation.

Table S2.2. Antimicrobial and cytotoxic activity of other peptides under study.
Minimum Inhibitory Concentration, μM
Bacterium

Peptide

Fungus

% Cell Viability
(@ MIC vs E. coli)

S.
aureus

E. coli

P.
aeruginosa

C.
albicans

HeLa

HEK293

ixosin1-12

>128

>128

>128

>128

73 ± 11

97 ± 10

ixosin12-23

>128

>128

>128

>128

72 ± 6

90 ± 5

ixosin1-18

>128

>128

>128

>128

87 ± 6

94 ± 10

ixosin4-18

>128

>128

>128

>128

97 ± 5

86 ± 14

ixosin7-18

>128

>128

>128

>128

85 ± 3

82 ± 14
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Table S5.1. MIC of synthesized peptides against Pre-logarithmic phase bacteria.

Peptide

Minimum Inhibitor Concentration, μM
E. coli MG1655 (WT) E. coli TD172 (ΔrecA)

L-sh-Buforin

64

32

L-RTH-L-sh-Buforin

32

16

L-VIH-L-sh-Buforin

64

32

D-RTH-L-sh-Buforin

32

16

D-VIH-L-sh-Buforin

64

16

D-sh-Buforin

8

4

L-RTH-D-sh-Buforin

2

1

L-VIH-D-sh-Buforin

2

1

D-RTH-D-sh-Buforin

2

2

D-VIH-D-sh-Buforin

2

1

Ampicillin

2

2

Kanamycin

0.125

0.125

Table S6.1. Activity of DAB-10 pre-incubated with Cu(II).
Minimum Inhibitory Concentrationa
(MIC), µM

Mycobacterial Species

a

DAB-10

Cu-DAB-10

M. smegmatis mc2155

0.125 – 0.25

0.25

M. bovis BCG (SSI 1331)

1–4

2–4

Results obtained from three independent trials done in duplicates.
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